











This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
• This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
• A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
• This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
• The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
• When referring to this work, full bibliographic details including the author, title, 





Next-generation bioinformatics analysis of 
bacterial genomes, with a focus on serovar 
















This thesis is presented for the degree of 
Doctor of Philosophy 




















I declare that the work described within this thesis and the thesis itself is solely mine 






















I want to thank the people who have supported me throughout; my supervisors, my 
friends and my family.  
 
The process of completing my PhD and writing my thesis has been a long and 
difficult one. I particularly want to thank my parents and my good friend Ksenia, 
they had faith in me even when things seemed so bleak and impossible. I don’t think 












Salmonella is one of the most important pathogens of mankind and animals alike, 
causing several billion pounds worth of damage worldwide each year. We have 
sequenced, annotated and published 4 genomes of Salmonella of well-defined 
virulence in farm animals. This provides valuable measures of intraserovar diversity 
and opportunities to formally link genotypes to phenotypes in target animals. 
Specifically, we have examined pathway detrition and mutagenesis and linked this to 
host specificity of the serovars.  
 
With the advent of next generation sequencing there has been a boom in genomic 
sequence submission, and an onslaught of -omics data has ensued. Integrating these 
different data types is complex and there is little available to visualise this data in the 
context of its genome. We present GeneBook, a web-based tool that synchronously 
integrates disparate datasets, displaying a fully annotated genome, enriched with 
publicly available data and the user's private experiments. It is accessed through a 
user-friendly interface that allows scientists to interrogate genomic features across 
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Plan/Aims & Objectives 
 To ask fundamental questions about host specificity and pathogenicity, focussing 
on the biology of Salmonella 
 To annotate novel genomes of recently sequenced Salmonella strains and submit 
to public databank. 
 To analyse currently available data for similarities and differences between 
serovars and elucidate genes associated with host specificity and pathogenicity. 
 To provide a flexible bioinformatics platform for the integration of a diverse 
range of data types available in pathogen biology 
 To develop a method of viewing genomes in the context of their disparate data 
sets which incorporates web services 
 To use the developed tool to interrogate both public and private data and 
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This chapter introduces the core concepts that form the basis of this thesis. Section 
1.1 describes the general biology of the Salmonella genus. It goes on to outline the 
proposed relationship between host specificity and pathogenicity. Section 1.2 
explains the current state of sequencing, introducing next generation sequencing 
(NGS) and some of its challenges. After sequencing, the genomes are annotated, 
section 1.4 describes generic bacterial genome annotation and some of the limitations 
of automated annotation. With the increase in bacterial genomics there is an increase 
in post-genomic data, 1.5 introduces some diverse types of bacterial data and 1.6 
explains how this is stored and presented to the public. It presents a critical review of 
the currently available databases, which store bacterial genomes and their post-
genomic data. Finally, section 1.7 looks at the types of web technologies available, it 
explains the principles of webservices and the various methods available.  
 
The background outlined in this section is designed to form the justification and basis 
of this thesis. Some parts of this chapter have been published previously in 







1.1 Salmonella Biology 
Pathogenic bacteria are of wide economic importance, causing thousands of deaths. 
In 2009 there were over 10,000 cases of human Salmonellosis in the UK [3], 
although it is estimated that only a quarter of cases are actually reported [4]. In 2000 
there were over approximately 21 million instances of Salmonellosis and more than 
200,000 deaths worldwide [5]. Although we see a decrease in human infection, the 
incidence in livestock such as Cattle and poultry has seen an increase (Figure 1). 
Controlling the incidence of Salmonella is complex because the trends in infection 
vary between serovars. Reducing the incidence of one type often results in another 
differentially adapted serovar filling the niche [6]. Initially antibiotic treatment was 
successful, but indiscriminate use has resulted in the manifestation of multiple drug 
resistant strains of Salmonellae [7]. These effects have fuelled research into the 
biology of Salmonellae in an effort to ultimately discover new drug targets and 
develop methods of disease treatment. 
 
Salmonellae as a genus are promiscuous, infecting a broad range of hosts [8]. The 
genus is comprised of two species; Salmonella bongori and Salmonella enterica. The 
most extensively studied species is S. enterica subsp. enterica because it is 
pathogenic to warm blooded animals [9]. The usual mode of infection is through oral 
ingestion of contaminated food or water [10] resulting in the host contracting 
salmonellosis. Their ability to cause food poisoning is due to Salmonella’s capability 
to colonise the alimentary tracts of livestock, ensuing contaminated carcasses and 
entry into the human food chain [11].  
 
Within livestock populations some individuals enter a carrier state after clearing an 
initial infection. They show no clinical signs but still carry and excrete Salmonella. 
into the environment [12], making it difficult to truly eradicate that incidence of 








Figure 1 Number of incident reports of Salmonella in livestock according to the VLA’s Salmonella in 







Host-pathogen interactions are complex, both party’s cells are engaged in the 
exchange of biochemical signals, resulting in changes to the host cell’s physiology to 
allow pinocytosis of the pathogen cells [14]. A major factor influencing the extremity 
and symptoms of salmonellosis is the specific serovar which has caused the infection 
[8]. Systemic infections, such as typhoid, caused by uptake into phagocytic cells can 
occasionally occur; this type of infection is more severe [15]. The reproductive tract 
can also be infected by Salmonella during the gestation and laying period of 
mammals and birds respectively. This form of infection is also systemic and can lead 
to abortion [16]. The other type of infection is caused by Salmonella invading gut 
epithelial cells, leading to gastroenteritis [16]. 
1.1.1 Characterising Salmonella 
Within the species S.enterica there are over 2,400 serovars. Each serovar is 
distinguishable by its serology, that is the variation of surface exposed antigens (O,H 
and Vi) [17]. Salmonella diversity doesn’t end at the serovar level [7, 18]. For 
example, Typhi strains vary in their drug resistance, number of plasmids, prophages 
and island structures [7]. The use of serology as a method of identification can only 
differentiate strains with a limited level of success. In 2004 Porwollik et al. used 
microarray analysis to reveal strains within the same serovar which differ by 
hundreds of absent/present genes [9, 19]. They proposed to group strains based on 
their gene profile, namely ‘genovars’. The fact that multiple genovars can appear in 
one serovar suggests that genes coding antigens and flagella are passed via horizontal 
gene transfer (HGT) [9]. 
 
There is an essential core gene set which all Salmonella share. Jacobsen et al. tried to 
define this along with the Salmonella pan genome by comparing 45 publically 
available Salmonella genomes (21 serotypes) [20]. They estimated that the core 
genome consisted of 2800 genes and that the pan genome had at least 10,000 genes 
[20]. 
 
Each serovar has a niche specific sub-gene pool, which can vary dramatically within 






the more recently diverged (e.g. Typhi) [21]. The homogeneity of serovars like Typhi 
can also be attributed to their restricted host range. A recent comparison of 19 strains 
of Typhi revealed scarce adaptive selection except in the gyrA gene which is 
associated with fluoroquinolone resistance [22]. 
1.1.2 Host Specificity 
The range of hosts that S.enterica subsp. enterica can infect is broad. Each serovar 
varies in its host range, specificity and pathogenicity. There are serovars which can 
infect many hosts, these are host ubiquitous (e.g. serovar Typhimurium). Some 
serovars can only infect a narrow selection of hosts, these are host-restricted (e.g. 
serovars Dublin and Choleraesius). Finally some serovars can only infect one host, 
these are host specific (e.g. serovars Typhi and Paratyphi A). The use of serovars to 
distinguish host specificity is not failsafe, there is evidence that some strains of the 
ubiquitous serovar Typhimurium have a very narrow host range [23]. 
 
In general terms the specificity of a strain is linked to its pathogenicity; host-
generalists tend to cause acute but self-limiting gastroenteritis with little systemic 
involvement in healthy outbred adults compared to host restricted strains that cause 
systemic disease [24]. Lawrence et al. outline the evolution from a broad host range 
to host-dependency (Figure 2, [25]). Unfortunately, livestock populations are not 
purely comprised of the model healthy outbred adults. For example, young animals 
are especially vulnerable to systemic infection, regardless of the accepted host 
specificity of the strain [12]. Also, latent carriers can show clinical signs again when 
under stress [12]. 
 
Comparative genomics has demonstrated that host-specialists evolved from host-
generalists. A comparison between the chicken restricted serovar Gallinarum and 
serovar Enteritidis has determined that Gallinarum is a recent descendent of 
Enteritidis. It is primarily through genome degradation that Gallinarum has become 
host restricted [26]. Comparisons between two different human specific serovars, 
namely serovar Typhi and serovar Paratyphi A revealed they are similar genetically 
[20, 24]. McClelland et al. in their 2004 study found that they not only shared 






pathway. Host specifist gene loss is often linked to motility or fimbriae formation 
[27], it is suggested that this degradation may augment the evasion of TLR-5-induced 
pro-inflammatory responses of the host [26]. 
 
Genome degradation is linked to pseudogene formation. Pseudogenes are formed by 
mutations, leading to either a frameshift or a stop codon for example. High levels of 
pseudogenes imply gene loss, possibly removing genes which are redundant since 
adhering to a host-specific niche [24]. Identifying pathogenesis-associated genes that 
are common between two highly degraded genomes indicates their importance in 
enteric disease and highlights potential target genes [24]. Loss of gene function can 
be beneficial on an economic level, where oral vaccines are developed from strains 
which lose their pathogenicity through the down-regulation of virulence genes [28]. 
It is worth noting that on occasion gene acquisition also plays a part in host-specific 
adaptation. The viaB locus is present in S. Typhi but not in S. Typhimurium it is 
believed to prevent detection of pathogen lipopolysaccharides by the TLR4-mediated 
host response [29]. 
 
The other driving force behind niche adaptation is HGT. This produces quantum 
leaps in evolution allowing exploitation of new niches and rapid adaptation to 
environmental pressures (such as host antibiotic use) [25]. It is estimated that over a 
quarter of the Typhimurium genome is from HGT [30].  
 
Genomic islands are products of HGT and many are associated with pathogenicity, 
namely Salmonella pathogenicity islands (SPIs). These can be identified by their low 
G+C content compared to the rest of the genome [31]. Salmonellae are able to 
manage HGT in the genome by selectively repressing transcription in areas with a 








Figure 2 shows the effects of horizontal gene transfer and gene loss on increased host dependency in 







1.2 Genome Sequencing 
With the arrival of ultra-high-throughput sequencing, we are in the midst of a 
revolution in comparative genomics. The success of this is partially dependant on 
suitable tools and analysis techniques [33]. Comparative genomics is a major aspect 
of pathogen studies. It is often used as a basis for lab based experiments, identifying 
candidate genes and giving a biological insight into niche adaptations. The number of 
fully sequenced genomes available in GenBank, the National Center for 
Biotechnology Information’s (NCBI) sequence repository, is soaring (Figure 3 [34]).  
 
Inevitably, with the proliferation of sequenced genomes, the post genomic revolution 
has ensued. This increase in information has resulted in the release of hundreds of 
new databases and datasets every year. For example, Nucleic Acids Research 
publishes a database edition every year, which records many of the biological 
databases that have been released that year. The 2009 edition is recorded as having 
over 1000 databases available [35]. Furthermore, Oxford University Press have 
recently announced a new journal entitled ‘Database: The Journal of Biological 
Databases and Curation’ [36]. The journal is dedicated solely to biological databases 
and “aims to help strengthen the bridge between database developers and users” [36]. 
The increase in database publications demonstrates the importance of data 
management and integration in modern biological research. 
 
Not only is there much repetition across these databases they also reside in many 
different locations. This makes it difficult for scientists to find all the information 
relevant to their research interests. When they do find it the fact that it is in multiple 
locations makes extracting anything useful an expansive task consisting of multiple 









Figure 3 showing the number of sequenced genomes submitted to GenBank between 1998 and February 
2012. The legend describes different kinds of genomes; Bacterial (blue, B), Archael (pink, A), Eukaryotic 
(yellow, E) and Metagenomic (cyan, M). [34] 
  







1.2.1 Advancements in Sequencing Technology 
In 1977 Frederick Sanger and his colleagues announced a new method for DNA 
sequencing, later called ‘Sanger Sequencing’ [37]. Recently we have seen a new 
generation of technologies that have strived to become faster and cheaper. In the past 
decade genome sequencing has become a lucrative business, and several new 
companies have emerged with their own sequencing technologies, collectively 
referred to as next generation sequencing (NGS). There are papers and reviews 
available [38-42], but these rapidly become out of date as the pace of change in DNA 
sequencing can be faster than the peer review process. Information for this section is 
taken from the above reviews, from personal communications with sequencing 
experts within ARK-Genomics, and from my own knowledge gained from reading 
blogs, forums, and papers and from attending conferences. Below is a review of the 
current platforms available, which have been summarised in Table 1. 
 
The revolution in DNA sequencing began in 2005 with 454 Life Sciences, bought by 
Roche in 2007. The 454 technology is a sequencing-by-synthesis technology 
whereby molecules of fragmented DNA are bound to beads which then undergo 
emulsion PCR. Each bead therefore represents multiple copies of a single strand of 
DNA. These beads are arranged in wells on plates, and single nucleotides are washed 
across the plate in sequence. As each nucleotide is incorporated, a fluorescent label, 
coloured according to base, binds to it preventing further amplification. A laser is 
projected across the wells and the fluorescence is captured by a camera. A chemical 
wash then releases the dye allowing the incorporation of the next base. Images are 
built up sequentially and when analysed, these images can be translated into the 
underlying sequence in each bead. The average read lengths on the Roche 454 FLX 
machine are approximately 400-500bp. A recent advance is the 454 FLX+ which 
produces reads of approximately 700bp. The number of reads obtained for both FLX 
and FLX+ is typically 1 million. 
Competing technologies came from Solexa, later bought by Illumina, and ABI’s 
SOLiD system. Both of these systems are also sequencing-by-synthesis, single 
strands of DNA are used as a template and the technology measures incorporation of 






technologies, producing reads around 35bp. Solexa’s technology is based around 
bridge amplification. Fragmented single-stranded DNA has adapters ligated, and is 
attached to a slide. Due to adapters attached to the slide, each single strand is able to 
form a loop between two adapters, and a second strand is built. The two strands then 
separate, the process is repeated, and in this way the original molecule is amplified 
many times. This process is called bridge amplification, and results in clusters of 
single stranded DNA. After cluster generation has occurred, the four bases are again 
washed across the slide, and the fluorescence is measured by a camera after each 
base is incorporated. The images produced by the camera can then be analysed to 
deduce the underlying sequence. The Solexa technology underwent huge advance 
after being bought by Illumina, with read lengths now up to 250bp on the MiSeq, and 
reads-per-lane up to 180 million on the HiSeq. 
 
The ABI SOLiD system measures DNA sequence in “colour space”. Similar to the 
454 technology, fragmented single stranded DNA is bound to beads and undergoes 
emulsion PCR such that each bead represents only one DNA molecule in multiple 
copies. Bases are then incorporated as dinucleotides with each dinucleotide being 
represented as one of four colours. The reaction then moves along one base of the 
template and is repeated. Thus each base in the template is measured twice, by two 
different dinucleotides/colours. Reads are provided not as bases but as a sequence of 
colours, which can be translated into “base space”. Reads are generally quite short, 
with a maximum of 75bp, and approximately 50 million reads per lane. 
 
Each of the three major companies also provide benchtop sequencers that allow rapid 
analysis of DNA samples. The Roche 454 Junior employs the same technology as the 
454 FLX system, so reads are on average 400bp and the junior produces about 
80,000 reads. The Illumina MiSeq employs the same technology as the Illumina 
HiSeq, but due to a smaller slide size and improved fluidics, longer read lengths are 








In 2010, ABI/LifeTech bought Ion Torrent, a small sequencing company created by 
Jonathon Rothberg, the inventor of 454. Ion Torrent’s technology is similar to that of 
454, except instead of measuring the release of light during the incorporation of 
bases, a semiconductor measures the release of Hydrogen ions. The Ion Torrent 
system is very quick in terms of sequencing, and can produce 200-400bp reads and 







Table 1 Summary of current next generation sequencing platforms. Where N is a general platform, B 
refers to the smaller benchtop machines and S are single molecule sequencing (SMS) platforms. 
Machine 
Type 
Read lengths Chambers/Lanes 
Reads per 
chamber/lane 
HiSeq 2500 traditional) N 35, 50, 75, 100 16 150-180,000,000 
HiSeq 2500 (rapid run) N 50, 150 2 150-180,000,000 
Roche 454 N 400 (mode) 1 1,000,000 
ABI SOLiD N 35, 60, 75 12 50,000,000 
Ion Torrent B Up to 400 1 2-3,000,000 
MiSeq B 50, 150 1 13,000,000 
454 Junior B 400 (mode) 1 80,000 
PacBio S 2.5-5kb (mean) 1 35-80,000 








All of the above technologies are limited in that they rely on PCR, or amplification, 
of the DNA template. Third generation sequencing is already available, still in its 
infancy, ‘Single-Molecule Sequencing’ (SMS), Gupta summarises SMS in her 2008 
review [43]. There are two so-called single-molecule sequencing technologies that do 
not rely on amplification and sequence DNA and RNA directly.  
 
With the Helicos heliscope sequencer, single-stranded fragmented DNA is created 
with polyA tails and attached to a flow cell surface. The incorporation of 
fluorescently labelled nucleotides is then measured sequentially by camera and 
records the incorporation of the second strand into each single molecule. Read 
lengths are limited to 55 base pairs and the system is capable of 1 billion reads per 
run. Unfortunately, the system suffers from quite high error rates, 1-3% indel rates, 
which coupled with the short reads, can cause problems for mapping to reference 
genomes. The system is the only technology to date to demonstrate direct sequencing 
of RNA (without conversion to cDNA). 
 
Finally, Pacific Biosciences also produce a single-molecule sequencing technology. 
Here, a version of the DNA polymerase enzyme is placed at the bottom of a well, 
and single strands of DNA fed into it along with fluorescently labelled single 
nucleotides. The system measures the fluorescence as the DNA polymerase 
incorporates bases into the template. Reads can average 2-3kb, with ultra-long reads 
possible, notably, a 17kb read has been reported. There are 80,000 wells though not 
all produce a useable sequence. The error rate is quite high, 15% has been reported, 
and many of these are indels. The error rate, coupled with the low throughput, has 
prevented the wider adoption of this technology. Accuracy can be increased at the 
expense of read length by circularising the template and measuring each base 
multiple times. 
 
With these advancements whole genome sequencing is no longer restricted to 
sequencing centres; any research group with a small amount of funding can pay to 
sequence their genome of interest. The fact that this is process is becoming quicker 






need annotation. Further to this ‘desktop sequencers’ have been developed by 
Illumina, Solexa and Ion Torrent (MiSeq, 454 GS Junior and ION Torrent IGM 
respectively). These are designed to be held in any lab, even hospitals for quick and 
relatively inexpensive sequencing. This is especially exciting for bacterial genomics 
as these machines can sequence an entire genome in 24 hours or less [42]  
 
On the horizon, and predicted to be a big contender, is nanopore sequencing, which 
uses nanoscale technology to produce larger reads in real time. That is, the process of 
sequencing is physical rather than chemical, feeding DNA strands through nanopores 
and reading the sequence molecule by molecule [44]. This technology is predicted to 
be much faster and produce considerably longer reads. Companies like ON (who are 
closest to market), IBM and Visigen have previously made announcements 
predicting that they will be offering single molecule sequencing services in 2010, at 
this time (2012) no nanopore technologies have been made available to the public 
[44, 45].  
1.2.2 NGS and bacterial genome sequencing 
The advances in NGS technologies have changed the state of bacterial sequencing. 
The luxury of having a relatively small genome (compared to Eukaryotes) means that 
it is actually possible to sequence a complete bacterial genome for less than £100 in 
under 24 hours. As a result of these benefits we see a movement towards whole 
genome scale analyses. The fact that analyses are on the genomic scale allows for 
more holistic comparisons between strains. For example, it is possible to identify 
mobile genetic elements and look for all single nucleotide polymorphisms SNPs 
rather than regions restricted to a microarray. Sometimes the differences between 
strains of bacteria can be due to SNPs. These single base changes can actually result 
in different amino acids and sometimes different phenotypes [1]. Mostly, SNPs are 
synonymous, that is the amino acid sequence remains intact. The identification of 
non-synonymous SNPs can be indicative of niche adaptation. In terms of bacterial 
evolution all SNPs (synonymous and non-synonymous) can be used as a means of 







SNP detection can be useful for distinguishing between strains, this can be for 
epidemiological traceback (to the origin of an outbreak for example) and for insights 
into ecological niches (such as host adaptation). Traditionally, for subtyping isolates 
pulsed field gel electrophoresis is used. However for highly related clones the PFGE 
pattern is often shared between strains making outbreak origin difficult to elucidate. 
Whole genome sequencing can be used for single nucleotide polymorphism 
prediction, which can be used as a basis subtyping of strain [46],[47] . In their 2012 
study Allard et al. examined the SNPs for many serovar Montevideo isolates [48]. 
They showed that the isolates are well conserved using PFGE regardless of their 
geographical/temporal differences. However, when using WGS comparisons 
between isolates from an outbreak other isolates, not associated with the outbreak, 
there were only a few SNPs difference within the outbreak isolates and up to 
thousands of SNPs difference between the other isolates; demonstrating that the NGS 
approach shows strain differences at a much higher resolution.  
 
As many bacteria are pathogenic, one of the uses of NGS in terms of bacterial 
sequencing is outbreak analysis. A vision for desktop sequencing in particular is the 
use in diagnostics; a pathogen can be isolated from a patient and sequenced within 
the hospital, giving the medical staff a clear idea of what they are dealing with and a 
means to decide on how to administer care based on the specific infection. During 
the 2011 E. coli outbreak there was a worldwide collaborative effort to solve why 
strain O104:H4 was so virulent. Different laboratories were sequencing outbreak 
isolates and then making the output publically available [49, 50]. Collectively they 
identified that the strain carries a shiga toxin gene, known for its haemorrhagic 
properties. This was only possible due to the low cost and quick turnover of NGS 
technologies.   
 
Comparative genomics is enhanced by NGS, the whole genomes of serovars can be 
used to look at the divergence of strains. Looking at the genomic scale allows for 
comparisons between recombination, loss of gene function and distribution of SNPs. 
This type of research has elucidated the phylogeny of strains with low genetic 






divergence of the host into domestication [22] [51] and further to this NGS has 
allowed Salmonella to be divided into two distinct clades based on SNPs and HGT 
and demonstrated the genetic differences isolates of the same strain that show 
different egg colonisation abilities [51]. 
 
Just the fact that NGS is so accessible in terms of cost and time and the fact that 
many sequenced strains are made publically available means that we can look at pan 
genomes [20].Studying these allows us to get a better understanding of what defines 
that species/strain/serovar which ultimately can allow us to identify what results in 
what phenotype. The Salmonella pan genome has been compared to the E. Coli pan 
genome, identifying potential species specific gene profiles [52]. This type of 
analysis can be used as a basis for finding the origin of genes, that is whether they 
were a result of HGT or from a common ancestor [52]. 
1.2.3 NGS genome assembly 
After an isolate has been sequenced some kind of genome construction usually 
occurs. Broadly speaking this can be performed in one of two ways, either mapping 
the reads to an existing reference genome or using an ab initio method to assemble 
the reads without a reference, namely reference alignment and de novo assembly.  
There are many papers which have performed comparisons of these but Magoc et al. 
use real data for a very extensive comparison [53]. 
1.2.3.1 Aligning reads to a reference genome 
In terms of bacterial sequencing there are many novel and resequencing efforts. 
Being able to map the reads to the original sequence allows for simple detection of 
errors and resolving repeat regions. 
 
The premise of read mapping is to use a reference as a back bone and align the reads 
iteratively to this resulting in a pileup of reads across the genome. From this a 
consensus sequence can be made which calls the most likely base for each nucleotide 
location in the genome. The base is decided based the nucleotide which occurs most 
frequently at that location and a quality score is assigned depending on the frequency 






As the reads are actually mapped against the reference the coverage for each base 
location in the reference is available. This can help with distinguishing SNPs (bases 
that differ from the reference) and sequencing errors. High coverage means that a 
location where there is a sequencing error will also be saturated by reads that have 
the correct base meaning. For example if the location has 50x coverage and 48 of the 
reads predict one base it is a fair assumption that the two bases with a converse base 
are either sequencing errors or a mismapped read. 
1.2.3.2 De novo assembly 
In cases where there is no reference genome available or when regions of difference 
(such as mobile genetic elements and plasmids) are being identified mapping reads to 
a reference is not a suitable method. In these scenarios de novo assembly is required, 
most assemblers rely on graph based methods such as de bruijn graph. These build 
up the reads (or fragments of the reads) into bigger structures called contigs. If a 
reference genome is available the contigs can be mapped to this (using a tool such as 
abacas) in order to build a scaffold of the whole genome and look for regions of 
difference.  
1.3 NGS Challenges 
The impact that NGS technologies have had on research is titanic, but that is not to 
say that next generation sequencing does not have its own limitations and challenges.  
 
Current NGS datasets are notoriously large with a single lane of HiSeq providing 
6000x coverage of a 5Mb bacterial genome and the average bacterial alignment file 
being many gigabytes in size. This causes problems for software that tries to load the 
entire dataset into RAM, thus, many require a 64 bit operating system with larger 
amounts of RAM. Tools such as Samtools have been developed for dealing with 
alignment data, enabling users to convert their data to binary format and use fast 
random access of alignment data [54]. Tools such as IGV and Tablet are available for 
visualising this type of data [55, 56], but the sheer amount of information in one file 
makes visualisation difficult whilst displaying regions of the sequence, they are also 
liable to crash if the region viewed is too large or has very high coverage. The 






associated with current ‘NGS’ processing and analysis will no longer apply, the new 
technology will have its own limitations. Although, the advent of single molecule is 
imminent we are still a long way from using this technology in day-to-day analysis, 
new software will need to be written to handle and analyse the new data types, new 
databases will need to be made for the storage. With that in mind the bottleneck will 
be the computational post sequencing aspect of the process. 
1.4 Genome Annotation 
Prokaryotic genomics has seen an explosion in the number of genome projects, 
driven by the advent of next generation sequencing (NGS), resulting in a huge 
reduction in the time and money investment per project [57] Microbial genome 
annotation often consists of running an automatic annotation pipeline followed by 
manual curation of the results [58]. Most annotation pipelines use homology methods 
to transfer information from a closely related reference genome to the new sequence. 
Automatic pipelines can lead to the introduction and propagation of poor annotation 
and errors, and it is the purpose of the manual curation step to identify and remove 
these. However, as it is now possible to sequence multiple microbial genomes in a 
single day at low cost using a single sequencing machine [3], it is no longer feasible 
to manually curate the annotation of all sequenced genomes. Fully-automatic 
annotation pipelines, while essential to the modern microbial genomicist, may 
introduce and propagate inconsistent and incorrect gene annotations. 
 
Transferring annotation purely based on the closest annotated relative does have its 
limitations. When we consider the reason the new strain has been sequenced, often it 
will be to identify how this strains differ genetically to its close relatives. This is 
paradoxical because we are trying to find the differences between these strains but 
using a similarity based method to annotate it. Potential areas of interest may not be 
annotated because they are not in the reference genome. 
1.4.1 Generic annotation process 
Upon sequencing a genome the next step is gene annotation, which forms the basis 
for many comparative studies. Gene prediction tools are used to ascertain the 






and GeneScan [59, 60]. These techniques apply ab initio methodologies; that is they 
predict genes based on patterns in the sequence rather than homology with other 
sequences. Using homology, when available, can enhance gene prediction as highly 
similar sequences are likely to code for the same gene. Orpheus uses both ab initio 
and homologs with apparently high levels of prediction [61]. 
 
Once the gene locations have been determined, they are annotated by homology 
searches to databases such as Pfam [62], NCBI gene [63], and the Kyoto 
Encyclopaedia of Genes and Genomes (KEGG) [64]. Orthologous gene relationships 
between species are also calculated and stored in databases such as KEGG and 
Clusters of Orthologous Groups (COGs) [65]. 
 
A range of automatic bacterial annotation pipelines have been published, including 
web-based systems such as RAST [66], BASys [67], WeGAS [68] and 
MaGe/Microscope [69]; and systems to be locally installed, such as AGeS [70], 
DIYA [71] and PIPA [72]. There is also MICheck [73] which checks annotated 
sequences for syntactic errors. All of these systems carry out the basic process 
outlined above, with various additions to check for errors or add additional 
information. It is worth noting that in order to submit to a genome repository that the 
annotation needs to be in a compatible format (e.g. .tab or .asn). Some pipelines do 
not output in this manner as they are designed to either hold the annotation online or 
for in-house analysis [67], [68]. Further processing may therefore be necessary 
before submission to a public database. 
 
In many cases there is a closely related strain/serovar available which has already 
been sequenced and annotated. Most annotation pipelines employ gene prediction 
software, the most common of which is GLIMMER [60]. This uses a reference set of 
sequences to train a model and then utilises that model to predict coding regions in 
the genome of interest. Many other ab initio gene prediction algorithms exist and 
these are reviewed by Do and Choi [74]. Alternatively, gene finding can be 
performed by extrinsic methods, identifying open reading frames directly from 






Once coding regions have been identified, they are aligned either to a reference 
genome annotation or the entirety of UniProt [77] using fast sequence alignment 
tools (e.g. FASTA [78] or BLAST [79]), the top hits are accepted as homologues and 
the annotation is transferred across for genes displaying high similarity. Other 
features such as tRNAs and rRNAs may then added using other prediction software 
[80].  
 
Here we describe a very general process used for bacterial genome annotation 








Figure 4 A generic process for automated bacterial genome annotation, the dashed box shows iteration for 






1.4.2 Limitations of the annotation process 
In an ideal world this would be the end of the annotation process. The fact that 
homology is the basis for these pipelines means that many genomes currently 
available may have been annotated using old, out of date genomes as a reference 
which in turn have been annotated based on even older more out of date genomes.  
 
The misannotations and errors may perpetuate throughout each new genome, 
ultimately propagating into secondary databases such as UniProt [77] and KEGG 
[81]. 
 
The public sequence databases have recognized the need for controlling this 
replication of errors and provide validation software for checking the standard of 
one’s annotation prior to submission [82, 83]. This section looks at common errors 
that are the product of automated annotation and tries to address methods of 
overcoming these.  
 
Many bacterial genera now have multiple species and strains with complete 
genomes, representing a fantastic resource for comparative genomics. However, each 
genome is annotated separately, by a range of different groups using different 
protocols, and this introduces inconsistencies. Meaning that reference genome choice 
can actually result in different numbers of genes predicted/annotated [20]. One 
particular problem is that of split/fused genes and domains; Kummerfield and 
Teichman [84] found that, of 7116 distinct domain architectures examined across 
131 archaeal, bacterial and eukaryotic genomes, 47% showed evidence of gene 
fusion/fission events. An example of this is the eutM/eutN locus in Salmonella. 
Figure 5 shows six different models that have been used to annotate this region in the 
17 RefSeq records for Salmonella in 2012. In Salmonella typhi CT18 (NC_003198) 
and Salmonella typhi Ty2 (NC_004631) there is a single ORF of 690bp annotated as 
eutN (Figure 5A). The protein sequence maps to two domains in PFAM, a BMC 
domain (PF00936) and a eutN_CcmL domain (PF03319). In all other Salmonella 
genomes in RefSeq, stop codons within this region split the gene, and the domains, in 






pseudogene of 690bp (Figure 5B); a further four genomes annotate two intact 
gene/CDS features, eutM and eutN, each ∼300bp in length (Figure 5C). A further 
three genomes are annotated with one pseudogene, a 291bp ORF equivalent to the 
eutM gene in Figure 5C, and one intact gene, a 288bp ORF labelled as eutN (Figure 
5D). A further two genomes annotate two ORFs, 291bp and 300bp in length 
respectively, both annotated as pseudogenes (Figure 5E), equivalent to the eutM and 
eutN genes in Figure 5C. Finally, one genome (NC_006511) includes two intact 
genes, but has reversed the order of eutM and eutN (Figure 5F). 
 
The various ways in which the eutN and eutM genes have been annotated represents 
a problem for further genome annotation. We cannot know, simply from the genome 
sequences alone, whether this locus represents a single long gene that has been split 
in two, or two shorter genes that have become fused. All six models represent 
different interpretations of a locus that is highly conserved at the nucleotide level 
across Salmonella species, and any novel genome that is compared to just one of 
those models will have annotation heavily influenced by that model. For example, if 
a novel genome is compared only to genomes represented by Figure 5B (two short 
ORFs annotated as a single long pseudogene) the interpretation will be very different 
than if the genome were compared to Figure 5C (two short ORFs annotated as two 
separate intact genes).  
 
Predicting domains directly, rather than genes, using tools such as PfamAlyzer [85], 
may help in regions with split genes. In the case of eutM/eutN in Salmonella, a 
domain search would identify two intact domains in all cases; however, the question 
of whether or not those domains come from the same or separate genes would remain 
unresolved. We are left with two different versions of the eutN gene from Salmonella 
in the public databases, one of 690bp containing two domains, and one of ∼290bp 
with one domain.  
 
The only way to annotate this region correctly in silico would be to compare any new 
genome to each of the six different models. It is difficult to imagine a set of rules that 






of this region and apply that interpretation to a newly sequenced genome. To truly 
get the full story we would need to look at experimental data (such as RNA-Seq data) 
to see what the patterns of expression are. Sections 4.3.1.4 and 4.3.1.5 show 









Figure 5 The six different models present across 17 RefSeq entries for Salmonella species at the eutM/eutN 
locus. Green indicates normal gene/CDS features, grey indicates gene features annotated as pseudogenes. 
(A) A single intact gene of 690bp; (B) a single pseudogene of 690 bp; (C) two short intact genes ∼300bp in 
length; (D) one pseudogene and one intact gene, each ∼300bp in length; (E) two pseudogenes, each 300bp 







In the eutN/eutM example, we see a case where genes of vastly differing lengths 
have been given the same gene name in different genomes; in contrast to this, it is 
also possible for orthologous genes to be assigned different gene names. Figure 6 
shows a syntenic block of genes annotated in Escherichia coli K12 MG1655 
(NC_000913) and E. coli O157:H7 Sakai (NC_002695). These two regions are more 
than 97% identical at the nucleotide level; however, the annotation differs 
considerably. While E. coli K12 MG1655 contains features with gene names araA, 
araB and araC, the equivalent features in E. coli 0157:H7 Sakai do not have those 
gene names and have been assigned uninformative locus tags. Further information is 
available for the features with only locus tags, including their involvement in 
arabinose metabolism, however, the gene names remain absent. At the far right of the 
gene block, two orthologous features exist, both with gene names, however, this time 
the problem is that they are different: thiB in K12 MG1655 and tbpA in 0157:H7 
Sakai. A simple search of the NCBI gene database (search term ‘thiB AND 
Escherichia coli [Organism]’ versus search term ‘tbpA AND Escherichia coli 
[Organism]’) reveals that both features code for a thiamin(e) transporter subunit, but 
the gene is given the gene name tbpA in over 30 E. coli species, whereas it is given 
the name thiB in only one. Luckily, the thiB feature in K12 MG1655 lists tbpA as a 
‘synonym’. Finally, in the centre of the image, K12 MG1655 contains a feature with 
the gene name yabI, whereas its ortholog in 0157:H7 Sakai only has a locus tag. This 
is an example of a y-gene, which we discuss in greater detail in the ‘Hypothetical 
proteins’ section, 2.4.2.3.  
 
The major issue here is that not only do different genomes annotate orthologous 
genes differently, and provide inconsistent information; they also contain differing 
amounts of information. This means that, when annotating a new genome, it is 
essential to choose a reference genome that contains the most accurate and up-to-date 
information, and that it is also preferable to compare any new genome to multiple 






















The definition of orthologous and paralogous genes is of great importance when 
annotating novel genomes. Whereas ‘homology’ refers to genes that simply share a 
common origin, ‘orthology’ refers to genes that arise by speciation and ‘paralogy’ 
refers to genes that arise by duplication. Figure 7 shows some of the processes that 
can lead to, and define, orthologs and paralogs. Beginning with a single ancestral, a 
gene duplication event occurs to create two paralogous genes. After a speciation 
event, there are two different organisms that both contain the paralogous genes from 
the gene duplication event. Gene 1a in Organism 1 has three homologs after the 
speciation event. Gene 1a in Organism 1 and Gene 1a in Organism 2 are orthologs as 
they have only been separated by the speciation event. Gene 1a in Organism 1 and 
Gene 1b in Organism 1 are in-paralogs, as they have only been separated by the gene 
duplication event. Finally, Gene 1a in Organism 1 and Gene 1b in Organism 2 are 
out-paralogs, as they have been separated by the gene duplication and the speciation 
event.  
 
These processes are not only crucial in defining evolutionary relationships, but also 
functional relationships, as orthologs tend to retain similar functions, whereas 
paralogs tend to diverge over time to perform different functions (reviewed in [86]). 
Therefore, when transferring functional annotation from a sequenced genome to a 
novel genome, it is essential that orthologs are accurately defined. There are several 
computational approaches which can be used to accurately define orthologs 
(reviewed in [87]). Phylogenetic tree-based approaches attempt to reconstruct the 
evolutionary relationship between gene sequences and thus define orthologs and 
paralogs; however, it may be impractical to construct a phylogenetic tree for every 
gene in a newly sequence genome. An alternative is the “bidirectional” or 
“reciprocal” best-hit approach [88], usually determined by comparing the top-
ranking matches found by a search algorithm such as BLAST or FASTA [78, 79]. 
Gene Synteny, the conservation of local gene order, can also help distinguish 
orthologs from paralogs in closely related genomes. However, it is important to note 
that a number of processes can lead to the breakdown of absolute gene synteny, 
resulting in genuine orthologs having a different gene order. These processes include 






translocations. It is important that we model these processes to allow the correct 
identification of orthologs in complex cases, and the MaGe [69] system attempts to 
do this. Finally, it has been observed that orthologs exhibit a greater level of protein 
domain architecture conservation than paralogs [89]. In practice, it may be essential 
to use a combination of approaches, and several software applications exist [87]. 
 
The process of running an annotation pipeline is straightforward. However, there will 
be errors in the annotation. This section has outlined some of the shortcomings of 
automatic annotation. Some of the annotation discrepancies such as ortholog/paralog, 
pseudogenes and gene fusion events can be resolved by integrating the annotation 








Figure 7 The processes that can lead to, and define, orthologs and paralogs. Gene duplication and 







1.5 Post-genomic data 
The advancement of experimental techniques has seen a multitude of disparate 
datasets. This is often confounding, as a scientist may have to access several 
disparate resources to ask a relatively simple question. The data available from 
Salmonella research is no exception; ranging from the gene specific through to 
comparison of whole genomes. 
1.5.1 Metagenomics 
A fairly recent branch of microbiological research is metagenomics. Research 
revolves around the microbial genomes collectively in a particular niche or 
ecosystem, the microbiome [90]. Metagenomics can give information on species and 
strains which are unculturable in vitro [91]. A study by Kurokawa et al. inferred that 
many of the micro-organisms are involved in pathways essential for host survival, 
which the host itself cannot carry out [91].  
 
Microbiome members can survive within the host, carrying genes which confer 
defence to the host’s immune responses. Due to the environmental pressure of the 
host the intestine is a HGT hotspot [90] meaning that pathogens can also acquire 
these advantageous genes. 
1.5.2 Transcriptomics 
The transcriptome is all of the RNA expressed at a given time. This differs from the 
genome in that the genome, broadly speaking doesn’t change. The expression of 
messenger RNA (mRNA) and the other RNAs vary according to how a cell is 
responding to its environment, for example different genes are expressed in vivo 
rather than in vitro, these genes could be linked to pathogenicity [92, 93].  
 
Microarrays are commonly used to measure the expression of mRNA or 
complementary DNA (cDNA). The array is comprised of a number of spots, each 
spot holds many copies of a unique probe. The probes are single stranded DNA 
sequences that can define a particular gene or region of interest. The expressed 
mRNA/cDNA is labelled with a fluorescent dye (this can be two dyes when looking 






bind to the probes and the intensity of light produced when shone under a laser is 
recorded. This intensity is quantified into a measurement of concentration. The 
change in intensity between two samples is used to define differential expression. For 
example genes which show a significant decrease in expression relative to the control 
group are described as down regulated, conversely, those which are unregulated 
show a significant fold increase in expression. 
 
Identifying differentially expressed genes can give an insight into the pathogen’s 
mechanisms of infection and regulation. Studies have explored how Salmonella grow 
in cell culture compared to broth, this has shown what genes are required for 
colonisation of different cell types or hosts [94]. There has also been work looking at 
how Salmonella can infect wild type host vs. hosts mutated to be deficient in a 
particular gene, for example, Wright et  al. showed that there is differential 
expression of genes when Salmonella infects TLR4 deficient mice [95]. Other than 
looking at host/environmental differences microarrays have also been used to 
compare wild type strains of Salmonella with mutated strains. These type of 
knockout studies can show how Salmonella regulates gene expression, for example 
IHF mutants show decreased expression of growth and virulence genes compared to 
the wild type [96].    
 
It is worth noting that microarrays are not just isolated to gene expression profiling. 
In terms of bacterial research they can also be used for pathogen detection and SNP 
discovery. 
The volume of gene expression data is vast, and the quality is varied. The Minimum 
Information About a Microarray Experiment (MIAME) standard has been developed 
by the microarray gene expression data (MGED) society as a basic standard for any 
publishable microarray experiments [97].  
 
Two of the main public repositories are the NCBI’s Gene Expression Omnibus 
(GEO) [98] and the European Bioinformatics Institute’s (EBI) ArrayExpress [99]. 
ArrayExpress also has the Array Express Data Warehouse, a database of gene 






Microarrays are extensively used but have their limitations. Each spot can be 
considered an autonomous experiment. However, there are many systematic errors, 
and normalising the data is not an easy task. The data also contains a lot of noise, and 
accurate measures of expression can be difficult [97, 100, 101]. Statistics and 
machine learning techniques (such as clustering) are often used to reduce and 
summarise the data. 
 
Converse to looking at the expression of specific genes, microarray research can take 
a more holistic standpoint. Genomotyping is the comparison of the presence/absence 
of genes between genomes using microarrays [102]. Genomotyping research can 
help to identify genes linked to drug resistance, giving an insight into the evolution 
of such traits and aid classification [103]. Probes using variable genes (those varying 
between strains) have been developed for several purposes, including distinguishing 
between different strains within the same serovar [104] and for quick identification 
of food borne pathogens within the food industry [105]. However, genomotyping can 
be subject to nonspecific hybridisation; that is the probe is hybridising to the wrong 
area, giving a false positive. This is especially common in regions of nucleotide 
repeat.  
 
In terms of NGS RNA-Seq is the transcriptomic technology, in comparison to 
microarrays which are limited to the spots that you have on the array, RNA-Seq can 
discover new genes as well as quantify existing genes. RNA-Seq is short for "RNA 
sequencing", though in reality most sequencing technologies actually sequence 
cDNA (complementary DNA). Single stranded RNA is reverse-transcribed to cDNA 
and the resulting pool of cDNA molecules sequenced. The number of sequences that 
align to a reference gene set is then used as a quantitative measure of gene 
expression. In eukaryotes, mRNA molecules have a polyA tail and this can be used 
to enrich for mRNA molecules (often those of most interest) compared to other RNA 
such as ribosomal RNA (rRNA) and transfer RNA (tRNA). However, in prokaryotes, 
mRNA molecules do not have a polyA tail, and often a ribo-reduction technique is 







Whereas microarrays allow scientists to study mRNA abundance, proteomics allows 
protein abundance to be measured. Measuring protein abundance in certain 
conditions or over a time period, for example at different stages of infection, 
provides insight into how the pathogen is responding to its environment at the protein 
level. Finding relevant proteins can then be followed by knock-out analysis to find 
the effects of turning off the gene which codes for the protein [106]. 
 
One of the limitations of transcriptomics is that mRNA can be transcribed even when 
a protein is not being made, so the results can be misleading. Proteomics on the other 
hand only detects for the presence of proteins. There are two main ways of doing this 
they are: 2 dimensional electrophoresis followed by peptide mass fingerprinting 
using mass spectrometry (MS) and Shotgun proteomics which breaks the proteins 
into peptides, uses a chromatogram to sort by size followed by MS [107].  
 
Proteomics can be used for different applications in bacterial research. The main use 
is to compare the protein profile in different states. This has been used to find novel 
proteins associated with infection [108]. White et al. used proteomic analysis to 
identify that periplasmic binding proteins are required to form rdar biofilm colonies 
[109]. It can also be used to improve genome annotation, by identifying true start 
sites of open reading frames and identify coding regions that were not identified via 
in silico ORF prediction [107]. 
1.5.4 Metabolomics 
As with other -omics data, metabolomics takes a whole organism perspective, 
specifically of the metabolites being produced for a given state (i.e. grown on 
different media). Looking at this snapshot of metabolism can give insights into the 








The techniques required for metabolomics are complex, sometimes requiring 
multiple techniques for isolating the different groups of metabolites. Different 
techniques have varying efficacy for extracting metabolites [111]. Once the 
metabolites have been extracted they are identified using spectrometry techniques 
such as NMR spectroscopy and MS. NMR spectroscopy doesn't require the usual 
complex metabolite extraction techniques, making the results far more reproducible, 
however MS is more sensitive and accurate [112]. 
Biofilm formation/regulation is often studied using metabolomic techniques. This is 
because many bacteria can switch between a planktonic state and biofilm formation, 
meaning that they carry the gene repertoire for both states. Further to this there 
doesn't seem to be an obvious pattern for genes linked to biofilm formation. It is 
believe that this is due to different combinations of pathways playing a role in 
biofilm formation depending on factors like growth media and organism [110]. 
White et al. 2010 used a combination of NMR and MS to look at the metabolite 
profile for S. typhimurium and a CsgD mutant which prevents the formation of the 
extra-cellular matrix. They were able to show that the metabolites used in the 
glucogenesis and major osmoprotectant pathways were up regulated compared to the 
mutant, suggesting the role of these pathways in biofilm formation [109, 110]. 
1.5.5 Mutagenesis 
In terms of functional genomics a popular method of identifying genes essential for 
virulence in pathogens is mutagenesis. A gene is mutated and the effect on the 
mutant strain is observed. This can be achieved by directly enumerating the bacteria 
during infection studies using single strains [113] or by quantifying signals from 
marked strains following screening of mutants in complex pools [114]. If there are 
not many mutants shed by the host then the gene gets a high attenuation score; the 
bacterium has decreased in virulence. Mutagenesis can take a genome-wide 
approach, where genes are randomly mutated via transposon insertion, this is called 
Signature Tagged Mutagenesis (STM). Each transposon is uniquely labelled, 
meaning that the researcher can compare composition of input and output pools by 






Chain Reaction (PCR) amplicons of the tags. This method has been used to prove 
that host ubiquitous strains infect each species of host with different gene sets [115]. 
 
Conversely, targeted mutagenesis looks at a particular selection of genes, isolates 
them and mutates them. This process is laborious compared to STM, it is however 
more specific and can be used to confirm the findings from STM studies [113]. 
Mutagenesis does have some short-comings. Firstly, some tags do not amplify from 
chromosomal DNA after the passage through the host. Also, some virulence genes 
that are knocked out may be returned as false negatives because there are other genes 
which have compensated for the loss of gene function.  
 
With the advancements in NGS we see more practical applications of sequencing 
technologies. In 2009 Langridge et al. [116] developed a high-throughput sequencing 
(HTS) technique for genome wide mutagenesis, namely, transposon directed 
insertion-site sequencing (TraDIS). TraDIS creates a pool of millions of transposon 
mutants, a hundredfold that of STM. It has been used to successfully identify genes 
in Salmonella Typhi that are essential for growth in bile [116]. The potential 
applications of this technology are exciting but the scarcity of further publications 
using this method suggests that there are some limitations to the technique. 
1.6 Data storage and availability 
There are many diverse databases tailored to hold the data types described above. 
There are also multiple bacterial genome databases. This section examines some of 
the better known resources, assessing what they offer in comparison to the other 
available genome databases. Do they essentially offer the same data and if so what 
do they offer above and beyond the standard? 
 
There are databases that combine genomic and post-genomic data into a central hub 
of information. For prokaryotes the major example of this is Xbase (encompassing 
ColiBase), which caters for Escherichia coli, Shigella spp. and Salmonella spp. 
[117]. The array of data is vast, including several types of genome alignment and 






linked to many major prokaryotic resources but doesn’t hold any quantitative data 
[118]. However, most of the data is pre-computed meaning that the viability could be 
compromised if the primary data is changed; for example if a genome is 
reannnotated. The Pathosystems Resource Integration Center (PATRIC) on the other 
hand is subject to continuous update [119]. As with Colibase, PATRIC can perform 
multiple sequence alignments and uses the GBrowse genome browser. PATRIC also 
has an enteropathogenic equivalent to Pfam [62], called Enterofam. As with Pfam it 
uses profile Hidden Markov Models (HMMs) to identify functional families based on 
protein sequence [119].  
 
There are other, smaller scale databases such as IMG [120], this has most of the 
features that ColiBase and PATRIC boast. It also handles fused genes, for example 
eutN in Typhi is recognised as a fused gene. Unfortunately, the pseudogenes are not 
easy to look at in the context of the genome, meaning that the eutM/N paradox might 
recognisable but it would be hard to see it in the light of other genomes and their 
pseudogenes. Finally, GeneDB is the generic database created to hold the data of 
small genomes. Besides the sequence data it holds extensive genomic and proteomic 
information integrating experimental evidence with computational analyses. It has an 
exhaustive array of information ranging from predicted peptide properties to 
expression data; which can be analysed with in-house microarray tools [121]. Its 
main limitation is that it contains a dearth of bacterial genomes.  
 
The resources currently available are cumbersome in terms of their update status, 
mainly due to their static nature. Many are limited to one area of microbiology [122, 
123] and some require a user login, which can be a hindrance when trying out 
different genome databases [123].The information they contain is only accurate at 
the time it was uploaded. If this information becomes superseded it would be a very 
time consuming task to make changes. Another consideration is if new data types are 
made, adding these to the schema could be complex. Finally, people who access 
these resources are limited to publicly available data, and there is no option for them 







The World Wide Web Consortium (W3C) defines a web service in the strictest 
sense, explaining that web services are the programmatic interfaces used for 
application to application communication via the World Wide Web [124]. Tools with 
a web browser interface do not fall under this classification [125]. True web services 
carry the disadvantage that they require some level of programming skills to utilise 
them. This is why web browser tools are so popular; they provide a simple way of 
analysing data. However, the user is still limited to a form to perform the queries, 
rather than the capabilities provided from web services. 
 
Many web services are based on eXtensible Markup Language (XML), a self-
describing structured text format [125].The advantage of using XML is that it is 
language independent and both computer and human readable.  
 
Representational State Transfer (REST) and Simple Object Access Protocol (SOAP) 
communicate between the server and the client using XML. The main difference is 
that REST is closely affiliated with Hypertext Transfer Protocol (HTTP) whereas 
SOAP, rather than following HTTP, extensively uses Web Services Definition 
Language (WSDL). WSDL provides a model of the web service as an XML 
document. 
 
Large centres such as the EBI and the University of Manchester champion the 
provision of web services for biological use. One example is the BioMART project 
which offers several different kinds of web service [126]. The simplest access is 
provided through a uniform resource locator (URL), where the query is defined in a 
URL statement. BioMart also offers SOAP and Perl application programming 
interface (API) access. The advantage of the BioMart project is that when a user 
access BioMart using the web GUI any query they perform can be translated into the 
URL, XML for SOAP or Perl script. This makes the transition to web services a lot 
easier for biologists who can see how to form relevant queries. In terms of SOAP 
access the EBI offers the SoapLab [127] as an example, which provides 







Other international genomics centres also offer web-services. KEGG is a suite of 
databases for genomics, pathways and other metabolomic data. The KEGG API 
offers over 40 functions ranging from querying and producing coloured pathway 
maps to returning orthologous genes. This can all be accessed through SOAP [128].  
 
It is worth noting that since originally writing this section KEGG have expanded 
their webservices to include a RESTful API and Ensembl have released REST 
webservice access [128, 129]. This demonstrates that webservices are still on trend 
and are being used by some of the more prestigious biological groups. 
 
Classically bioinformatics tools are available as downloadable applications, where 
the user can access them through a graphical user interface (GUI) or the command 
line. With post-genomic analysis establishing itself as a major biological focus we 
see a transition towards web based bioinformatics services. For example, the 
EMBOSS suite [54] and ClustalW [55] are common applications in bioinformatics. 
They are typical desktop applications, and recently, both have been incorporated into 
a number of web services [56]. 
 
A recent database of web-services for biological sciences is BioCatalogue [130]. 
This resource serves as a central registry of web services, currently holding over 
1000 entries. Developers are encouraged to put their service’s description up and 
offer help to potential users. Each entry has a concise explanation and the 
programming methods needed to access the resource. The entry also has a list of 
similar resources that could be relevant to the user’s enquiry. 
 
There are projects and programs available which attempt to link web services and 
desktop applications into a workflow. That is the user defines a pipeline of analyses, 
the application then takes this and forms a workflow drawing in analyses from 
remote web services and desktop applications. Taverna [131] is an example of a 
well-established workflow application, and many web services offer Taverna access 






scientists who share their workflows rather than duplicating efforts designing 
workflows which already exist. Users can easily download and run the workflows 
locally on their computer. 
 
Workflow applications are often installed locally and provide a means of performing 
a pipeline of analyses. However, clearly these web-services could also be used to 
provide a lightweight and flexible framework for genome annotation, displaying up-
to-date and novel information from remote data sources. This would be user specific, 
flexible, easy to interpret and require no programming skills. This report 
demonstrates how such systems will be implemented to provide novel information 
about Salmonella. 
 
As previously described in sections 1.2 and 1.5 there are many different data types 
available, in diverse formats. NGS data for example, is very large and it isn’t 
economic to store this in multiple locations. NGS webservices allow the data to be 
located in one place and accessed when needed via the internet. Not only do 
webservices offer users direct access to remote data, they allow them access to tools 
without the problems of installation and the responsibilities that ensue such as 
maintenance and version control. The plug and play paradigm means that the 
interfaces to webservices are none language specific. The data is retrieved directly 
from the original source meaning that it is up to date and there is no need for regular 
updates. 
 
The movement towards webservices isn’t a panacea but it will allow 
bioinformaticians and those accessing the data to do so in a more facile way, rather 
than spending time on red tape such as downloading the correct module or learning a 
new programming language in order to use the specific tool at hand.  
1.8 Concluding remarks 
We have seen that Salmonella has adapted to many different niches. Some serovars 
are able to infect multiple hosts whilst others have very restricted host specificity 






virulence and host specificity are also associated with increased pseudogene 
formation. Of the Salmonella genomes that have been sequenced few have well 
defined virulence. Sequencing these could provide a link between known phenotypes 
and genotypes. Integrating the sequence data with post-genomic data can lead to 
insights in Salmonella biology. A limiting factor of many analyses that involve 
sequence data is annotation quality. Most annotation methods are based on homology 
and perpetuate misannotations when used as a reference. 
 
The integration of genomic and post-genomic data will be performed in this project 
by two main methods. Namely, the analysis at genomic level integration and the 
development of feature specific integration software. This will be achieved by using 
the Salmonella model of host specificity as a basis for the integration analysis. Firstly 
four serovars that infect different hosts will be sequenced. The analysis stage will 
integrate the genomes with pathways and mutagenesis data in order to elucidate 
genes and pathways linked to host specificity and pathogenicity. The integration 
software will use web services to integrate publically available remote data and the 
in-house private data with genome annotation. This type of integration will help to 
identify misannotations and provide a platform for viewing genomic features in the 
















Sequencing and submission of four 
Salmonella serovars that are 
pathogenic to livestock 
 
A great deal of Salmonella research focusses on the mouse model [17, 133]. 
Although there is merit in this, it is recognised that different serovars show different 
clinical signs in the same hosts [23].We have sequenced and annotated the genomes 
of four serovars with well-defined virulence in food-producing animals. Table 2 
(Section 2.2.1) summarises these genomes and their pathogenicity in healthy outbred 
hosts.  
 
The importance of these serovars is that their virulence has been described across 
three different hosts (namely, calves, pigs and chickens, see Table 1). The fact that 
we know the virulence of these strains across different hosts means by sequencing 
them we can link the clinical observations (phenotype) to the strains’ genotypes and 
ultimately build hypotheses based on host specificity and pathogenicity. All of the 
strains were isolated from animals showing clinical signs rather than from a lab 
culture. This is of importance because model strains such as S. Typhimurium LT2 
were isolated many years ago and being in a lab for such a duration of time means 
that the clinical signs that originally observed are not always induced upon infection. 







This chapter describes the process of taking four raw genome sequences and their 
progression into fully annotated genomes residing in GenBank. The first step was to 
sequence and assemble the genomes, this was followed by an initial attempt at 
automatic annotation with some manual curation for refinement (sections 2.2.2 and 
2.2.3). The stage of submission, communication and ultimately acceptance into 
GenBank was the bottleneck in the process, taking four rounds of corrections before 
the annotations were accepted. 2.2.4 states the file types needed, iterates through the 
resubmissions and conveys the communications with the GeneBank submission 
team. After successfully submitting four genomes into GenBank it became clear that 
there are some common pitfalls in both the submission process and automated 
genome annotation. Section 2.3.1 describes these, explaining the rules that slow the 
submission process and possible solutions for these submission hurdles. The chapter 
as a whole highlights that automated genome annotation isn’t at a standard where a 
genome can be submitted to public databases like GenBank without manual 
intervention. The discussion 2.3.2.1 considers some of the limitations of automatic 
annotation. It also reflects on what is needed to make good quality genome 
annotations and whether groups annotating novel genomes have a responsibility to 
produce an annotation that goes beyond the minimum requirement to get into a 
sequence database like GenBank. 
2.1 Aims 
This chapter encompasses work published in Richardson et al 2011 [1] and 
Richardson and Watson 2012 [2]. The main objective is to take four serovars 
relevant to livestock pathogenicity from genome sequence to assembled, annotated 
genomes available publicly. 
 The aims of this chapter are: 
 To annotate the assembled sequences sequenced in [1] 







 To define/discuss the rules needed to successfully submit a genome into a 









Four servoars were isolated, namely Salmonella serovar Typhimurium strain 4/74 
(from this point Typhimurium 4/74), Salmonella serovar Choleraesuis strain SCA50 
(from this point Choleraesuis SCA50), Salmonella serovar Dublin strain SD3246 
(from this point Dublin SD3246) and Salmonella serovar Gallinarum strain SG9 
(from this point Gallinarum SG9). The four isolated serovars are summarised in 











Calf Pig Chick 
Typhimurium ST4/74 Acute enteritis Acute enteritis 
Asymptomatically 
colonises the gut 
Isolated from a calf with 
Salmonellosis in the UK. 
 
Parent of strain SL1344 
[134-138] 
Choleraesuis SCA50 Systemic infection 
Systemic infection 
and mild enteritis 
- 
Isolated from a pig with 
swine typhoid in the UK 
[137-140] 
Dublin SD3246 
Severe enteritis and 
systemic infection 
Cleared - 
Isolated from a calf with 
systemic salmonellosis in 
the UK 
[138-141] 
Gallinarum SG9 Cleared - Systemic infection 
Isolated from chicken with 
fowl typhoid 
[139, 142] 






2.2.2 Sequencing and assembly 
36 cycle paired-end sequencing was carried out on an Illumina GAIIx [143], yielding 
between 80 and 150X coverage. SOAPdenovo [144] was used to generate de novo 
contigs, and reads aligned to a reference using Novoalign (Novocraft, Selangor, 
Malaysia). S. Typhimurium 4/74 reads were assembled on the genome and large 
plasmid of strain SL1344 (from this point described as Typhimurium SL1344) [145]. 
S. Choleraesuis SCSA50 reads were assembled on the genome of strain Choleraesuis 
SC-B67 [31] and its virulence plasmid [146] S. Dublin SD3246 reads were 
assembled on the genome of strain CT_02021853 (accession no. CP001144). S. 
Gallinarum SG9 reads were assembled on the genome of Gallinarum strain 287/91 
[26]. The de novo and reference contigs were combined using MUMmer [147] and 
Gap4 [148] Assembly was carried out with help from Mick Watson. 
2.2.3 Genome annotation 
Sequences were annotated using a combination of GenoPipe 
(http://genopipe.bioinfo-portal.cdac.in/) and the pipeline described. They both work 
by incorporating different feature prediction software [60, 79, 149, 150]. Manual 
curation followed to enhance the annotation, including pseudogene assessment and 
assignment of start sites. This section takes the process of genome annotation 
described in section 1.4 and explains the design, development, and implementation 
of a basic prokaryotic annotation pipeline 
 
Designing an annotation pipeline might seem obsolete, but this aspect of the project 
was complete prior to the other resources offering quick bacterial annotation 
services. This stage has still served as an opportunity to understand bacterial 
annotation through a hands-on approach.  
 
The design steps of this were based on the techniques learnt on a placement at the 
Pathogen Sequencing Unit (PSU) at the Sanger Institute. The Sanger Institute uses a 
mixture of genome analysis tools, in house Perl libraries and manual annotation. At 






months due to the manual curation aspect, the automated step as little as 5 minutes 
(for a 2.5mb genome) [151]. 
 
There are five scripts/tools used in this annotation pipeline. The commands for these 
were put into a batch file which executes the commands sequentially. 
 
The first command uses the gene prediction tool GLIMMER. Rather than using a 
reference genome to predict genes it uses an iterated approach. GLIMMER makes a 
training set based on long open reading frames (ORFs) which is then run through 
GLIMMER to predict genes. A second run of GLIMMER is then performed to 
increase the accuracy. This outputs a ‘.predict’ file which is a tab delimited file 
showing each predicted gene and its location. 
 
This ‘.predict’ file is the input for the GLIMMER to tab script. This script takes the 
‘.predict’ file, parses it into Embl format, assigns a systematic ID to each gene and 
integrates the FASTA sequence into the parsed Embl file. The output is an Embl file 
with gene locations but no annotation. 
 
The Embl file is the input for the reciprocal FASTA script, which is part of the 
Sanger in house library of scripts. It takes an unannotated Embl file and a reference 
genome as input. A FASTA search [78] is performed with every gene from the query 
genome against every gene in the reference genome.  
 
Query_Gene1 -> Reference_Gene1  
Query_Gene1 -> Reference_Gene2 
Query_Gene1 -> Reference_Gene3 Match! 
 
If there is a match then the FASTA is performed reciprocally. That is, the FASTA is 
performed with the reference gene against the query gene. 
 






If the reciprocal analysis returns a match then the annotation from the reference 
genome is transferred onto the query gene. Once all of the query genes have been 
compared to the reference genome the array is saved as Embl format.  
 
A few modifications were added to the reciprocal FASTA script. One modification 
was to transfer more of the annotation across, including protein ID and annotation of 
pseudo-genes. The inference was also added, that is how the genes were predicted (in 
this case GLIMMER 3.0) and the protein ID from the gene whose annotation was 
transferred. The script was also modified to record any unannotated genes into an 

















The next script takes the unannotated genes from the reciprocal FASTA and repeats 
reciprocal FASTA against a second genome of the user’s choice. This script can be 
adjusted to run BLAST or FASTA of the unannotated genes against one of the 
nucleotide databases rather than against a reference genome. 
 
Finally any genes which have not been annotated after this second run are submitted 
to NetBLAST (network-client BLAST) [152]. NetBLAST takes batch files of 
FASTA sequences and use the NCBI BLAST server to search against the user’s 
database of choice. They are converted back to FASTA format and sent to the 
NetBLAST server, the results are returned in XML format. This is parsed and 
merged into the annotated Embl file (for the output from the pipeline see Appendix 
8). 
 
This pipeline was used for the annotation of the Salmonella serovars mentioned in 
2.2.2. The annotation served as a basis for the manual intervention needed for 
submission. It takes approximately 4 hours to annotate a 5mb genome. This is slow 
when compared to RATT’s performance but at the time of its conception was 
relatively fast. 
 
As with many pipelines discussed in section 1.2.1 this pipeline does have its 
limitations, it will reproduce errors from homology methods. However, as the 
genomes will be integrated into a resource which takes remote data live from its 
source any mistakes should be easily detectable as they will conflict with the other 








2.2.4.1 File formats 
In order to submit the genomes to GenBank each .tbl file and the corresponding 
FASTA sequence were submitted to the tbl2asn software. This makes an asn.1 
format file which contains the sequence data and annotation, it carries the .sqn suffix. 
A template file was made for each genome, using the sequin software. The template 
file holds the metadata (the headings in a GenBank file) such as authors and 
taxonomy. This file is also in the asn.1 but has a .sbt suffix. 
 
The Typhimurium 4/74 strain was submitted with these two files. However, three of 
the genomes, namely Gallinarum SG9, Dublin SD3246 and Choleraesuis SCA50, 
could not be assembled fully, these had to be submitted as Whole Genome Shotgun 
(WGS) submissions. WGS submission requires .sqn files for each contig and a 
scaffolding file (.agp). The scaffolding file describes how the contigs are assembled 
and the size of the gaps between them. 
2.2.4.2 Submission process 
The genomes were all annotated based on genomes available in GenBank and 
UniprotKB. Based on this our genomes were submitted to GenBank after they were 
annotated according to the method in 2.2.3. The sequences and their corresponding 
files were uploaded using the genome submission tool [153] 
 
These annotations were not accepted by GenBank based on various annotation 
discrepancies (described in 2.3.1). The volume of these was so large that scripts were 
needed to process the discrepancies. Figure 9shows the process for the first round of 
submission, the further sections explain the steps taken to make further submissions 
ultimately meeting GenBank’s new annotation standards. A full explanation of the 







Figure 9 Schematic of the first round of submission, taking the output from the annotation pipeline 
described in section 2.2.3 and converting to a GenBank friendly format 
2.2.4.2.1 2nd Submission 
Asn2disc, the NCBI programme for detecting annotation discrepancies 
(http://www.ncbi.nlm.nih.gov/GenBank/asndisc.html), was run against our primary 
submissions and proteins without a function or those with suspect names were 
processed (Figure 10) 
 
Figure 10 Schematic of the second round of submission of genome annotation to GenBank comprised of 







2.2.4.2.2 3rd Submission 
Many of the annotations still had suspect names according to the discrepancy file but 
we believed that because they hit proteins in reference genomes with functional 
domains that these names would be acceptable, the annotation was rejected on this 
basis (Figure 11). 
 
Figure 11 Schematic of the third round of submission of genome annotation to GenBank. Suspect protein 







2.2.4.2.3 4th Submission 
All of the overlap discrepancies that were kept in the 3
nd
 submission were present in 
reference genomes or UniprotKB. They were kept even if they were very short or did 
not have domain because of their high conservation to other genomes. 
Communication with the GenBank submission team explained that overlapping 
proteins are rare in bacterial genomes and that conservation across genomes does not 
indicate a true CDS, amending this resulted in acceptance of the four serovars into 
GenBank. 
 
Figure 12 Schematic showing the final round of genome annotation submission to GenBank. Hypothetical 








The genomes, their assembly details and features are summarised in Table 3. 
Typhimurium 4/74 has the largest genome, the most coding proteins and the fewest 
pseudogenes. Conversely, Gallinarum SG9 has the smallest genome, the least coding 
proteins and the most pseudogenes. This correlates with the gene loss hypothesis 
section 1.1.2. 
 
The four serovars where successfully submitted into GenBank. Typhimurium 4/74 
was the only serovar to be accepted as a complete genome. The other three serovars 
were submitted as WGS sequences, with the Dublin SD3246 scaffold having the 
most contigs. Genome maps showing the order and location of the genomes which 
could not be fully assembled are in Figure 13-Figure 15. 
 
The genome annotation pipelines alone did not provide an annotation suitable for 
GenBank submission standards. A total of four submission attempts were required 














Table 3 The genome summaries for each of our serovars sequenced and their plasmids 
  
Typhimurium 4/74 Dublin SD3246 Choleraesuis SCA50 Gallinarum SG9 
Chromosome TY474p1 TY474p2 TY474p3 Chromosome p3246_74 Chromosome pSCV50 Chromosome 
Unnamed 
plasmid 
GenBank ID CP002487 CP002488 CP002489 CP002490 CM001151 CM001152 CM001062.1 CM001063 CM001153 CM001154 
Size (bp) 5,067,451 193,842  286,908 38,688 4,842,911 74,548 4,740,379 49,558 4,658,698 87,371 
Contigs 1 1 1 1 29 1 16 1 3 1 
Max.contig 
length - - - - 1117118 - 1013670 - 2968510 - 
Min. contig 
length - - - - 36 - 105 - 580095 - 
Max. gap 
length - - - - 90 - 214 - 93 - 
Min. gap 
length - - - - 1 - 2 - 1 - 
Coverage 80 80 80 80 65 200 150 150 59 228 
Proteins 4624 116 90 11 4580 102 4503 51 4113 86 
Genes 4776 116 90 11 4819 102 4722 51 4487 87 
Pseudogenes 44 0 0 0 135 0 116 0 277 1 
tRNA 84 0 0 0 82 0 82 0 75 0 












Figure 14 The de novo assembly order and sizes for the Choleraesuis SCA50 genome (ordered against the 













































2.3.1 Validating sequencing quality 
The majority of the work in chapters 2 and 3 is based on the assumption that the 
annotation of our sequences is correct and there are few misannotations/sequencing 
errors. One way of validating the quality of the sequencing is to use well known 
phenotypes that have been linked to the sequence and look for these in our serovars. 
 
For example the pyridine auxotrophy of Salmonella serovar Dublin strains is due to a 
missense mutation in the nadA gene. Figure 16 shows that out serovar Dublin 
SD3246 holds the mutation that is unique to Dublin strains and linked to auxotrophy 
[154]. 
 
Our serovar Typhimurium 4/74 genome is the parent of hisG auxotroph 
Typhimurium SL1344. Comparisons between the two showed eight SNPs clustered 
around the hisG gene with one SNP actually in the hisG gene, this is expected as 
Typhimurium 4/74 is not auxotrophic [1]. 
 
Further to these two examples the fact that there was at least 58x coverage across our 
serovars is considerably better quality than the reference sequence’s low coverage 
from Sanger sequencing. The high coverage of our data, plus the recovery of known 
phenotypes, gives us a measure of confidence in our sequence data and annotations. 
Also, the manual annotation step provided the identification of selenocysteine read-
throughs in Choleraesuis SCA50 which were not detected in the original annotation 
of Choleraesuis SC-B67. 
 
We were satisfied with the quality of our sequencing data due to the high coverage 
and linking known phenotypes to the sequence data. There are methods of 
systematically assessing sequence quality. For example when comparing the 
sequence to a reference we can identify SNPs. Randomly selecting some of these 
SNPs and performing PCR on these regions would give a better quality of sequence. 
From this we can work out the percentage of errors for the regions that underwent 






wouldn’t incur the cost of extra PCR is to use something like shadow regression. 
This works on the premise that for any given read there are shadow reads (reads that 
differ by up to two bases). The number of shadow reads that are a result of 
sequencing error is linear to the frequency of the read and the number of legitimate 
shadow reads is independent of read count. A linear model is used to estimate error 
rates based on this [155]. We didn’t incorporate any of these as we were confident 
that our sequencing quality was of a good standard, one reason for this is the fact that 
in the Typhimurium 4/74 serovar there were only eight SNPs, if there had been 
sequencing errors we would have expected to see a random distribution of SNPs 
throughout the genome (not just located around the gene known to separate it from 
its parent strain). If we were to repeat this work again, we would perform more 















Figure 16 subsection of a ClustalW multiple alignment of nadA sequence for two Salmonella serovar Dublin strains and our other three serovars. The red circles highlights the 







2.3.2 The Submission process  
The process of annotation and submission has highlighted some of the common 
discrepancies and how to deal with them. Table 4 shows a summary of the 
discrepancies for each submission. Typhimurium 4/74 had the lowest number of 
‘suspect names’, this is interesting as it had the most coding proteins. One reason for 
this discrepancy could be that the reference genome Typhimurium LT2 is much 
better studied and has a lot of experimental data to support the annotation. 
 
Across every genome the ‘BLAST hypotheticals’ step increased the number of 
‘suspect names’. This shows that proteins flagged as hypothetical do have hits to 
other more informative annotations which would not be discovered by using 
reference genomes alone. It also demonstrates that many proteins in TREMBL (and 




 submission consisted of BLAST-ing all suspect protein names against 
Swissprot and TREMBL. The method of prioritising Swissprot annotation and going 
beyond the reference genome annotation greatly reduced the number of suspect 
protein names. Combined with the script for reducing overlap discrepancies the 
manual annotation stage was more manageable, dealing with tens of discrepancies 







Table 4 Feature and discrepancy counts for each submission stage organised by serovar. 
GALLINARUM SG9 
1st Submission 2nd Submission 3
rd Submission 4th Submission 
Original annotation BLAST hypotheticals Manual Stage BLAST suspect names Remove overlaps Manual Stage 
Number of CDS 4145 4138 4138 4114 4114  4113 
Gene Prod Conflict 47 49 49 49 49 49 
Duplicate gene locus 71 77 77 77 79 79 
EC number quote 1 1 1 0 0 0 
Overlapping CDS 28 34 34 34 32 32 
Contained CDS 42 42 42 42 12 0 
RNA_CDS overlap 9 9 9 9 0 0 
Suspect Product names 132 142 132 35 35 14 
 
CHOLERAESUIS SCA50 
1st Submission 2nd Submission 3
rd Submission 4th Submission 
Original annotation BLAST hypotheticals Manual Stage BLAST suspect names Remove overlaps Manual Stage 
Number of CDS 4536 4536 4536 4502 4502 4503 
Gene Prod Conflict 148 152 152 144 144 142 
Duplicate gene locus 216 222 222 234 234 232 
EC number quote 0 0 0 0 0 0 
Overlapping CDS 52 71 71 71 60 62 
Contained CDS 47 47 47 47 32 30 
RNA_CDS overlap 9 9 9 9 1 1 








1st Submission 2nd Submission 3
rd Submission 4th Submission 
Original annotation BLAST hypotheticals Manual Stage BLAST suspect names Remove overlaps Manual Stage 
Number of CDS 4626 4626 4626 4626 4580 4580 
Gene Prod Conflict 54 54 54 50 50 50 
Duplicate gene locus 95 99 99 99 99 99 
EC number quote 0 0 0 0 0 0 
Overlapping CDS 20 50 50 52 20 20 
Contained CDS 38 38 38 38 0 0 
RNA_CDS overlap 7 7 7 7 0 0 
Suspect Product names 307 312 289 48 47 27 
 
TYPHIMURIUM 4/74 
1st Submission 2nd Submission 3
rd Submission 4th Submission 
Original annotation BLAST hypotheticals Manual Stage BLAST suspect names Remove overlaps Manual Stage 
Number of CDS 4656 4656 4656 4656 4627 4624 
Gene Prod Conflict 60 61 61 57 57 57 
Duplicate gene locus 99 99 99 101 101 101 
EC number quote 0 0 0 0 0 0 
Overlapping CDS 88 93 93 91 86 86 
Contained CDS 32 32 32 32 0 0 
RNA_CDS overlap 9 9 9 9 1 1 









2.3.2.1 Examples of acceptable protein names that are flagged as suspect 
The program Asn2Disc gave a detailed description of potential annotation 
discrepancies. However, some features labelled as discrepancies, although correctly 
annotated are exceptions to the general GenBank annotation rules. 
 
For example STM474_1118 is labelled as ‘bifunctional protein putA’. 
The label ‘bifunctional protein’ should not be accepted but it as it is a hit 
to a Swissprot protein this was accepted. Proteins with the word gene will flag up a 
discrepancy too, however, the protein name ’gene 60 protein’ is allowed for 
submission. 
 
Some CDSs overlap one another by a small number of bases. This is acceptable but 
flagged up by asn2disc if both features have the same product name, this can be 
indicative of a pseudogene or split gene. However, some product names are so 
generic that many features in the genome will share the same product name, and 
some of those will reside next to one another. Descriptions such as 
’hypothetical protein’, putative exported protein’, ‘tail 
assembly protein’ and ‘putative membrane protein’ are all 
acceptable overlapping descriptions. 
2.3.2.2 Problems with coding regions 
The NCBI validation software flags up all instances where a coding region 
completely contains another coding region on the opposite strand. The submitter is 
asked to check these coding regions and decide whether these are true features. If the 
coding region only hits hypothetical proteins and doesn’t contain any domains, it 
may be either removed or demoted to a miscellaneous feature.  
2.3.2.3 ‘Same gene name, different product name’ 
This issue occurs when two features, either within or between genomes, are assigned 
the same short gene name yet different product names. The NCBI validation software 
specifically highlights when this occurs intra-genomically with the description ‘Same 





2.3.2.4 CDS Nomenclature 
There are many words which may be unacceptable in protein names, such as 
‘binding’, ‘domain’, ‘like’, ‘motif’, ‘gene’ and ‘homolog’. 
Submitters may be encouraged to change these: for example ‘bacteriophage 
replication gene’ can be changed to ‘bacteriophage replication 
protein’ and ‘peptidyl-tRNA hydrolase domain protein’ can be 
changed to ‘peptidyl-tRNA hydrolase protein’; a note may be added to 
state that the feature contains the aforementioned domain. 
2.4 Discussion 
Although the methods in this chapter may seem straightforward, the entire process 
took a lot longer than anticipated. This was mainly due to higher standards of 
annotation required for new genome submission compared to the currently available 
genomes. This skew in annotation quality makes it difficult to produce a good quality 
submission when most of the available genomes are substandard in terms of 
GenBank criterion.  
 
Genome annotation does predominantly rely on orthology to other sequences (e.g. 
genomic, protein, domain). When a similar high quality reference is available the 
annotation is quite straightforward. This is apparent when comparing the number of 
discrepancies in Table 3. Typhimurium 4/74 took most of its annotation from a better 
quality annotation compared to the other genomes. 
 
Further to the quality of reference genomes the orthology transfer has other 
limitations. If the reference genome carries a pseudogene, where the query genome 
does not, the annotation could be completely missed or misannotated as a 
pseudogene.  
2.4.1 The submission process 
The process of successfully submitting to GenBank took a long time. This was 
mainly due to the time between communications with the GenBank submission team. 
For example the overlapping proteins that were kept during the early submissions 







explaining all the problems with our annotations we were shown new problems with 
each submission (which we had assumed were up to submission standard because 
they weren’t highlighted as a problem originally). If they had given all the feedback 
in one email it could be a bit disheartening for the annotator but in terms of time 
taken for a successful submission, this would be greatly reduced for both the 
submitters and the GenBank team. 
 
The format for submission is ASN.1, this is complex, it is not human-readable, it is 
very bulky and requires special tools for conversion. It would be difficult to make a 
tab-delimited format of an annotation submission because each feature has many 
different tags (potentially meaning a lot of empty columns). XML format allows for 
a more straightforward, human-readable format, which would be easily parsed and 
edited during the annotation process, rather than converting between multiple 
formats.  
2.4.2 Improving automated annotation 
Advances in sequencing technologies are allowing researchers to sequence microbial 
genomes at a huge rate. It is becoming harder to devote time to manually annotate 
these genomes, leading to a rise in automatic annotation pipelines. However, due to a 
range of problems, the output of these automatic annotation pipelines is unsuitable 
for publication. Some changes can be made to improve this output; however, it is 
difficult to envisage an end to manual checking and curation.  
2.4.2.1 Spelling mistakes 
There are 128 proteins in UniProt that contain the word ‘syntase’, an incorrect 
spelling of the word ‘synthase’. To put this into context, the RefSeq entry for 
Rhizobium etli CFN 42 (accession NC_007761) assigns the function 
‘dihydrofolate syntase’ to gene folC. This has propagated into other 
databases such as UniProt (accession: Q2KE79), KEGG (accession: 
RHE_CH00024), and xBASE (accession: RHE_CH00024). If a user was to visit any 
of these databases and search for ‘dihydrofolate synthase’ the misspelled 
entries would be omitted from the search results. Large scale detection and correction 





on the submitter to correct these. Automatic annotation pipelines simply copy and 
propagate what is there already. Spelling mistakes may be highlighted by the 
validation software provided by the public databases during submission, however, an 
alternative correct spelling isn’t offered, making it difficult to amend the mistakes 
without manual intervention.  
 
This can be solved by writing rules to find spelling mistakes [76]. However, this 
approach is limited to spelling mistakes which are explicitly written in the code. A 
solution may exist beyond biological science. The search engine Google upon 
receiving the input ‘syntase’ automatically states ‘Did you mean: synthase’. There 
are programming languages which have classes or plugins to produce such ‘did you 
mean’ results [156, 157]. 
2.4.2.2 ‘Same gene name, different product name’ 
In the current set of 2696 microbial genome and plasmid sequences in RefSeq, we 
detected 23,843 genes with at least two different product names (see http://www.ark-
genomics.org/genomeannotation.html for the full list). The most extreme example of 
this is gene ‘tnp’ which has 151 different product names (‘tnpA’ has a further 97). A 
more manageable example can be seen in Table 5. The ‘int’ gene has a total of 12 
different product names across 17 Salmonella RefSeq entries. These product names 
contain huge variation in terms of information content. When using an automatic 
annotation pipeline, there is a danger that if the top hit is to an entry labelled 
‘Hypothetical protein’, then you will capture far less information than if 
your top hit is to ‘phage integrase family site specific 
recombinase’. In order to correctly annotate this gene in a new genome, it is 
necessary to take into account all of these product names in the annotation process. It 
is difficult to imagine a set of text-mining rules that could efficiently interpret the 








Table 5 Different product names assigned to features with the gene name ‘int’ across 17 different RefSeq entries for Salmonella species [2] 
Gene 
name  Product name  Accession 
int  bacteriophage integrase  NC_003198, NC_004631, NC_015761 
int  Gifsy-1 prophage Int  NC_006905 
int  hypothetical protein  NC_006905 
int  Integrase  NC_003198, NC_004631, NC_006511, NC_012125 
int  integrase (fragment)  NC_003198 
int  phage integrase family site specific recombinase  NC_006905 
int  putative cytoplasmic protein  NC_006905 
Int  Putative integrase  NC_003384 
int  putative integrase protein  NC_006905 
int  putative P4-type integrase  NC_006905 
int  putative phage integrase protein  NC_006905 






2.4.2.3 Hypothetical proteins 
The term ‘hypothetical protein’ often refers to a gene that has been 
predicted by software but which finds no homolog of known function in the 
databases, and which has no known functional domain. There are currently 53 035 
proteins whose product name contains both words in UniProt (search term: 
‘name:hypothetical AND name:protein’) and there are a further 5 178 212 proteins in 
UniProt that contain the words ‘uncharacterized’ and ‘protein’ (search term: 
‘name:uncharacterized AND name:protein’). These may be real genes with no 
known function or they may be artefacts of the gene prediction process.  
 
Many bacterial genes of unknown function are assigned y-gene names based on their 
orthologous location in E. coli K-12 [158]. The letters denote the location in terms of 
minutes around a circular genome. This gene annotation has propagated throughout 
many strains and species of bacteria, losing the relevance and context of its name as 
the genes are not all in the same relative location to the original annotation in E. coli 
K-12. For example the yabF gene has a known function, ‘glutathione-regulated 
potassium-eflux system ancillary protein’. The gene name yabF is completely 
meaningless in all genomes other than the original and actually has a synonym kefF. 
With that in mind annotators should use more informative gene names as a 
preference, choosing alternative gene names over the original y-gene annotation.  
 
Often there are features which are only orthologous to other hypothetical features 
and do not contain any domains. These could either be regions with no functionality, 
a relic of the feature prediction software or the domains present have not been 
discovered yet. Whether or not to include them is often a decision made by the 
annotation team and varies between groups. Thus, many artifactual ‘hypothetical 
proteins’ may be annotated, published and disseminated into the public databases, 
reinforcing the annotator’s belief that their new gene predictions do indeed have 
homologs in other species. It would be more informative to actually state in the 
annotation a score for each feature. This will allow users to make informed 







hypothetical proteins based on their quality of hits. Gilks et al. [159] discuss the 
possibility of assigning scores based on the source of annotation. 
 
There are arguments for and against keeping these proteins in the annotation. If they 
are indeed a misannotation by the gene prediction software they should be removed 
as they will perpetuate through secondary and tertiary databases as a recognized 
protein awaiting functional discovery. Searching for conserved domains or motifs in 
databases such as Pfam or InterPro can give an indication of whether a hypothetical 
protein is functional but this has pitfalls too. The fact that a protein has a domain hit 
doesn’t necessarily convey its function. Pfam [160], for example, contains over 3000 
“domains of unknown function”, or DUFs, representing over 20% of known families 
[161] and as more novel genomes are sequenced the number of new DUFs will 
increase. A hit to a DUF does not inform us of a feature’s function, but as they are 
areas of high conservation they indicate a potential region of biological interest.  
 
Through computational methods alone there are no means to conclusively determine 
whether a genomic region is functional. With that in mind conserved features of 
unknown function should be kept because in the future they may be recognized as a 
true region of interest; however, they should be annotated differently to discriminate 
them from features with stronger evidence. Evidence tags are available but they are 
often not present, and are not a prerequisite for submission to GenBank or Embl. 
Evidence qualifiers such as how the feature was predicted (e.g. GLIMMER, BLAST, 
homology) and what entries it hits in a given database provide a clear audit trail for 
anyone who wants to assess the quality of a particular annotation. The type of data 
source used, that is, whether it is manually curated or automated should be stated, 
providing the user with a clear method of judging the annotation. As experimental 
data becomes more ubiquitous evidence tags should play a larger role in annotation.  
Experimental methods such as RNA-Seq [162] and Signature Tagged Mutagenesis 
(STM) [163] may help to identify regions of functionality. RNA-Seq data can help 
delineate and quantify areas of transcription, and overlaying this expression data on 





features. STM can help identify the function of genes by monitoring the phenotype 
of single-gene mutants. 
 
The most important point is that one’s annotation is only ever as good as the 
reference data sources. In terms of publicly available genome sequences the quality 
is varied. It is worth actually looking at the annotation and assessing the quality. 
Choosing a genome because it is the closest relative will give the most homologous 
features but might not give the best quality annotation.  
 
Combining additional data with the original annotation gives scientists a new way of 
viewing the genome. Experimental data could be able to solve the eutM/eutN 
problem described above; for example, RNA-Seq data would show which areas of 
the genome are actively transcribed and STM may indicate whether knocking out 
either of the genes alters the phenotype of the mutant.  
 
Many scientists go through the process of annotation with the final aim of submitting 
to a genome database such as GenBank or EMBL. In order to realize this goal there 
are many rules which need to be followed [82, 83] and often validation software is 
provided to verify one’s annotation. These rules are imposed to ensure a better 
standard of genome annotation, however, they do mean that often the output of an 
automatic annotation pipeline must be manually checked and altered prior to 
publication. Many of the issues described in the ‘Limitations of the Annotation 
Process’ section may be identified as potential problems and the submitter is 
provided with long lists of features that represent these. They must be checked, and 
either altered or justified. In addition to those mentioned above, there are others 
described below.  
2.4.2.4 CDS nomenclature 
These rules add complications if the submitter wants to fully automate the process of 
annotation. As a rule of thumb, if a predicted coding region has homologs in 
SwissProt these are the best protein names to transfer across and running the 







suspect names. As an aside, ‘probable’ and ‘predicted’ are not flagged up 
by the validation software but ‘putative’ is the preferred alternative.  
 
Some CDSs have the same protein name as the protein next to them, which can be 
the sign of either a disrupted gene or a valid gene duplication event. It can also be 
because the protein name is very general such as ‘hypothetical protein’ or 
‘inner membrane protein’. These features may be flagged up by the 
validation software and, if they are not pseudogenes, need a note stating that they 
overlap a CDS with the same protein name.  
CDS gene names that appear more than once in a genome and have different proteins 
names to one another (e.g. Table 5) may also be identified as potential errors. These 
may be brought to the submitter’s attention who often has to use their discretion and 
knowledge to assign gene names correctly. This can be as simple as performing a 
similarity search and seeing which gene names are associated with the hits.  
2.4.3 Gold standard genomes 
RefSeq is one attempt to standardize and improve the quality of genome annotation; 
however, as we have shown, problems persist. With the implementation of stricter 
rules for submission we should see an increase in annotation quality. While genomes 
of varying quality are available there should be a means for scientists to see the 
quality of any given annotation. Evidence qualifiers such as how the feature was 
predicted and what entries in a given database the feature sequence hit, including the 
database version and date, would provide a clear audit trail for anyone who wants to 
assess the quality of a particular annotation. The type of data source used, that is, 
whether it is manually curated or automatically generated should also be stated, 
providing the user with a clear method of judging the annotation.  
 
Out of the 1851 publicly available completed bacterial genomes 102 have a version 
number of .2 or higher [164]. This means that the submitting group have revisited the 
original sequence and changed it. The fact that the sequences have been changed is 
indicative of a higher quality sequence. This, however, does not reflect the quality of 
the annotation. It is possible to look at the revision history of genomes within 





small feat when there are 1851 genomes available. In the literature there have been 
several papers which have revisited and reannotated genomes, these include strains 
of E. coli, Campylobacter jejuni and Mycobacterium tuberculosis [165-167]. In 
terms of what is currently available these genomes are likely to be the closest to 
realizing ‘gold standard genome annotation’.  
 
Janssen et al. [168] calculated the number of publications per gene for all completed 
genome to calculate a Species Knowledge Index (SKI) for each genome. They 
showed that, in bacteria, there is a pronounced bias toward certain organisms namely 
E. coli, Pseudomonas aeruginosa and Bacillus subtilis. With this in mind perhaps 
there should be a focus to annotate genomes with a high SKI to the highest level 
possible as there is such an abundance of experimental data available. These can then 
be used as gold standard genomes for annotations of other species.  
 
As we learn more about genes and protein function it becomes clear that a simple 
protein name is inadequate. Some proteins are multi-functional, performing different 
tasks depending on the context it is expressed in. We can say that a protein has a one-
to-many relationship with function, meaning that assigning a protein name based on 
the first function associated with it can be misleading and inaccurate. The Gene 
Ontology (GO) may provide a more flexible way of describing a range of functions 
explicitly and concisely, and GO annotations natively include evidence qualifiers. 
However, GO terms are not frequently included as part of the initial annotation of 
bacterial genomes. The EBI offer UniProtKB-GOA Proteome Sets [169], GO 
annotations for all completely sequenced genomes in the public domain, however, 
these are not included with or clearly linked to the original genome submission. The 
development and use of GO annotations is encouraged and these should be included 
in genome annotation efforts.  
2.4.4 Going beyond the minimum 
For acceptance to databases such as GenBank or EMBL, only gene, CDS and 
structural RNA features need to be added [82, 83]. However, many other features 
should be added. This section gives a broad overview of some of the other features 







Gene prediction software sometimes assigns the wrong start/termination sites. 
GLIMMER for example assigns the start site as the most upstream start codon [171]. 
By searching for ribosomal binding sites (RBS), one can infer and reassign the start 
site; RBSFinder does this by looking for motifs such as the Shine-Dalgarno sequence 
pattern [171]. For termination sites, TransTerm searches for rho-independent 
transcription terminators to assign the correct termination site [172]. As well as 
correcting start/termination sites these features should be added to the annotation, 
using the tags ‘RBS’ and ‘terminator’ respectively. 
 
Regions of conservation within proteins such as motifs and domains should be added 
to the annotation after the gene finding step. There are many databases which store 
protein families such as ProSite, PRINTS and Pfam [160, 173, 174]. InterproScan 
can perform searches against a range of domain/motif databases [175]. Hits to 
motif/domain databases should be assigned the qualifier ‘db_xref’ within the 
corresponding CDS feature [82, 83] 
 
Areas of horizontal gene transfer (HGT) such as pathogenicity islands and prophage 
can be predicted by looking at asymmetries in codon composition and the GC 
content as these will often differ between areas of HGT and the rest of the genome 
[176]. They are often associated with the presence of integrases, transposases and IS 
elements [176]. Software tools exists to predict these [21, 177], and these are 
reviewed and compared in by Langille et al. [178]. There are clear guidelines for 
annotating phage, this should be assigned under the ‘source’ feature with the name of 
the bacteriophage in the ‘organism’ qualifier and the type of sequence in ‘mol_type’ 
(usually genomic DNA). There is no specific annotation tag for other GIs so these 
should be annotated as miscellaneous features. The mobile genetic elements 
themselves use the ‘mobile_element’ tag. 
 
Sequence repeats such as “clustered regularly interspaced short palindromic repeats” 
(CRISPRs) and other tandem repeats are of biological interest. For example, they can 
be used to understand the bacterial defence mechanism [179] and to distinguish 





such as MICdb store predicted microsatellites as well as offering a prediction tool for 
user inputted sequence [183].  
 
Identifying a protein’s cellular localization can be indicative of function and this can 
be used in the identification of drug targets. There are many methods of prediction 
including homology and keywords [184], amino acid composition [185-187] and a 
mixture of these [188], Gardy et al. have performed a comprehensive review of the 
many tools available [189].  
2.5 Concluding remarks 
The entire procedure took several months, primarily due to two post-assembly 
bottlenecks. Firstly, a manual annotation stage was required for assessment of 
features such as pseudogenes. Secondly, the requirements for a successful 
submission into GenBank are more stringent than they were in the past. This became 
evident when some annotations transferred from genomes already in GenBank were 
not acceptable. The fact that GenBank has made a move towards higher quality 
genomes is commendable, it does however slow down the submission process as the 
‘old’ genomes, which are commonly used for annotation transfer, are not up to the 
more stringent annotation standard. 
 
The pipelines currently on offer do not take many of the pitfalls outlined above into 
account, meaning that a lot of manual effort is required to correct errors and 
inconsistencies. It is easy to imagine adjustments to current pipelines that take into 
account certain aspects (e.g. common spelling mistakes) but not others (e.g. correctly 
interpreting pseudogenes). Realistically, completely removing the manual stage of 
annotation would be imprudent, however, improving current automated pipelines 
may greatly reduce the time spent manually checking the annotation. There have 
been a flood of new genome-wide data types in the post-genomic era, for example 
microarray and RNA-Seq data, many of which can assist with genome annotation. 
However, these are often large, unwieldy, come in a variety of different formats and 
can be hard to integrate with one another. Allowing scientists to visualize this data 
alongside genome annotation can be hugely powerful [190]; however, genome 







virtually impossible. Secondary and tertiary databases may include additional data 
alongside the original genome annotation [20], but these “data warehouse” 
approaches employ copies of the original data which can become out-of-date and 
out-of-sync with the original data. The advent of bioinformatics web-services [191] 
may allow new systems that query data live over the internet, ensuring the latest data 
is displayed.  
 
If we had to do this work again it would take considerably less time. The time and 
cost of sequencing is reduced compared to two years ago when we started the 
process. The software available for de novo assembly is now faster and more 
accurate [192, 193]. Further to this read lengths are becoming longer (from 36bp to 
250bp on Illumina Miseq). With this in mind it is likely that we would have been 
able to submit all the genomes as complete rather than WGS. Also, there are 
annotation tools that claim to take less than four minutes to transfer the annotation 
across to closely related bacteria (compared to the 4 days it originally took) [151]. 
Now that we are familiar with the GenBank annotation requirements means that less 
time would be spent revising resubmissions and some scripts could be written to 
automate the process further. 
 
There is a need for reannotation of the currently available genomes as these are often 
used as reference genomes. This project did not add to the effort of reannotation of 
reference genomes, this is predominantly due to the amount of time to get four novel 
genomes accepted. In terms of future work, with the experience that we gained in the 
submission process it is feasible that we could add to the reannotation effort. I 
believe that the main factor that will contribute to improving reannotation is the 
inclusion of trackable trail of annotation. Meaning that it would work like citations in 
a scientific paper, one can ultimately reach the primary source of the original 
research. For reannotation, specifically genomes that are used as model 
annotations/organisms the inclusion of experimental evidence from the literature 
would be a good starting point to validate annotation and remove hypothetical 
proteins. Mining the literature for this kind is not a small feat, semantic literature 





heavily manually annotated genomes, until we get to a standard which allows for the 
integration of diverse experimental results into the annotation we will have to 
continue with manual annotation as the highest quality method of annotation.  
 
The fact that the virulence of these strains across different hosts is well defined 
means that the genomic data can be used to make hypotheses based on host 
specificity and pathogenicity of the serovars in different hosts. Additional data from 
post-genomics experiments can help improve genome annotation; however, a line 
has to be drawn regarding what data should be included in the annotation and what 
should be in separate databases. Tools and services need to be developed which offer 
scientists a means of viewing genome annotation augmented with other experimental 
data. This will empower the user to make meaningful judgments on the quality of 
annotation and the relevance of a particular region to their research.  
 
For the foreseeable future bacterial annotation requires both automated and manual 
steps. Offering users a measure of quality for the whole genome and individual genes 
will allow user to make an informed choice regarding reference genomes and 
transferring annotation between genomes. Using GO terms, for example, would 









Functional analysis of Salmonella 
genomes for signatures of host 
specificity and pathogenicity. 
 
Broadly speaking the relationship between host specificity and pathogenicity is well 
defined in Salmonella, with the majority of strains adhering to the model described in 
1.1.2. The mechanisms behind these phenotypes are still being explored. The 
sequencing and annotation of the four servoars described in chapter 2 are used in this 
chapter as a basis for investigating the patterns between host specificity and method 
of infection. Our serovars are of particular interest because they have well defined 
virulence due to the fact that they were isolated from infected livestock. 
 
The chapter can be divided into two main sections. The first part, 3.2, links KEGG 
pathways to the annotations and explores patterns of pseudogene formation in these 
in an attempt to answer the following questions: 
 
 Do strains in the same serovar show similar patterns of pathway attrition and 
how suitable are our strains as representatives of their serovar? (3.2.2.1)  
 Is pseudogene formation in KEGG pathways random? (3.2.2.2) 
 Are there any pathways that only show pseudogene formation in one serovar? 





 Are there any pathways that show pseudogene formation across all servoars 
except one? (3.2.2.2.1 and 3.2.2.2.4) 
 What pathways are enriched for pseudogene formation in each servoar, 
showing more pseudogene formation that expected by random chance? 
(3.2.2.2.1 – 3.2.2.2.4) 
 
Section 3.2.3 tries to apply some biological interpretation to the results such as the 
use of one strain as a representative for its serovar and whether the suitability is 
actually linked to host specificity. A major finding was that pathways linked to 
genetic processing such as ‘nucleotide metabolism’ and ‘replication and repair’ were 
highly conserved across all serovars, conversely the variation between servoars was 
predominantly seen in metabolic pathways (section 3.2.3.2). 
 
The other main section of this chapter, 3.2.3.5, uses genomic wide mutagenesis 
(TraDIS analysis) of Salmonella serovar Typhimurium strain SL1344 across chicks, 
calves and pigs to firstly look for areas of negative selection compared to pseudogene 
formation in serovars of known pathogenicity. Further, the genes in the TraDIS data 
were assigned to pathways and enrichment analysis was used to elucidate pathways 









The purpose of this chapter is to augment the genome annotations from chapter two 
with post genomic data. Showing that by integrating functional descriptions and 
experimental data one can elucidate patterns between genotypic information such as 
pseudogene formation and phenotypes like host specificity and pathogenicity. 
 
The specific aims of this chapter are: 
 To assign KEGG pathways to gene/pseudogene features 
 To compare areas of pseudogene formation within serovar to assess the use of 
serovar representatives 
 To compare areas of pseudogene formation between serovars 
 To find enriched pathways for negative selection in the TraDIS data 
 To assign orthologs from our serovars to the TraDIS data 







3.2 Pseudogene Analysis 
KEGG is a resource comprising of three areas namely; genomic, chemical and 
network information. Within the network section lies the pathway database, this 
consists of manually drawn maps for metabolic pathways [64].  
 
This chapter refers to KEGG pathways in many of the figures. KEGG describe their 
pathway maps as “molecular interaction/reaction network diagram represented in 
terms of the KEGG Orthology (KO) groups, so that experimental evidence in 
specific organisms can be generalized to other organisms through genomic 
information” [64], for example Figure 27 shows the KEGG pathway for Starch and 
Sucrose metabolism. There are three main types of object which are explained below 
(from the KEGG description [64]):  
 
 boxes - genes or gene products identified by the combination of the KEGG 
organism code and gene identifiers 
 circles - other molecules, usually chemical compounds identified by C 
numbers, but including glycans identified by G numbers 
 lines - reactions identified by R numbers in metabolic maps; ortholog (KO) 
groups identified by K numbers in global metabolism maps 
 
These maps can be integrated with individual genomes using the EC numbers 
assigned to the genomes’ genes [64]. The pathways are organised hierarchically with 
pathways and higher descriptions (the full pathway map is available Appendix A: 
KEGG_pathwaymap.docx). 
 
The relationship between pathways and genes is ‘many to many’; this means that 
each pathway can be assigned to no genes, one gene or multiple genes. Conversely, 
each gene might be associated with no pathways, one pathway or many pathways. 
Assigning genes to their respective pathway is a useful method of grouping genes, 
based on their function. Although pseudogenes aren’t technically part of a pathway, 








In this chapter pathways which had pseudogenes assigned to them are referred to 
‘pseudogene pathways’. Conversely, pathways which only had non-pseudogenes 
assigned to them are described as ‘functional pathways’.  
 
This section describes the assignment of KEGG pathways to the genes and 
pseudogenes in each serovar sequenced in Chapter 2. Once assigned, a functional 
enrichment test can be used to look for pathways which have significant gene loss in 
each serovar. This can give an insight into which pathways are essential/non-
essential for each serovar potentially implying the pathways required for infecting 
different hosts. Looking at pseudogene formation in pathways can give a different 
perspective to the host specificity/gene loss model for example two servoars that 
share a similar phenotype but don’t have the same pseudogenes might share 
pseudogene formation in the same pathways. The concept of this type of resilience in 
biological pathways is discussed in section 3.2.3. 
 
The analysis of pseudogene enrichment in KEGG pathways provides a solid 
foundation for making testable hypotheses around the Salmonella host specificity 
model. However, KEGG pathways are bite size chunks of a single network, the 
pathways are all interlinked. In order to remove the bias associated with KEGG 
pathways pseudogene formation should also be looked at in the context of the entire 
KEGG network. This can be achieved by clustering the network and looking for 
clusters that are enriched for pseudogene/gene absence. This type of analysis is 
complicated by the fact that KEGG now require a subscription fee for ftp access, 
running software that can handle the entire KEGG network requires a considerable 
amount of computing power and the analysis itself requires a considerable amount of 
time, this section provides a proof of concept, exploring how this type of analysis 
could be performed and some of the difficulties associated with it. The methods are 
described in 3.2.1.5 and as this is a proof of concept and there are no results the 
outcome of this section is discussed in 3.2.3.5. 
 
It is worth noting that at the time of writing this the serovars were in the process of 






3.2.1.1 Intraserovar Analysis 
For Gallinarum our strain SG9 was compared to the only publically available 
Salmonella serovar Gallinarum strain 287/91 (from this point Gallinarum 287/91). 
Our Choleraesuis strain, SCA50 was compared to Salmonella serovar Choleraesuis 
strain SCB-67 (from this point Choleraesuis SCB-67). 
 
The pseudogenes for each strain were extracted from their annotation using the 
get_pseudogenes.pl script (Appendix A: get_pseudogenes). A file of FASTA 
sequences was made for each strain using embl2FASTA_leftovers.pl 
(Appendix A: embl2FASTA_leftovers.pl). 
 
These FASTA sequences were BLAST against a local copy of the KEGG database 
using BLASTn. The results were parsed and the pathway counts were calculated 
using BLAST_kegg.pl (Appendix A: BLAST_kegg.pl) . 
 
It is worth noting that intraserovar analysis between Salmonella serovar Dublin 
strains was not performed because the reference annotation from Salmonella serovar 
Dublin strain CT_02021853 was not annotated in a consistent format throughout the 
genome, making the pathway assignment difficult. Arguably, the annotation could 
have been reformatted and used in the analysis but this would have been a time 
consuming process because the inconsistent nature of the annotation meant that 
manual reformatting would have been required. 
3.2.1.2 Pathway mapping 
Each functional gene was mapped to the corresponding gene from Salmonella 
Typhimurium LT2 using the reciprocal_fasta.pl script described in section 
2.2.3 (Appendix A: Reciprocal_fasta.pl). This script also assigned KEGG pathways 
to each gene based on the assigned orthologs from LT2, the LT2 pathways are 
publicly available from KEGG as .list files. Any genes which did not hit LT2 were 








Finally the genes which also didn’t map to the reference were BLASTed against all 
KEGG sequences. If the hit was above 75% identity and 85% in length it was 
accepted as an ortholog. Blast_kegg.pl was then used to take the KEGG Gene ID 
from the hit, parse the corresponding genome .list to assign the correct pathways 
Appendix A: BLAST_kegg.pl). 
 
KEGG doesn’t store pathway data on pseudogenes, and the 
reciprocal_fasta.pl script uses amino acid sequences. Sequence 
comparisons for pseudogenes needed to be at the DNA level to allow for frameshifts. 
To assign KEGG data to pseudogenes a BLASTn was performed for every 
pseudogene against all KEGG sequences. If the hit was above 75% identity and 85% 
in length it was accepted as an ortholog and the pathways were mapped to the 
pseudogene using BLAST_kegg.pl as described above. 
 
The pathway counts were converted into percentages for visualisation purposes, so 
that functional pathways could be easily compared to pseudogene pathways. These 
were sorted into descending order by functional pathways and visualised as radial 
diagrams. 
3.2.1.3 Higher KEGG description mapping 
In the KEGG database all pathways are sorted into hierarchical groups based on their 
functions (http://www.genome.jp/kegg/pathway.html). The pathways results were 
sorted into these groups to look at patterns in pathways loss from the first tier of the 
KEGG hierarchy. This was performed as 3.2.1.2 but with the higher level of KEGG 
description. Higher KEGG descriptions were also analysed because they can give an 
overview of general areas of gene loss which wouldn’t be apparent when looking at a 
specific pathway. 
3.2.1.4 Enrichment testing 
Counts for all descriptions (KEGG first tier and pathways) were made using the 
test_BLAST_kegg.pl script (Appendix A: test_BLAST_kegg.pl) The R script 





hypergeometric distribution and perform fisher’s exact test on the data (Appendix A: 
updated_analysis.R). 
 
In each genome the combined totals for functional and non-functional pathways were 
used as the population. From this we could predict how many genes we would expect 
to see associated with a particular pathway by random chance. This can then be 
compared to the quantities we actually observe. A p-value is calculated as an 
indication of statistical significance, for multiple comparisons it is standard to adjust 
the p-value because the rate of false positives is higher thus an unadjusted p-value 
will give a much less stringent threshold [195]. For this particular analysis the results 
have been ordered by statistical significance (both the standard and adjusted p-values 
have been included), this is a good starting point for examining areas of greatest 
pathway loss/pathway preservation. 
3.2.1.5 Proof of concept of the network analysis of the entire KEGG network 
The entire KEGG network was downloaded from the KEGG website in KGML 
format. The KEGGtranslator tool was used to convert the network into OWL format. 
The output kept the most of the node information but many of the interactions were 
lost during conversion. KEGGtranslator was then used to convert the original 
network to sif format. Nodes which represented multiple enzymes only kept the 
annotation for one enzyme, but the interactions were intact. The sif file was opened 
in BioLayout, and clustering was performed to see how well the network clusters 
[196]. The clustering was performed using the inbuilt MCL (Markov Clustering) 
function. The network clustered into over three thousand clusters with many of the 
nodes remaining unassigned. This is due to some metabolites being very ubiquitous 
across the entire network (for example H20 and ATP). BioLayout was used to 
identify these nodes by ordering all nodes by the number of interactions. Nodes that 
were very promiscuous (having a disproportionately high number of interactions) 
were pruned from the network to see if this improved the clustering. Opening the 
pruned network showed that some sub-networks had formed (between 5 and 15 
nodes in size), these had no interaction with the main network any longer. The MCL 







into a cluster this time but the cluster structure consisted of 5 or more metabolites 
and one or two gene nodes.  
 
For the proof of concept a sub-network was used as the previous network was not 
clustering well. The sub-network was made from the Microbial metabolism in 
diverse environments overview network. This network was chosen because it was 
considerably smaller than the entire network, did not contain superfluous compounds 
and the KGML format node assignment was in a more consistent format. The 
network was pruned to only include gene-gene interactions, this was purely to reduce 
the network into a manageable size. A mock set of pseudogenes were then manually 
assigned to the network. The network was clustered a before using the MCL 
function. The clustering produced nine clusters with a minimum size of six genes in 
node. The cluster lists were extracted. The list, consisting of pseudogenes, functional 
genes and the cluster that they group into were analysed for enrichment using 
Fisher’s exact test (as described in 3.2.1.4).  
3.2.1.5.1 Mapping pseudogenes onto the network 
As the proof of concept used a relatively small network the mapping of pseudogene  
could be performed manually, however, in life size data set this would not be 
possible. For the given time frame mapping the pseudogenes to the network was not 
feasible. The previous work in this chapter produced lists of genes and pseudogenes 
mapped to KO (kegg orthology) IDs. The sif format does not seem to have a 
consistent way of annotating enzymatic nodes, some have common gene names, E.C 
number or truncated protein product. The fact that each node only held information 
on one enzyme meant that a lot information would be lost.  
 
In order to get all of the node information the KGML format would need to be 
parsed. This could be parsed into a hash where the KO ID would be the key and any 
KOs that share a node would be recorded as values. Files which have KO ID mapped 
to gene name and protein product could be downloaded from the KEGG server 
(subject to paying their subscription fees). These could then be integrated into the 
aforementioned hash. The hash could then be iterated through with the pseudogene 





recorded as having a pseudogene and added to a list. This list would be just the nodes 
that contain an enzyme with a pseudogene.  
 
A script could then be written that would go through the sif file and the list of 
pseudogene nodes systematically looking for matches between the sif node and the 
pseudogene list. If the node does contain a pseudogene this mode would be assigned 
to the pseudogene class. The assignment of the pseudogene class means that a sub-
network can be viewed. 
 
3.2.2 Results 
This section is divided into intraserovar comparisons, to ascertain the suitability of 
representative strains and interserovar comparisons to look at similarities and 
differences between different serovars. The full results for this section are available 
Appendix A: KEGG_summary.xlsx 
3.2.2.1 Intraserovar comparisons 
3.2.2.1.1 Gallinarum 
Strain 287/91 had more pseudogenes than SG9, 309 and 276 respectively. There 
were 35 different pathways involving pseudogenes in 287/91 and 38 in SG9. 
 
Table 6 shows that there were six unique pathways in Gallinarum SG9 all associated 
with one gene (SG9_2441). There were three unique pathways in 287/91 assigned to 
3 separate genes. 
 
The Gallinarum strains show high similarity at the KEGG higher description level 
(Figure 17). Looking more specifically at pathways, there are some deviations 
between pseudogene formation in KEGG pathways, showing slight variation of 
pathway frequency rather than complete omission of a particular pathway. Figure 18 
is in descending frequency of pseudogenes to pathways in Gallinarum SG9, the 
pseudogene frequency in Gallinarum 287/91 shows the same descending pattern but 








Table 6 Pathways showing pseudogene formation unique to one strain in the Gallinarum serovar after comparison between SG9 and 287/91 for pseudogene formation in 
pathways. 
Strain Pathway Pathway Description Pseudogene Function 
SG9  00280 
Valine, leucine and isoleucine 
degradation SG9_2441 3-ketoacyl-CoA thiolase 
SG9  00281 Geraniol degradation SG9_2441 3-ketoacyl-CoA thiolase 
SG9  00362 Benzoate degradation SG9_2441 3-ketoacyl-CoA thiolase 
SG9  00410 beta-Alanine metabolism SG9_2441 3-ketoacyl-CoA thiolase 
SG9  00592 alpha-Linolenic acid metabolism SG9_2441 3-ketoacyl-CoA thiolase 
SG9  00642 Ethylbenzene degradation SG9_2441 3-ketoacyl-CoA thiolase 
287/91 00633 Nitrotoluene degradation SG0855 nitroreductase A; K10678 nitroreductase [EC:1.-.-.-] 
287/91 00920 Sulfur metabolism SG1654 
protein MalY (EC:4.4.1.8); K14155 cystathione beta-lyase 
[EC:4.4.1.8] 
287/91 00020 Citrate cycle (TCA cycle) SG4145 
class I fumarate hydratase (EC:4.2.1.2); K01676 fumarate 













































Figure 18 Comparison of frequency of pseudogenes in KEGG pathways between two Gallinarum strains, SG9 and 287/91, the order of pathways is based on decreasing 
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Choleraesuis strain SC-B67 had 154 pseudogenes compared to the 116 in 
Choleraesuis SCA50. There were no unique pseudogene pathways in Choleraesuis 
SCA50, Choleraesuis SC-B67 on the other hand, had 9 unique pseudogene pathways 
from 6 different genes. 
 
The distribution of pseudogenes in higher KEGG terms showed a similar pattern but 
there were proportionally less for each description in Choleraesuis SCA50 (Figure 
19). However, Figure 20 shows that the distribution between the two strains was 







Table 7 shows pathways with pseudogene formation unique to one serovar in the Choleraesuis strain. 
Strain Pathway Pathway Description Pseudogene Function 
SC-B67 00230 Purine metabolism SCH_PS80 5'-nucleotidase/2',3'-cyclic phosphodiesterase 
SC-B67 00230 Purine metabolism SCH_PS83 
bifunctional phosphoribosylaminoimidazolecarboxamide 
formyltransferase/IMP cyclohydrolase (EC:2.1.2.3 3.5.4.10) 
SC-B67 00680 Methane metabolism* SCH_PS37 esterase (EC:3.1.1.1) 
SC-B67 00240 Pyrimidine metabolism SCH_PS80 5'-nucleotidase/2',3'-cyclic phosphodiesterase 
SC-B67 00620 Pyruvate metabolism SCH_PS81 
formate acetyltransferase 2; K00656 formate C-acetyltransferase 
[EC:2.3.1.54] 
SC-B67 00640 Propanoate metabolism SCH_PS81 




acid metabolism SCH_PS72 acetolactate synthase 2 catalytic subunit 
SC-B67 00670 
One carbon pool by 
folate SCH_PS83 
bifunctional phosphoribosylaminoimidazolecarboxamide 
formyltransferase/IMP cyclohydrolase (EC:2.1.2.3 3.5.4.10) 
SC-B67 00760 
Nicotinate and 
nicotinamide metabolism SCH_PS80 5'-nucleotidase/2',3'-cyclic phosphodiesterase 






Figure 19 Comparison of higher level KEGG assignment of pseudogenes between two Choleraesuis strains 
(SC-B67 and SCA50) ordered by decreasing frequency in SC-B67. 
 
 
Figure 20 Comparison of pseudogene frequency in KEGG pathways between two different Choleraesuis 








































































3.2.2.2 Interserovar comparisons 
The number of functional pathways vs. pseudogenes pathways was much bigger. 
With that in mind, the pathway counts were converted into percentages so that 
functional pathways could be easily compared to pseudogene pathways. These are 
presented on a logarithmic scale because some of the KEGG descriptions (such as 
‘Metabolism’) were far more frequent, skewing the visualisation in a graph. These 
were ordered in descending order by functional pathways and visualised as radial 
diagrams. Figure 21 shows that all four serovars have a very similar distribution of 
pathways assigned to functional genes. The radial diagram in Figure 22 shows the 
distribution of pathways assigned to pseudogenes. It is in the same order as Figure 
21, and shares the spiral pattern in the first four pathways. After this point the 
pathway distribution is unique across serovars and between functional and non-
functional gene assignment within serovars. 
 
Of 397 pathways in KEGG only 72 actually had genes assigned to them. This is 
probably because many of the pathways are Eukaryote or Mammal specific, such as 
‘Lysosome’ and ‘Taste Transduction’ respectively. 
 
For the ‘higher pathways’ rather than 397 there were only 50 more general terms 
which encompass the original terms. Of these 50 terms only 20 had genes assigned to 
them. 
 
There were 53 different pathways (in both tiers) that have functional genes but no 
pseudogenes across all serovars (Appendix C). Many of the pathways were 
associated with genetic information processing, higher terms included ‘Nucleotide 
Metabolism’ and ‘Replication and Repair’, the KEGG pathways included ‘Mismatch 
Repair’, ‘Protein Export’ and ‘DNA Replication’. The five most common terms 
(based on functional gene frequency) that had no pseudogenes were ‘Nucleotide 
Metabolism’, ‘Purine Metabolism’, ‘Replication and Repair’, ‘Pyrimidine 
Metabolism’ and ‘Folding, Sorting and Degradation’. Other notable pathways such 
as ‘Streptomycin Biosynthesis’, ‘Lipopolysaccharide Biosynthesis’ and ‘Novobiocin 





















































































11 pathways were found to have pseudogenes across all serovars, 9 of these were 
‘Metabolism’ pathways. The other two were the ‘Phosphotransferase system (PTS)’ 







The five pseudogene pathways unique to Choleraesuis SCA50 were ‘Oxidative 
phosphorylation’, ‘Glycerophospholipid metabolism’, ‘Pantothenate’ and ‘CoA 
biosynthesis’ and ‘Peptidoglycan biosynthesis’ which is part of the higher pathway 
‘Glycan Biosynthesis and metabolism’ (Table 8). 
 
There was one higher description and one pathway with pseudogene formation that 
were present across all serovars except for Choleraesuis; the higher description being 
‘Metabolism of Other Amino Acids’, which contains the aforementioned pathway 
‘Selenocompound metabolism’ (Table 9). 
 
The pathways for Choleraesuis SCA50, ordered by significance are shown in Figure 
23. None of the results showed any significance for the adjusted p-values. ‘Pentose 










Figure 23 Choleraesuis SCA50 - Observed and expected pseudogene counts in KEGG pathways and higher 
descriptions calculated using Fisher's exact test, ordered by ascending p-value. Pathways with a ‘*’ 
indicate significance before adjustment. 
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Table 8 Shows pathways which display Choleraesuis SCA50 specific pseudogene formation. Pink cells show less observed pseudogenes than expected (according to Fisher’s 
exact test), Amber cells show identical observed and expected counts, Green cells show more observed pseudogene formation compared to that predicted by Fisher’s exact test. 
Pathway Description 
Functional Count Expected Pseudo Count Observed Pseudo Count 
Gall Chol Dub Typh Gall Chol Dub Typh Gall Chol Dub Typh 
15 
Glycan Biosynthesis and 
Metabolism 49 50 50 52 2 1 1 0 0 1 0 0 
00190 Oxidative phosphorylation 41 41 42 41 2 1 1 0 0 2 0 0 
00564 
Glycerophospholipid 
metabolism 26 27 25 27 1 0 0 0 0 2 0 0 
00550 Peptidoglycan biosynthesis 23 24 24 24 1 0 0 0 0 1 0 0 
00770 
Pantothenate and CoA 
biosynthesis 21 21 21 22 1 0 0 0 0 1 0 0 
 
Table 9 Shows pathways only disrupted in Gallinarum Dublin and Typhimurium. Pink cells show less observed pseudogenes than expected (according to Fisher’s exact test), 
Amber cells show identical observed and expected counts, green cells show more observed pseudogene formation compared to that predicted by Fisher’s exact test. 
Pathway Description 
Functional Count Expected Pseudo Count Observed Pseudo Count 
Gall Chol Dub Typh Gall Chol Dub Typh Gall Chol Dub Typh 
9 
Metabolism of Other Amino 
Acids 66 62 65 63 3 1 1 0 5 0 1 1 









Salmonella Dublin SD3246 had eight pathways and one higher description which 
only showed pseudogene formation in this serovar. The only higher description, 
Translation, holds the Ribosome pathway which is one of the eight pathways. The 
other 7 pathways were either ‘Metabolism’ pathways or ‘Xenobiotics and 
degradation’ pathways (Table 10). 
 
There were no KEGG descriptions/pathways showing pseudogene formation that 
were present across all serovars except for Dublin. 
 
There were no significant pathways according to adjusted Fisher’s exact test. Those 
significant prior to adjustment were ‘Toluene degradation’, ‘Chlorocyclohexane and 









Figure 24 Dublin SD3246 - Observed and expected pseudogene counts in KEGG pathways and higher 
descriptions calculated using Fisher's exact test, ordered by ascending p-value. Pathways with a ‘*’ 
indicate significance before adjustment. 
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Table 10 Shows pathways which display Dublin specific pseudogene formation. Pink cells show less observed pseudogenes than expected (according to Fisher’s exact test), 
Amber cells show identical observed and expected counts, Green cells show more observed pseudogene formation compared to that predicted by Fisher’s exact test. 
Pathway Description 
Functional Count Expected Pseudo Count Observed Pseudo Count 
Gall Chol Dub Typh Gall Chol Dub Typh Gall Chol Dub Typh 
6 Translation 82 79 78 84 3 1 1 0 0 0 1 0 
03010 Ribosome 55 52 50 56 2 1 1 0 0 0 1 0 
00620 Pyruvate metabolism 41 42 41 43 2 1 1 0 0 0 1 0 
00730 Thiamine metabolism 12 12 13 13 1 0 0 0 0 0 1 0 
00750 Vitamin B6 metabolism 10 10 10 10 0 0 0 0 0 0 1 0 
00380 Tryptophan metabolism 9 9 9 9 0 0 0 0 0 0 1 0 
00623 Toluene degradation 9 8 1 9 0 0 0 0 0 0 1 0 
00361 
Chlorocyclohexane and 
chlorobenzene degradation 2 2 1 2 0 0 0 0 0 0 1 0 










Gallinarum SG9 was the only serovar with a pathway, ‘Starch and Sucrose 
Metabolism’, that shows significant pseudogene formation after adjusting the p-value 
from the Fisher’s exact test. There were 6 pathways that were flagged as significant 
prior to adjusting the p-values, they were ‘Arginine and Proline Metabolism’, 
‘Nucleotide Metabolism’, ‘Glutathione Metabolism’, ‘Ascorbate and Aldarate 
Metabolism’, ‘Ethylbenzene Degradation’ and ‘Flagellar Assembly’. It is worth 
noting that Nucleotide is under represented, that is there were less pseudogenes in 
this pathway than expected according to Fisher’s exact test. 
 
There were 16 pathways and two higher descriptions that showed pseudogene 
formation in Gallinarum SG9 only (Table 11). The two higher pathways were 
‘Infectious Diseases’ and ‘Metabolism of Terpenoids and Polyketides’ both only had 
one pseudogene. With that in mind the pathways they encompassed were ‘Bacterial 
Invasion of Epithelial Cells’ and ‘Geraniol Degradation’; respectively making those 
Gallinarum specific in terms of pseudogene formation too. The other 14 pathways 
could be broadly grouped into, ‘Amino acid metabolism’ (6 pathways), ‘Xenobiotics 
Biodegradation and Metabolism’ (4 pathways), ‘Lipid Metabolism’ (two), 
‘Carbohydrate Metabolism’ (‘Glycolysis/Gluconeogenesis’) and, ‘Energy 
Metabolism’ (‘Methane metabolism’). 
 
There were no KEGG descriptions/pathways showing pseudogene formation that 









Figure 25 Gallinarum SG9 - Observed and expected pseudogene counts in KEGG pathways and higher 
descriptions calculated by Fisher's exact test, ordered by ascending p-value. Pathways with a ‘*’ indicate 
significance before adjustment. 
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Table 11 Shows pathways which have Gallinarum specific pseudogene formation. Pink cells show less observed pseudogenes than expected (according to Fisher’s exact test), 
Amber cells show identical observed and expected counts, Green cells show more observed pseudogene formation compared to that predicted by Fisher’s exact test. 
Pathway Description 
Functional Count Expected Pseudo Count Observed Pseudo Count 
Gall Chol Dub Typh Gall Chol Dub Typh Gall Chol Dub Typh 
00330 Arginine and proline metabolism 43 44 41 44 2 1 1 0 5 0 0 0 
00680 Methane metabolism 37 31 34 38 2 1 1 0 2 0 0 0 
00010 Glycolysis / Gluconeogenesis 35 34 33 37 1 1 0 0 3 0 0 0 
00480 Glutathione metabolism 18 18 19 18 1 0 0 0 3 0 0 0 
00071 Fatty acid metabolism 12 13 11 13 1 0 0 0 2 0 0 0 
00260 
Glycine, serine and threonine 
metabolism 31 31 32 31 1 1 0 0 1 0 0 0 
19 
Metabolism of Terpenoids and 
Polyketides 26 24 27 27 1 0 0 0 1 0 0 0 
05100 Bacterial invasion of epithelial cells 10 9 8 9 0 0 0 0 1 0 0 0 
14 Infectious Diseases 10 9 8 9 0 0 0 0 1 0 0 0 
00280 
Valine, leucine and isoleucine 
degradation 9 9 8 10 0 0 0 0 1 0 0 0 
00410 beta-Alanine metabolism 9 9 8 9 0 0 0 0 1 0 0 0 
00460 Cyanoamino acid metabolism 9 8 9 8 0 0 0 0 1 0 0 0 








Chloroalkane and chloroalkene 
degradation 6 5 5 6 0 0 0 0 1 0 0 0 
00626 Naphthalene degradation 5 5 4 5 0 0 0 0 1 0 0 0 
00281 Geraniol degradation 4 4 4 4 0 0 0 0 1 0 0 0 
00592 alpha-Linolenic acid metabolism 3 3 3 3 0 0 0 0 1 0 0 0 






There were two pathways with pseudogene formation that were unique to Salmonella 
Typhimurium 4/74, namely, ‘Sulfur Metabolism’ and ‘C5-Branched acid 
metabolism’ (Table 12). 
 
The data was also interrogated for pseudogene formation across all serovars bar 
Typhimurium. Eight pathways were found, these could be indicative of 
Typhimurium’s method of infection (Table 13). The pathways included ‘Fructose 
and mannose metabolism’, ‘Two-component system’ and ‘Cell Motility’. 
 
Using the unadjusted p-values there were four significant pathways for pseudogene 
formation according to the unadjusted Fisher’s exact test. Namely, ‘Nitroluene 
degradation’, ‘C5-Branched dibasic acid metabolism’, ‘Sulfur metabolism’ and 










Figure 26 Typhimurium ST4/74 - Observed and expected pseudogene counts in KEGG pathways and 
higher descriptions calculated using Fisher's exact test, ordered by descending observed count. 
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Table 12 Pseudogene pathways only found in Typhimurium 4/74. Pink cells show less observed pseudogenes than expected (according to Fisher’s exact test), Amber cells show 
identical observed and expected counts, Green cells show more observed pseudogene formation compared to that predicted by Fisher’s exact test. 
Pathway Description 
Functional Count Expected Pseudo Count Observed Pseudo Count 
Gall Chol Dub Typh Gall Chol Dub Typh Gall Chol Dub Typh 
00920 Sulfur metabolism 14 14 14 15 1 0 0 0 0 0 0 1 
00660 C5-Branched dibasic acid metabolism 12 11 12 12 0 0 0 0 0 0 0 1 
 
Table 13 Shows host specific pathway loss, that is pathways only lost in Gallinarum, Choleraesuis and Dublin. Pink cells show less observed pseudogenes than expected 
(according to Fisher’s exact test), Amber cells show identical observed and expected counts, Green cells show more observed pseudogene formation compared to that predicted 
by Fisher’s exact test. 
Pathway Description 
Functional Count Expected Pseudo Count Observed Pseudo Count 
Gall Chol Dub Typh Gall Chol Dub Typh Gall Chol Dub Typh 
02010 ABC transporters 165 171 168 175 7 3 3 0 9 3 5 0 
02020 Two-component system 137 142 136 147 6 2 2 0 6 3 3 0 
5 Signal Transduction 137 142 136 147 6 2 2 0 6 3 3 0 
7 Metabolism of Cofactors and Vitamins 154 153 160 159 6 3 2 0 4 1 3 0 
16 Cell Motility 51 54 52 54 2 1 1 0 5 1 1 0 
00051 Fructose and mannose metabolism 46 47 47 55 2 1 1 0 2 2 2 0 
03070 Bacterial secretion system 44 42 54 45 2 1 1 0 2 1 1 0 
00040 
Pentose and glucuronate 







Table 14 Shows pathways which have no pseudogenes across all hosts. Pink cells show less observed pseudogenes than expected (according to Fisher’s exact test), Amber cells 
show identical observed and expected counts, Green cells show more observed pseudogene formation compared to that predicted by Fisher’s exact test. 
Pathway Description 
Functional Count Expected Pseudo Count Observed Pseudo Count 
Gall Chol Dub Typh Gall Chol Dub Typh Gall Chol Dub Typh 
10 Nucleotide Metabolism 104 101 102 99 4 2 1 0 0 0 0 0 
00230 Purine metabolism 80 77 78 75 3 1 1 0 0 0 0 0 
17 Replication and Repair 57 55 59 59 2 1 1 0 0 0 0 0 
00240 Pyrimidine metabolism 53 51 51 51 2 1 1 0 0 0 0 0 







The comparison between observed and predicted pseudogene frequency can indicate 
non-essential and essential pathways for host adaptation. With the genomes 
published in chapter 2, we have a unique opportunity to compare host adapted 
serovars with a host generalist. 
 
The null hypothesis is that mutations within a genome can be considered as a 
randomly occurring phenomenon; therefore, if there were no essential genes in the 
genomes we would expect to see a pattern of mutation formation similar to the 
frequency of functional genes. That is if there are a lot genes linked to carbohydrate 
metabolism, for example, then we would expect to see gene loss for these pathways 
to be high based purely on chance mutation. If however there is some kind of 
selection pressure we would expect to see a much lower frequency of pseudogene 
pathways for essential genes. Figure 21 and Figure 22 show that pseudogene 
formation is not completely random and that there is a selection pressure on some 
pathways. For example, higher description ‘nucleotide metabolism’ and pathway 
‘replication and repair’ have no pseudogenes. These pathways are involved in core 
functions rather than pathogenesis, the data supports that any gene loss in these 
pathways would be detrimental. 
 
The suitability of using KEGG orthology and pathways is questionable, this analysis 
has shown inconsistencies in their pathway assignment quality and the fact that the 
KEGG ftp site is now only accessible for a fee is disappointing.  
 
It is worth noting that pseudogene formation does not confer complete loss of 
functionality, there could be alternate routes in a given pathway or even paralogs in 
the genome, with that in mind the next step to these analyses would be to explore the 
pathways of interest in more detail to actually look for paralogs and alternative routes 
(Figure 27 and Figure 28).   
 
In terms of in silico methods stochiometric formulas for known reactions can be 







mathematical model can be used to predict the optimum route for a given pathway 
[Beste 2010]. 
 
Not only can these models predict the potential resilience of a given pathway to 
pseudogene formation but they actually used the technique to predict errors in the 
annotation based on information from pathways, It has been shown that in the 
glycerol utilization pathway is dependent on the glpK gene. This is contrary to the 
genome annotation which showed several alternative routes. Knock-out of the glpK 
gene confirmed that the model was correct, and glpK is essential for growth on 
glycerol [197]. Beste et al. were able to prove that the other genes are misannotated 
as alternate routes [198, 199]. 
 
Further to this tools such as Acorn, are available now for integrating simulations of 
genome scale metabolic reaction networks with metabolic pathways and mapping 
them to genome annotation and from that predicting the essentiality of each gene 
[200]. 
 
Another possible method of large scale analysis would be the use of phenotypic 
arrays such as Biolog. Biolog looks at the cell growth of a given strain in different 
substrates. This has been used with Salmonella strains to examine functional 
reduction of pathways across different strains [201]. One could envision an 
experiment where genes are systematically knocked out for a given pathway. Each 
mutant could then be tested to see how it grows on different media. From this it 
would be possible to see how well the mutant grows in substrates associated with the 
pathway of interest.  
3.2.3.1 The suitability of representative serovars 
The intraserovar comparison is of interest because the previously sequenced strains 
do not have well defined virulence. They were isolated from infected livestock some 
years ago and have since been growing in a lab. Conversely, our serovars have 
known virulence, so finding areas of difference/similarity will shed light on the 






The fact that the pseudogene formation was similar between strains in the host-
specifist serovar (Gallinarum) and showed deviance in the host-restricted 
(Choleraesuis) serovar could be explained by their host specificity. As serovars 
become more host specific we see a higher level of gene attrition. As Choleraesuis 
can infect more than one different host, perhaps it is in the process of becoming host 
specific and shows an intermediate level of gene loss, where different pseudogenes 
have formed in different strains. For example, Choleraesuis SC-B67 has more 
pseudogenes, including shdA which is a well-known host colonisation factor. 
Mutation studies have shown that it is not needed in pigs [202], yet it is still a fully 
formed gene in Choleraesuis SCA50 (SCA50_2684) but has a frame shift in 
Choleraesuis SC-B67 (SCPS112). The fact that the gene is still functional in 
Choleraesuis SCA50 is not indicative of its requirement in the genome. The 
pseudogene formation in SC-B67 but lack of attrition in SCA50 could be indicative 
that SC-B67 has been host-adapted for longer. 
 
Another limitation with this comparison is that it is based on publically available 
annotations from different labs. This will contribute to some of the discrepancies. For 
example six of the pseudogenes in Choleraesuis SC-B67 were annotated as 
selenocysteine read-throughs in Choleraesuis SCA50’s orthologs. In terms of DNA 
these gene sequences are identical between strains, it is a question of which 
annotation one accepts when performing the comparisons. The only sure way of 
getting consistency for this type of comparison would be to annotate both genomes 
by exactly the same method. 
 
Host specific servoars seem to be streamlined enough that they predominantly carry 
genes that are specific to a small niche meaning that in theory any strain from that 
serovar could be used as a representative. The general idea of defining representative 
strains for a serovar is questionable, especially when the serovar has a broader host 
specificity or is in the transition towards host specificity. I believe that advancements 
could be made through combining experimental data such as transcriptomics and 
mutagenesis to find a core gene set for a given serovar’s host phenotype. For 







tolerance to acid. This integrated mutation studies with metabolic pathways, 
transcriptomics and phenotypic analysis [203]. 
 
As discussed, there were several limitations to this exercise, firstly the comparisons 
only consisted of two genomes from the serovar. It is recognised that some serovars 
are atypical of their expected phenotype [23]. Repeating this process now may be 
more informative as there are more Choleraesuis and Gallinarum genomes available 
in the public domain. Secondly, the annotation and assembly of our four serovars 
took considerable time. As there are now more tools available for assembly and 
annotation and bacterial sequencing is considerably cheaper it is more feasible to 
actually perform a more extensive analysis. 
 
The premise of serovars and genovars is in some respects limited. These definitions 
are manmade groupings, evolution doesn't fall neatly into groups. It is complex to 
fathom how many serovars would be needed for a comprehensive analysis of host 
specificity. Examining the pan-genome of Salmonella could offer some clues. By 
plotting all of the available genomes against the cumulative count of genes families 
one can look at where the graph plateaus, this gives an indication of how many 
genomes are required to see most of the genes representative of Salmonella. 
Recently, the Salmonella pan genome was described as a 'closed genome', meaning 
that adding a new serovar to the pan genome plot shows a jump in novel gene 
families, however, adding a second isolate for the same serovar has little effect on 
the number of gene families [20]. Other work with Salmonella has shown that within 
a given serovar there is a tendency towards low diversity [48]. For example, Holt et 
al. used 17 strains of S.typhi for SNP analysis, they described typhi as having low 
recombination and needed a higher number of strains in order to obtain SNP data 
[22]. When looking at the genes rather than polymorphisms far fewer than 17 strains 
would have been needed. From these experiments we can infer that although only 
four serovars seems like a low number of representatives perhaps adding more 
wouldn't enhance the study in terms of increasing our knowledge of host specificity. 
Nevertheless, adding more isolates of the same serovar would definitely increase the 






Another method of adding more gravitas to the intraserovar comparison would be to 
define the virulence of the reference strains Choleraesuis SC-B67 and Gallinarum 
287/91. This could be achieved by trying to infect pigs and chickens and observing 
the effects of infection. 
3.2.3.2 Universal preservation of genetic processing genes and loss in 
metabolism 
The comparison of pseudogene formation across all our serovars shows that it is 
variable, however there is a trend towards the preservation of certain pathways. The 
radial diagram (Figure 22) shows that there is no pseudogene formation in 
‘nucleotide metabolism’, ‘replication and repair’ and ‘folding sorting and 
degradation’. These are all involved in genetic information processing, these would 
all fall into the core genome and would likely be highly detrimental to the organism 
if disrupted. 
 
Converse to this most of the variation between pseudogenes is in different types of 
metabolism, this concurs with the paradigm that Salmonella serovars are extremely 
flexible in terms of nutrient use, previous studies have shown that they have a lot of 
scope for enzyme loss [204, 205]. 
3.2.3.3 Role of Starch and Sucrose Metabolism in Gallinarum 
This pathway shows significant enrichment in gene loss in Gallinarum SG9 and 
checking this against the Gallinarum 287/91 strain shows identical 
pseudogene/absence in this pathway. The pathway map shows the regions of gene 
loss (Figure 27). Gene loss/absence in the glg(ABC) genes (some of the genes lost in 
this pathway) have been recorded before in other chicken specific serovars [26]. 
Further to this there have been links between glgC and extra-host survival, that is 
survival outside of the host as these sugars are packed into endogenous stores for 
times of starvation [206]. This could concur with the way that Gallinarum is spread, 








To test this hypothesis a combination of gene mutation/recombinase would be 
required in Typhimurium and Gallinarum respectively. If the mutated Typhimurium 
strains show reduced survival in the extrahost environment or the Gallinarum strains 
show increased survival this would be indicative of the role of starch and sucrose 















Figure 27 KEGG pathway map of Starch and Sucrose Metabolism. Green shows functional genes common to Gallinarum SG9 and Typhimurium LT2. Red outline shows 
pseudogene formation in Gallinarum SG9 and Blue outline shows gene absence in SG9. Note that some green areas with a red outline, this occurs when this there is a version 
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3.2.3.4 Pentose and Gluconorate interconversion in Choleraesuis/pigs 
Both typhimurium and choleraesuis infect pigs, however it has been shown that 
typhimurium grows very quickly, causes an immune response, and is cleared by the 
host. In contrast, choleraesuis grows much more slowly and goes on to cause a 
systemic infection [137]. Counter-intuitively, this may be due to choleraesuis being 
less well adapted to the environment of the pig gut, enabling it to grow more slowly 
and therefore avoid the immune response that clears typhimurium. 
 
Pentose and Gluconorate showed pseudogene enrichment in Choleraesuis SCA50 
(Figure 23), closer inspection of this pathway shows that there is a lot of gene 
absence, compared to Typhimurium (Figure 28). These metabolites are commonly 
found in the gut, the ability to process these sugars can add a competitive edge 
against other intestinal microbiota. It has also been linked to increased production in 
response to intestinal inflammation in patients with microbiotal disorders such as 
Irritable Bowel Syndrome, supporting that it might help Salmonella compete against 
other microbes in the gut [207]. With that in mind the disruptions in this pathway in 
Choleraesuis SCA50 could explain why Choleraesuis is less effective at colonising 
the gut [137] compared to typhimurium. Whilst loss of this pathway is 
disadvantageous to growth, it may be advantageous to avoidance of the immune 
response. As we will see in the next section, there was no significance in the TraDIS 
data, supporting the theory that it is not an essential gene for pig colonisation. The 
loss of this function could be indicative that it is not required to colonise pigs (Figure 
23).  
 
A method of validation for the theory that pseudogene formation in Choleraesuis in 
sugar pathways leads to slower net replication in the gut because it is being out 
competed by other members of the gut flora could be to try growing Choleraesuis 
and Typhimurium on different mediums and measure their net replication. The 
relevant genes could be knocked out in typhimurium, or knocked-in in SCA50, to 









Figure 28 KEGG pathway map of Pentose and Glucuronate. Green shows functional genes in Choleraesuis SCA50 and Typhimurium LT2. Red outline shows pseudogene 
formation in Choleraesuis SCA50 and Blue outline shows gene absence in Choleraesuis SCA50. Note that some green areas with a red outline, this occurs when this there is a 
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3.2.3.5 Analysis of KEGG at the network level 
The initial KEGG network in its entirety is enormous, it is complex and there is a 
skew of interactions between nodes. That is, some nodes have very many interactions 
and others have a single interaction. These kinds of network produce a hairball with 
thousands of very small clusters (Figure 29). This is a limitation of manmade 
networks, much like the internet there is a bias towards certain nodes. In order to be 
able to use the network for clustering analysis it needs to be pruned, this requires 
biological knowledge, pruning the wrong nodes would result in losing vital 
information. After pruning, some small groups of nodes became sub networks 
(Figure 30). We found that the clustering improved considerably with pruning, the 
clusters were bigger and fewer (4-19 nodes per cluster and 342 clusters) compared to 









Figure 29 The entire KEGG network visualised in BioLayout, the different coloured nodes represent 




Figure 30 The KEGG network after pruning to remove ubiquitous compounds, sub-networks have formed 
ranging in size from 5-16 nodes. The clustering (groups coloured differently) consisted of 342 clusters with 
the number of nodes per cluster ranging from 4-19. 
 
Further to this, extreme pruning gave a tree that formed reasonable clusters. The 






network (Microbial metabolism in diverse environments). This sub-network was 
used because it was in a more parsable format and reactions were not nodes (see 
section 3.2.3.5.1). This made the network more manageable for a proof of concept as 
mapping pseudogenes had to be performed manually. Figure 31 (A) shows that it is 
possible to get reasonable clustering in the KEGG network but it needs to be 
performed on one of KEGG’s sub-networks. BioLayout served as a good means of 
visualising pseudogenes in the context of a larger network (Figure 31 B), the ability 
to easily cluster the network also meant that pseudogene cluster assignment could 
easily be extracted and used for enrichment analysis (Table 15). 
 
I believe that there is potential to expand the analysis here to the entire KEGG 
network but it requires time and resources beyond the scope of this project. 
 
 
Figure 31 The extreme pruned sub-network of microbial metabolism in diverse environments. A shows 




total expectation observation hypergeometric fisher 
Cluster01 415 28 21 0.999965 0.001025 
Cluster04 7 0 3 0.036668 0.021375 
Cluster02 15 1 4 0.036668 0.024445 
Cluster03 10 1 3 0.042344 0.031758 
Cluster07 6 0 1 0.436245 0.348996 










3.2.3.5.1 Difficulties with the analysis 
One of the main difficulties with this analysis was computing power, the computer 
that this analysis was performed didn’t not have the capacity to perform KEGG 
network scale analyses quickly; on occasion it took over twenty minutes just to open 
the file in BioLayout and another hour to perform the clustering. The KEGG network 
is large, it contains all of the compounds associated with every chemical reaction. 
This includes compounds like H
+
 and ATP which are virtually ubiquitous to every 
chemical reaction. There are other networks in KEGG, these are smaller and are 
formatted to not include reactions as nodes. Further to this the genes are all assigned 
KEGG orthology IDs, making the node annotation more standardised. Table 16 and 
Table 17 give examples of the different format. In order to be able to make a version 
of the entire network that is in the more cluster friendly format all of the pathways’ 
network files (KGML) could be downloaded individually and then combined. This 
would automatically link the nodes and interactions. The only limitation with this is 








rn:R00305 - AH2 
rn:R00305 - Gluconolactone 
E1.14.11.9 - rn:R02444_catalysis 
rn:R01563 - CO2 
rn:R01563 - NH3 
rn:R01563 - Sarcosine 
rn:R03197 - Coproporphyrinogen III 
rn:R03197 - CO2 
2-Dehydro-D-gluconate - rn:R02658 
rn:R01070 - Glyceraldeh... 3-phosphate 
rn:R01070 - Glycerone phosphate 
hemA - rn:R04109_catalysis 
glycine for...ltransferase - rn:R02729_catalysis 
Table 16 Part of the entire KEGG network showing that nodes are not annotated in a standard format, 
with some being truncated and a mixture of enzymes and gene names. 
 
#koK01702_koK01703_koK01704 SEQUENTIAL_CATALYSIS #koK00052 
#koK01687 SEQUENTIAL_CATALYSIS #koK00826 
#cpdC00026 REACTS_WITH #cpdC00407 
#koK00263 SEQUENTIAL_CATALYSIS #koK00053 
#koK00052 METABOLIC_CATALYSIS #cpdC00011 
#EC14123 METABOLIC_CATALYSIS #cpdC00003 
#cpdC00011 REACTS_WITH #cpdC00003 
#koK01649 METABOLIC_CATALYSIS #cpdC02504 










Figure 32 Shows the limitation of using combined data from pathways to infer the entire KEGG network, 







3.3 TraDIS Analysis of Typhimurium SL1344 
The TraDIS (Transposon directed insertion-site sequencing) data in this chapter is 
taken from Chaudhuri et al [208].  The authors studied Salmonella enterica serovar 
Typhimurium strain SL1344 in chickens, pigs and cattle. The importance of this 
study is that the authors are studying a pathogen in food-producing hosts that are of 
worldwide significance, rather than a model system.  
 
The group produced a library consisting of over 7000 mutants, where each mutation 
was identified through DNA sequencing. They compared relative frequencies of 
mutants in pools before and after oral delivery into the host in question and the 
abundance of each mutation was measured as the cell count in culture. From this the 
authors were able to assign a relative fitness score, and associated p-value, to each 
mutant. The locations of the inserts were cross-referenced with the locations of 
genes, providing insight into the importance of each gene during the colonisation and 
infection of each of the three hosts. The methodology employed by Chaudhuri et al. 
is shown in Figure 33. 
 
The group specifically looked for attenuating mutants, these are mutants that showed 
significantly decreased fitness relative to the wild type. They found enrichment in 
attenuation of pathogenicity islands and some species specific colonisation factors, 

















The mutagenesis data produced in the Chaudhuri paper can indicate whether a gene 
is needed for infection. This section is divided into two parts. The first part counts 
the occurrence of each pathway associated with these seemingly essential (negatively 
selected) genes and performs enrichment analysis for selection. If any of the counts 
are drastically lower in one host than the others this may indicate that this pathway is 
not essential for infecting that particular host. 
 
The second section maps our four serovars to the TraDIS data. By looking at patterns 
of pseudogene formation against the attenuation of mutations in a host generalist, it 
might be possible to find patterns between the mechanism of infection and the host. 
For example the data can be used to find non-essential genes for infecting a 
particular host systemically; if Gallinarum SG9 has a particular pseudogene whose 
ortholog in Typhimurium SL1344 is not negatively selected in chickens we can 
speculate that this pathway is required for the colonisation of chickens, systemically 
or enterically. Conversely, if a particular pseudogene is present in Gallinarum SG9 
but is negatively selected in chickens in the TraDIS data this suggests that the gene is 
linked to enteric infection but not essential for systemic infection. 
 
It is worth noting that at the time of this analysis Typhimurium SL1344 was not 
annotated, the TraDIS data was based on open reading frames. Repeating the 
analysis now may produce better mapping due to the available SL1344 annotation 
and the fact that some of the serovars are now available on KEGG, with KO 
assigned. 
3.3.1 Attenuation score 
The attenuation score shows whether more or less mutants colonise the host 
compared to the wild type’s colonisation number. Therefore, a mutation with a 
negative score implies that the gene is essential for infection of that host. Conversely, 
if a mutant has a positive score we hypothesise that the gene is not essential for 








The data for this chapter was analysed by the authors, and provided to me as a 
spreadsheet. The analyses presented in this thesis represent my work, although all 
work up to and including the generation of the original table were carried out by the 
authors of the paper. 
3.3.2.1 Pathway analysis 
Initially the pathways allocated to each serovar in section 3.2.1.2 were used. 
However, when the annotation of Typhimurium SL1344 became publicly available 
along with the orthology file in KEGG this section was repeated with SL1344 as the 
reference rather than LT2. The fact that the TraDIS analysis was performed on 
SL1344 meant that rather than using homology methods to transfer the pathways a 
new script was made. map_mutations.pl gets the genes assigned to each 
mutation point and then map the pathways across from the KEGG orthology file 
(Appendix A: map_mutations.pl). 
  
Enrichment analysis was then performed on this data set (as described in 3.2.1.4) 
with the population counts as all of the pathways that correspond to a mutated gene 
in the TraDIS data. Conversely, the sample group was made using 
TraDIS_sig_genes.pl, this script goes through each mutation and counts the 
pathway if the p-value was below 0.05 and the fold change was below the accepted 
threshold for the host defined by Chaudhuri et al. [208] (Appendix A: 
TraDIS_sig_genes.pl). 
3.3.2.2 Pseudogene ortholog analysis 
Each mutant in the TraDIS data was mapped to the corresponding genes from the 
four sequenced serovars in Chapter 2. This was performed as in section 3.2.1.2, using 








Some genes did not map across even though there was an ortholog in Typhimurium 
SL1344. The genes which showed significant negative selection and did not appear 
to have any orthologs were mapped across manually. 
 
 If the corresponding gene was actually a pseudogene this was recorded. The ‘FC’ 
columns are shaded with a gradient of colour going from red for positive fold change 
to green for negative fold change, the threshold for the individual host was applied as 
a centre point for the gradient (-2,-3,-3 in chicks, calves and pigs respectively). The 
p-value column has cells coloured in green if the value is significant (below 0.05). 
For the full TraDIS results with orthologs and alternative colouring see Appendix A: 
Tradis_with_orthologs.xlsx. 
3.3.3 Results 
This section initially describes the TraDIS results that are common across all hosts, it 
then goes on to look at the individual results for each host (Appendix A: 
Tradis_summary.xlsx) 
3.3.3.1 Results across all four hosts 
There were 6 gene mutations with significant negative selection across all hosts 
where the corresponding serovars (bar Typhimurium 4/74) either had a pseudogene 
or the gene was completely absent (Table 18). 
 
Two pathways were significantly enriched across all hosts after adjusting the p-
values, ‘Bacterial Secretion’ and ‘Lipopolysaccharide biosynthesis’. Three other 
enriched pathways were shared across all hosts' top ten pathways, namely 
‘Streptomycin biosynthesis’, ‘Polypeptide sugar unit biosynthesis and ‘Lipoic acid 







Table 18 Genes which show significant negative selection across all hosts and show pseudogene/absence (labelled as P/A in ortholog status respectively) in our host 
restricted/specific serovars 
SL1344 Locus STM 4/74 Locus Product KEGG Pathway 
Serovar Ortholog Status 
Chol Dub Gall 
SL1344_3228 STM474_3412 Putative phosphotransferase system 
fructose-specific component IIB 
00051 Fructose and mannose 
metabolism 
01100 Metabolic pathways 
02060 Phosphotransferase 
system (PTS) 
A A A 
SL1344_4149 STM474_4407 Putative phage tail sheath protein None P A A 
SL1344_2166 STM474_2278 Galactoside transport atp-binding 
protein mgla 
ABC transporters P P P 
SL1344_1930 STM474_2034 Tail protein None A P A 
SL1344_3227 STM474_3411 Putative fructose-1-phosphate 
kinase 
00051 Fructose and mannose 
metabolism 
A A A 






There were two pseudogenes in Typhimurium 4/74 that showed significant negative 
selection in the TraDIS data across all hosts. Firstly, SL1344_1437 and its ortholog, 
STM474_1517, are both annotated as pseudogenes. The other pseudogene was 
STM474_4286 whose ortholog, SL1344_4051, was not annotated as a pseudogene.  
 
STM474_1517 and its ortholog SL1344_1437 are both pseudogenes and closer 
inspection shows they have identical sequences. Their description is as follows: 
 
In-frame stop codon against amino acid: W; 'TGA' may be suppressed; 
corresponds to NP_455973.1 putative membrane transport protein; Pfam 
domain (MFS_1) truncated. 
 
Performing BLAST against nr shows that the annotation is correct (Figure 34) there 
is a stop codon (TGA) where there should be a W (Tryptophan TGG) and this stop 
codon disrupts the domain. 
 
The other pseudogene in 4/74 with negative selection was STM474_4286, its 
description is: 
 
In-frame stop codon against 'W'; stop codon 'TAG';corresponds to 
NP_462983.1 putative inner membrane protein/MscS Mechanosensitive 
ion channel; Pfam domain(MS_channel) truncated. 
 
The ortholog is SL1344_4051, this is not annotated as a pseudogene. Comparing the 
genomes in ACT showed that 4/74’s gene is larger, spanning a stop codon (Figure 
35). A BLAST search of the 4/74 sequence against nr shows that the hits are the 
same size but have a Tryptophan rather than a stop codon in the sequence (Figure 
36). As the sequence across both SL1344 and 4/74 is identical the larger 4/74 
annotation was accepted suggesting that SL1344_4051 is also a pseudogene with 









Figure 34 Blast results of the pseudogene SL1344_1437 against nr, shows that the stop codon, represented 







Figure 35 Comparison of 4/74 and SL1344 using BLAST shows the alignment for the region of pseudogene 
STM474_4286 (Typhimurium 4/74) and non-pseudogene SL1344_4051 (Typhimurium SL1344). The 4/74 
pseudogene STM474_4286 is larger and spans a stop codon. SL1344_4051 stops at the codon which is 
spanned by STM474_4286. 
 
 
Figure 36 Blast results of the pseudogene STM474_4286 against nr, shows that the stop codon, represented 
by a '-' and circled in red is in the middle of domain and confirms this gene as a pseudogene. It also shows 










Pseudogene analysis of the TraDIS data returned 4 calf specific genes. That is genes 
that are negatively selected only in calves and are only functional in Dublin SD3246 
(and Typhimurium 4/74) (Table 19). Two of them are labelled as phage protein. One 
gene is linked to the ‘Methane metabolism pathway’ and the other is a large repeat 
protein. 
 
Fisher’s exact test results for negative selection in Calves showed two significant 
results after adjusting the p-values, ‘Bacterial secretion system’ and 
‘Lipopolysaccharide biosynthesis’ (Table 20). ‘Citrate cycle’ was significant before 
adjusting the p-value with 11 negatively selected genes out of 20 (the expected 
frequency was 5). 
 
Positive selection tests showed negative enrichment in ‘Bacterial secretion system’ 
which means that there were less positively selected mutations in ‘Bacterial 
secretion’ than expected (Eight expected, two observed), this supports the negative 
selection results in calves. Other negatively enriched mutations for positive selection 
included ‘Nucleotide excision repair’. Conversely, the pathway ‘Folate biosynthesis’ 
and ‘Nicotinate and nicotinamide metabolism’ showed positive enrichment for 







Table 19 The four calf specific negatively selected genes (from TraDIS data for SL1344) which are only functional in Dublin 3246 and show pseudogene/absence in the other 
host specific/restricted serovars. F – functional, A – absent, S – Selenocysteine readthrough. 
SL1344 Locus SD3246 Locus Product 
KEGG 
Pathway 
Serovar Ortholog Status 
Typh Chol Gall 
SL1344_1486 SD3246_1735  Na+/H+ antiporter NhaC Methane 
metabolism 
F A P 
SL1344_2704 SD3246_2962 
 
Hypothetical bacteriophage protein None F A A 
SL1344_2709 SD3246_2967 Bacteriophage integrase ABC 
transporters 
F A A 
SL1344_2661 SD3246_2921 
 
VCBS repeat-containing protein and Large 
repetitive protein bapA 
None F S P 







Table 20 Top 10 negatively selected pathways in calves. Pathways are organised into those positive enrichment (more observed than expect) and negative enrichment (less 
observed than expected), green and pink cells respectively. Red text indicates pathways that are significantly negatively selected 
Pathway Description Population Expected Observed Hypergeometric Fisher’s 
Adjusted 
Fisher’s 
P03070 Bacterial secretion system 20 5 14 0.000864 8.64E-06 0.000864 
p00540 Lipopolysaccharide biosynthesis 7 2 6 0.040965 0.000819 0.040965 
p00020 Citrate cycle (TCA cycle) 20 5 11 0.060131 0.001804 0.060131 
p00521 Streptomycin biosynthesis 9 2 6 0.143674 0.006411 0.160279 
p00190 Oxidative phosphorylation 29 7 13 0.143674 0.011365 0.175344 
p00523 Polyketide sugar unit biosynthesis 5 1 4 0.175344 0.011481 0.175344 
p00785 Lipoic acid metabolism 3 1 3 0.175344 0.012274 0.175344 
p05132 Salmonella Infection 11 3 6 0.288654 0.023092 0.288654 
p05100 Bacterial Invasion of Epithelial Cells 6 1 4 0.313537 0.028218 0.313537 








Table 21 Top 10 positively selected pathways in calves Pathways are organised into those positive enrichment (more observed than expect) and negative enrichment (less 
observed than expected), green and pink cells respectively. Red text indicates pathways that are significantly positively selected 
Pathway Description Population Expected Observed Hypergeometric Fisher’s Adjusted Fisher’s 
p03070 Bacterial secretion system 20 8 2 0.999594 0.004574 0.457362 
p00790 Folate biosynthesis 6 2 5 0.042451 0.042451 1 
p03420 Nucleotide excision repair 7 3 0 1 0.045702 1 
p00500 Starch and sucrose metabolism 25 10 15 0.03578 0.060594 1 
p00400 
Phenylalanine, tyrosine and 
tryptophan biosynthesis 20 8 4 0.986431 0.066853 1 
p03030 DNA replication 5 2 0 1 0.084941 1 
p00640 Propanoate metabolism 14 6 9 0.060846 0.096731 1 
p00010 Glycolysis / Gluconeogenesis 25 10 6 0.975186 0.100385 1 
p00760 
Nicotinate and nicotinamide 
metabolism 11 4 7 0.10333 0.13088 1 









There were no genes that showed chick specific negative selection whilst having 
functional orthologs in Gallinarum SG9 and non-functional orthologs/absence in Dublin 
SD3246 and Choleraesuis SCA50. 
 
The enrichment analysis revealed three pathways that were significant after adjusting 
the p-value. As with the Calf enrichment analysis ‘Lipopolysaccharide biosynthesis’ 
and ‘Bacterial secretion system’ were significant. In addition other pathways including 
Streptomycin biosynthesis were significant after adjustment. Two negatively enriched 
pathways for negative selection were in the top ten enriched pathways for chicks. 
Negative enrichment in this case means that number of negatively selected mutations 
for a given pathway were less than expected. The two pathways were ‘Flagellar 
Assembly’ (4 expected, zero observed) and ‘Two-Component system’ (24 expected, 16 
observed). 
 
The positive selection enrichment analysis concurs with the above, showing enrichment 
for ‘Flagella assembly’ (Table 23). ‘Arginine and proline’ metabolism is also 
significantly enriched. This concurs with section 3.2.2.2.3 which shows Gallinarum 
specific pseudogene formation and higher observed pseudogene formation than 






Table 22 Top 10 negatively selected pathways in chicks. Pathways are organised into those positive enrichment (more observed than expect) and negative enrichment (less 
observed than expected), green and pink cells respectively. Red text indicates pathways that are significantly negatively selected 
Pathway Description Population Expected Observed Hypergeometric Fisher’s 
Adjusted 
Fisher’s 
p00540 Lipopolysaccharide biosynthesis 7 2 7 0.004247 4.25E-05 0.004247304 
p03070 Bacterial secretion system 20 5 13 0.004773 9.55E-05 0.004773002 
p00521 Streptomycin biosynthesis 9 2 7 0.032285 0.000969 0.032284944 
p02040 Flagellar assembly 18 4 0 1 0.010299 0.171210444 
p03018 RNA degradation 12 3 7 0.17121 0.010811 0.171210444 
p00523 Polyketide sugar unit biosynthesis 5 1 4 0.17121 0.013182 0.171210444 
p00785 Lipoic acid metabolism 3 1 3 0.17121 0.013697 0.171210444 
p03060 Protein export 3 1 3 0.17121 0.013697 0.171210444 
p01110 
Biosynthesis of secondary 
metabolites 190 46 58 0.17121 0.019843 0.220482497 









Table 23 Top 10 positively selected pathways in chicks. Pathways are organised into those positive enrichment (more observed than expect) and negative enrichment (less 
observed than expected), green and pink cells respectively. Red text indicates pathways that are significantly positively selected 
Pathway Description Population Expected Observed Hypergeometric Fisher’s Adjusted Fisher’s 
p02040 Flagellar assembly 18 3 8 0.004606 0.004606 0.271752 
p00330 Arginine and proline metabolism 26 4 10 0.005435 0.005435 0.271752 
p00400 
Phenylalanine, tyrosine and 
tryptophan biosynthesis 20 3 0 1 0.059588 1 
p01120 
Microbial metabolism in diverse 
environments 121 20 13 0.980817 0.064286 1 
p00600 Sphingolipid metabolism 3 0 2 0.072715 0.072715 1 
p00340 Histidine metabolism 11 2 4 0.09209 0.09209 1 
p05132 Salmonella Infection 11 2 4 0.09209 0.09209 1 
p02010 ABC transporters 89 15 9 0.975474 0.096154 1 
p00240 Pyrimidine metabolism 25 4 1 0.989906 0.102462 1 








There were no mutations in the TraDIS data that showed pig specific negative 
selection and loss of function in Gallinarum SG9 and Dublin SD3246 orthologous 
genes.  
 
The only two enriched negatively selected pathways in the TraDIS data for pigs 
(after adjusting p-value) were ‘Bacterial secretion system’ and ‘Lipopolysaccharide 
metabolism’, which are also significantly negatively selected in calves and chicks 
(Table 24). Of the top ten enriched pathways for negative selection, the following 
were unique to pigs, ‘Folate biosynthesis’, ‘Chloroalkane and chloroalkene 
degradation’ and ‘Naphthalene degradation’ (Table 24). 
 
There were three enriched pathways for positive selection, ‘Lipopolysaccharide 
biosynthesis’, ‘Nitrogen metabolism’ and ‘Alanine, aspartate and glutamate 
metabolism’ (Table 25 
). The positive selection of ‘Lipopolysaccharide biosynthesis’ is contrary to the 









Table 24 Top 11 negatively selected pathways in pigs. Pathways are organised into those positive enrichment (more observed than expect) and negative enrichment (less 
observed than expected), green and pink cells respectively. Red text indicates pathways that are significantly negatively selected 
Pathway Description Population Expected Observed Hypergeometric Fisher’s 
Adjusted 
Fisher’s 
p03070 Bacterial secretion system 20 4 15 3.42E-05 3.42E-07 3.42E-05 
p00540 Lipopolysaccharide biosynthesis 7 2 6 0.027007 0.00054 0.027007 
p00521 Streptomycin biosynthesis 9 2 6 0.141426 0.00437 0.141426 
p03018 RNA degradation 12 3 7 0.141426 0.005734 0.141426 
p00523 Polyketide sugar unit biosynthesis 5 1 4 0.141426 0.008748 0.141426 
p00785 Lipoic acid metabolism 3 1 3 0.141426 0.0099 0.141426 
p03060 Protein export 3 1 3 0.141426 0.0099 0.141426 
p00790 Folate biosynthesis 6 1 4 0.272881 0.021831 0.272881 
p00190 Oxidative phosphorylation 29 6 11 0.341871 0.03784 0.420442 
p00625 
Chloroalkane and chloroalkene 
degradation 2 0 2 0.421027 0.046313 0.421027 








Table 25 Top 10 positively selected pathways in pigs. Pathways are organised into those positive enrichment (more observed than expect) and negative enrichment (less 
observed than expected), green and pink cells respectively. Red text indicates pathways that are significantly positively selected 
Pathway Description Population Expected Observed Hypergeometric Fisher’s Adjusted Fisher’s 
p00540 Lipopolysaccharide biosynthesis 7 0 2 0.022938 0.022938 1 
p00910 Nitrogen metabolism 35 1 4 0.031348 0.031348 1 
p00250 
Alanine, aspartate and glutamate 
metabolism 21 1 3 0.034892 0.034892 1 
p00190 Oxidative phosphorylation 29 1 3 0.079215 0.079215 1 
p00640 Propanoate metabolism 14 0 2 0.085213 0.085213 1 
p00030 Pentose phosphate pathway 22 1 2 0.181939 0.181939 1 
p00240 Pyrimidine metabolism 25 1 2 0.221629 0.221629 1 
p00630 
Glyoxylate and dicarboxylate 
metabolism 25 1 2 0.221629 0.221629 1 
p00330 Arginine and proline metabolism 26 1 2 0.235054 0.235054 1 










The negative selection across all three hosts for ‘Bacterial secretion’ and 
‘Lipopolysaccharide biosynthesis’ is consistent with Salmonella biology. The 
lipopolysaccharide layer and bacterial secretion system are both essential 
components of gram negative bacteria allowing them to interact with the outside 
world, in terms of infection, reproduction and adherence for example. 
 
It is worth noting that one limitation of the TraDIS data is that there are many 
different mutations in a population, perhaps one mutation that would normally be 
viable in its own right is being outcompeted by something that is far more viable. 
One way to overcome this is to perform targeted mutagenesis on genes which are of 
specific interest after performing the TraDIS analysis. 
3.3.4.1 Fructose in the role of gut colonisation 
Pseudogene formation in ‘Fructose and mannose metabolism’ is seen across all 
serovars except Typhimurium 4/74 (Table 13). Coupled with this there is negative 
selection across all hosts in two genes associated with this pathway (Table 18). These 
genes are actually absent in the other serovars, meaning that they are not orthologous 
to the pseudogenes recorded in Table 13 Typhimurium had very few pseudogenes so 
the comparison seemed a little unfair, although this fact itself is indicative of its 
adaptation to multiple hosts. 
 
Fructo-oligosaccharides can be found in the gut of many different animals as there 
are high levels of fructose based compounds in fruit, vegetables and grains. Fructo-
oligosaccharides have been linked to competitive exclusion in gut microbiota [209] 
and the metabolism for these compounds is commonly found in bacteria associated 
with the gastrointestinal tract [210].  
 
There have also been associations made with pathogenicity where fructose presence 
causes a decrease in salmonella resistance in rats [211] and can act as a trigger for 






These findings give rise to some questions. Firstly, is the apparent attrition of this 
pathway in our host adapted serovars due to fructose and mannose being catabolised 
by other routes? We know that the genes in this pathway are significantly attenuated 
in Typhimurium, what would happen if these genes were reinstated in the other 
serovars? This would be especially interesting in Choleraesuis SCA50 because this is 
known to replicate more slowly in the gut compared to Typhimurium [137], could 
this metabolism disruption be causative? 
3.3.4.2 The loss of motility is linked to increased pathogenicity in chickens 
Gallinarum shows high gene attrition in pathways linked to motility such as ‘cell 
motility’ and ‘flagellar assembly’, compared to the other serovars and according to 
Enrichment analysis Figure 22 and Figure 25 respectively.  
 
It is known that Gallinarum as a serovar is non-motile and this has been linked to 
pseudogene formation in flagella genes [213]. The Enrichment analysis of the 
TraDIS data shows that a host generalist like Typhimurium strain SL1344 might 
actually gain an advantage by losing genes in these pathways, (Table 22 and Table 
23). 
 
The pseudogene and TraDIS data presented here clearly correlates well with what we 
already know about Salmonella serovar gallinarum, in that it is non-motile. The data 
highly suggest that being non-motile confers an advantage during infection of the 
chicken. This was observed by Iqbal et al. who in the 2005 study found that mutating 
the fliM gene in Typhimurium ‘showed an enhanced ability to establish systemic 
infection’ in chickens [136]. The exact mode of action of this process is unknown, 
but it is encouraging that both genome analysis and TraDIS analysis support the 
hypothesis that loss of motility is advantageous. One possible explanation is that, by 
losing the ability to construct flagella, gallinarum is able to better avoid the host 
immune response, the flagellum being an obvious target. However, more work needs 
to be done to explain this, particularly why loss of the flagellum confers an 









The fact that these results concur with the literature demonstrates that this method of 
analysis provides scientifically meaningful results. To further examine the role of 
flagella in pathogenicity further mutation studies could be applied, looking at the 
effects of other serovars pathogenicity in chickens. For example, would knocking out 
these pathways in Salmonella serovar Dublin enable it to infect chickens?  
3.4 Concluding Remarks 
This chapter has taken post genomic data, namely pathways and mutagenesis and 
used them to explore enrichment in pseudogene formation and negative selection 
respectively. We see that both genome analysis and TraDIS analysis supports our 
knowledge of the biology of Salmonellae serovars, and we can begin to build up a 
picture of the pathways needed for different serovars to infect different hosts. 
 
Making broad conclusions about phenotypes such as host specificity and 
pathogenicity are very difficult because they are complex traits. Further to this trying 
to do complete comparison between genomes is often hindered by different quality 
annotation. The rule of diminishing returns comes to mind. The current state of 
comparative genomics does mean that certain features will be missed. Ewan Birney 
explains in his blog some of the difficulties with large data sets stating that there will 
be errors, things will be missed and trying to compare work that has been done in 
two different labs won’t be perfect [214]. For example annotations of Typhimurium 
SL1344 and STM4/74 should be nearly identical but they have some inconsistencies. 
 
Trying to make sense of many large pieces of data is often cumbersome and can be 
difficult to interpret, methods of integrating many types of data into one hub would 
















Design and implementation of 
GeneBook 
 
Based on chapters 2 and 3 we have established that publically available data can 
contain errors and interpreting post genomic data is complex. Chapter 4 introduces 
GeneBook, a bacterial genome web explorer that integrates remote data sources into 
a single workspace. 
 
The chapter has two main sections. The first, 4.2, explains the design and 
development of GeneBook; this is followed by a section demonstrating scenarios of 
how GeneBook can be used to get information above and beyond the bacterial 






The main objective of this chapter is to produce a tool that allows users to 
synchronously analyse disparate datasets with a dynamic, intuitive interface. Taking 
their data from conception as a raw sequence and cultivating it into a fully annotated 
genome sitting at the hub of a web of unified heterogeneous data. It demonstrates 
how GeneBook incorporates data from different locations to see bacterial features in 
a more accurate and biologically meaningful way. 
 
The aims of this chapter are: 
 To design and implement an automated tool for a quick and rudimentary 
annotation of bacterial genomic sequences. 
 Provide an interface for uploading genomic sequences 
 To produce a database driven website that integrates heterogeneous data 
types into one central web-based focal point.  
 Provide tools to link quantitative data to the genome annotation; ensuing a 
method of integrating and visualising data such as targeted mutagenesis and 
microarray. 
 Provide tools for linking next generation sequencing (NGS) data with array 
data; integrating information about sequencing quality and expression studies, 
into the context of the genome. 
 Give users, with potentially no programming skills, the means to link remote 
data sources and their own private data.  
 To demonstrate how GeneBook: 
 Augments uninformative annotations with meaningful data. 
 Highlights omitted/missed connections in other databases. 
 Can be used to assess annotation inconsistencies.  
 Can assess pseudogene annotations. 











4.2 Design and development of GeneBook 
Section 4.2.1.1 uses the critical review in section 1.6 as a justification for a new 
method of storing and displaying bacterial genomic data, namely GeneBook. 4.2.1.2 
describes the development of a lightweight, novel genome database which integrates 
disparate datasets. The methodology of using existing and making new web services 
is demonstrated in 4.2.1.3, showing the potential for accessing data from remote data 
sources. Finally, new methods of visualising generic quantitative data and NGS data 
are developed and discussed, with consideration of future developments as 
sequencing technologies advance. 
4.2.1 Developing a system for managing disparate information resources 
Given the diverse range of data available for bacteria, both genomic and post-
genomic, and with the location of this data being spread across 10s if not 100s of 
different databases, we hypothesized that a new system that was lightweight and 
which used web-services to integrate data from disparate resources would enable 
scientists to gain a clearer picture of gene function. This hypothesis led to the 
development of GeneBook, a system for integrating diverse data types in one 
location using web-services. A diagram of how GeneBook works is shown in Figure 
38. There is an underlying database storing only sequence and the location of 
genomic features, taken directly from the genome annotation. Data is served to users 
from an Apache web-server. To enable efficient integration, GeneBook uses the 
open-source web content-management system (CMS), Drupal. Both public and 
private data were integrated with the genome annotation using web-services, with 
widgets (or web-apps) developed inside the drupal CMS. 
 
This section describes the database design and structure (4.2.1.1), the ethos behind 
the Drupal web CMS (4.2.1.2) and the web-services that were integrated (4.2.1.3) 
4.2.1.1 Managing gene data 
The resources described earlier are cumbersome in terms of their update status, 
mainly due to their static nature. Another consideration is if new data types are made, 
adding these to the schemas could be complex. Finally, people who access these 





view their data alongside the data within the resource. A system with dynamic 
content, taken from remote data sources, would have no need for monthly updates as 
it would be as up-to-date as the primary source that the data is retrieved from. This 
section describes the design and development of a generic gene-centric database.  
4.2.1.1.1 Database Design  
GeneBook, described in this chapter’s aims is based on a simple, lightweight, gene-
centric database. The database only needs to carry the basic genomic information, 
from a genome format such as Embl or GenBank. Any extra information will be 
integrated dynamically using remote data sources. This will make the system less 
cumbersome than some of the existing bacterial genome resources.  
 
There are a few relational database management systems (RDBMS) available at the 
Roslin Institute; Microsoft Access, Oracle, Firebird and MySQL. Both Microsoft 
Access and Oracle are not commonly used in the biological community as they are 
not open source. This means that there may be proprietary issues and little 
integration with other biological tools. Firebird and MySQL are both open source. 
MySQL was the chosen RDBMS because it is easily integrated with Apache, the 
web-server we will use, and PHP. Further to this, it is more universal, with a large 
community of users and is often the RDBMS of choice for biological database 
developers.  
 
In terms of actually designing the database there are some schemas already available 
specifically for biological databases. In order to ascertain whether one of the 
available schemas would be suitable or if a schema should be made specifically for 
this project some of the major schemas were reviewed. The schema has to support 
MySQL and must be lightweight and flexible. Schemas such as the Genomics 
Unified Schema (GUS) [215] and Chado [216] are very comprehensive and flexible. 
This means that they can cater for a plethora of biological relationships. On the other 
hand, the extensive nature of these schemas means that they can take a long time to 
learn and simple queries can be overly complex to implement. Considering that the 
database needs to be lightweight, using one of these schemas would be excessive, 








lightweight and can be easily integrated with most biological programming 
languages (BioPerl, BioJava etc.). After examining the different schemas available it 
became apparent that the entities which they incorporate are far beyond the scope of 
this proposed database, which will focus on genomic features exclusively. It was 
decided that using any current schema would not be necessary, as the database will 
only need a few entities with easily identifiable relationships.  
 
Figure 37 shows the final Entity Relationship Diagram (ERD. In terms of 
normalisation the gene entity should have been merged with the feature table. The 
justification for not doing this is that at the time of design it wasn’t certain whether 
the other features would actually be used in the website as it was initially designed to 
















4.2.1.1.1.1 Future improvements 
The database has been in use for over two years with virtually no problems. 
However, if I was to repeat the entity design aspect of this project I would put all the 
features together into one entity and store even less information than is currently 
stored. That is the entity should be limited to Genome ID, Feature (the type of 
feature), Locus tag (if available) and the location. As the genome sequences are 
stored locally the start and stop sites could be used to obtain the sequence which can 
be easily translated if necessary. 
 
Within a year of its conception the database had to be migrated to a different server 
on a different site. The tool mysqldump dump was used for the transition. A 
limitation of the MySQL dump process caused the entities to no longer cascade by 
their foreign keys. This means that when information in an entity is deleted the data 
which used the deleted information is not deleted. So in terms of this database if an 
entry from the genome entity was deleted all of the features and genes would remain 
in the database referring to a genome which no longer exists This defies the database 
rules of normalisation and could result in orphan piece of data. It is possible to 
modify the database to include the cascading, and if time permits this task will be 
performed. Although the database no longer cascades this would only be problematic 
if multiple users could delete entries, currently only the administrator can delete 
entries. 
4.2.1.1.2 Populating the database 
All of the Salmonella genomes available at the NCBI at the time of populating 
(2009) were downloaded and processed for inclusion into the database  
 
The process of parsing the genomes should have been straightforward. However, as 
there is no standard for bacterial genome annotation the quality and procedure was 
variable between genomes. This meant that parsing the GenBank files into a tab 
delimited file and dumping this into the database didn’t work. Individual MySQL 





RefSeq annotation was also used, which tries to standardise genome annotation, but 
even so there is variability in the way the annotations are described 
EMBOSS’s extractfeat was used to get the Coding Sequence (CDS) features from 
the genomes and these were then inserted into the database using SQL commands. 
4.2.1.1.3 Novel Genomes 
The availability of public data for each genome is skewed [2]. Newly sequenced 
genomes may not have much data in the public domain. This means that integrating 
some of the webservices which rely on locus tag will prove fruitless. As a future step 
part of the genome upload process could include an orthology step. That is the user 
can either include orthologs in their upload or orthologs could be calculate upon 
upload.  
 
The ortholog locus tag could then be used to retrieve information should there be no 
information in the public databases for the actual locus tag. This might be limited by 
services which take a long time to return a failed result. Alternatively, the user could 
choose they want to see the original locus tag or its ortholog. 
4.2.1.2 Developing GeneBook 
During the development of GeneBook it became clear that a CMS was needed. This 
prevented time being wasted on developing user administration, web page aesthetics 
and scalability. The web interface section, 4.2.1.2.2, specifically describes the 
development of the web interface to the database described in 4.2.1.1.1. The 
functionality of the website and how this uses web 2.0 technologies to give a 
dynamic data driven website is demonstrated by showing the integration of remote 
and private data using webservices. 
 
Webservices are an integral part of GeneBook, providing most of the information for 
each feature. They are defined in this section, using biological examples of in-house 









The final product, GeneBook has wrappers which allow it to interact with remote 
websites, pulling and displaying the information into one space meaning that the user 
can see the feature and its data holistically.  
4.2.1.2.1 Transition to a CMS  
The first step was to design a simple web page which connects to the database. This 
was done using html to hold the content of the page, Cascading Style Sheets (CSS) to 
define the layout and style, and PHP to interface between the database and the web 
site.  
 
Initially the interface was designed as a proof of concept, demonstrating that remote 
web services can be integrated into a web page on-the-fly. This interface was able to 
use web 2.0 to autopredict gene names and was able to show remote data on an ad-
hoc basis. It had some drag and drop functionality but this was not maintained 
between sessions.  
 
Implementation of a CMS handles user login and other data, it also records user 
activities and preferences. Most importantly it allows the project to focus on the 
scientific side of development rather than administration (CMS development, CSS 
modification for example). A new interface was developed to implement these 
features using Drupal (Figure 38). A CMS also gives scope for private user login, 
private workspaces and follows a logical directory framework providing a basis for 
webservice integration. 
 
The Drupal [218] CMS was adopted because it is written in PHP, which is widely 
used in web development. It has little installation requirements, is cross platform and 
is easy use from an administrative point of view. There are thousands of user 
contributed modules which expand Drupal’s capabilities and many JavaScript 
















Figure 38 The interface for GeneBook. The right hand section shows the search area. The boxes in the centre are ‘widgets’, each widget displays fetches, parses and displays 





4.2.1.2.2 Website Interface  
Search functionality was implemented to allow the user to query the database from 
the web site. A drop down menu populated with the genomes from the database was 
integrated onto the page. Below this a text box for the user to type in gene names. 
The search functionality currently lets the user find a gene of their choice by first 
selecting a genome and then typing the gene name into the text box.  
 
A dynamic interface is integral to the system. Web 2.0 encompasses dynamic 
content, user controlled design, and information sharing. Many of the websites have 
a desktop application appearance, rather than a static page of text. 
  
Autopredict capability was integrated with the gene name text box. This was 
achieved using AJAX. With each key stroke inside the text box a JavaScript script is 
activated which uses the HTTP request function to query the database. The query 
asks the database for any genes which start with the typed letters. Those that match 
are returned as a hyperlinked list. The fact that the HTTP request works 
asynchronously means that web page does not need to be refreshed in order to see the 
list changing. Clicking on one of these gene names uses the HTTP request function 
to show information (from the database and remote data sources) about that given 
gene displayed in widgets. 
 
Widgets, in the context of this project, are small boxes that can contain data from 
remote web services or tools for interrogating the system. The widgets are flexible, 
meaning the user can choose which widgets they want and where they want them to 










New widgets can easily be added, as the web services interface is kept completely 
distinct from the web page itself. This is simply a matter of clicking to make a new 
block (widget) through the Drupal CMS. Each widget uses a wrapper to connect to 
the webservice. In the text box for the new widget the user only needs to state the 
name of the wrapper and any extra parameters like so: 
 
<p class = 'invisible'>coverage</p> 
<div class = "widget">typhim_474_sorted.bam typhim_474.fasta 7500 
coverage1 </div> 
 
The text in the p tag (‘coverage’) is the name of the PHP wrapper that GeneBook 
uses to contact to the webservice. The information in the div tag is space delimited 
for each parameter, this information is fed to the PHP wrapper as parameters via the 
POST method. 
 
The widget boxes are made automatically using the Homebox module from Drupal 
[219]. Homebox widgets are draggable. Which widgets the user has chosen to 
activate and their location are recorded in the Drupal database, meaning that each 
user has a personalised space. This also ensures that the state is maintained between 
sessions.  
 
To fill the widgets with data from the remote web services the JavaScript framework 
jQuery [220] ‘live’ method was used. This applies an event to all elements, even 
those which are made after the page has loaded. As the data changes with each click 
of a different gene, the widget elements need to be filled on-the-fly, without page 
refreshes.  
 
The interface, by design, offers access to multiple different data types in a clean, 
unfettered environment. Behind the web browser GeneBook’s server is firing off 
multiple requests to many webservices and returning each set of results into a widget. 





4.2.1.2.3 Remote Data Access  
There are many tools/databases offering webservices. These allow users to use the 
remotely based service directly rather than via a website. This transition can be 
attributed to the following reasons;  
 
 Much of the data produced at the genomic level is large and computer 
intensive to analyse. Using a bioinformatics tool which is located on a server 
elsewhere means that anyone with a reasonable internet connection can 
perform these analyses; the user is empowered with computing capabilities 
beyond that which is provided to them locally.  
 The user does not have to deal with software installations, maintenance and 
updates which are common with desktop applications.  
 There is no need for database synchronisation or update.  
 Webservices are cross platform, meaning that they are not limited to one 
operating system/programming language.  
 The user can access large datasets quickly and efficiently.  
 The user just needs a web browser. 
 Accessing the tool/database directly (rather than via a website) means that the 
user can perform fuller queries. 
 
4.2.1.2.4 GeneBook structure 
GeneBook in its entirety is divided into three main components; the database, the 
web interface (CMS) and the webservices. Keeping the components completely 
separate from each other ensures that although they can interact they are not 
dependent on one another. This means, for example, that the database can be 
accessed without the web interface.  
 
The database and web interface simply connect using PHP’s MySQL functions, the 
parameters for which are contained in a database parameters folder located within the 









The way that GeneBook connects webservices to the database and the web interface 
is more complex. Figure 39 shows a general schematic of how GeneBook’s 
components interact. Figure 39 shows how the different aspects of GeneBook 
interact with one another. In order to access a given webservice a wrapper is created 
in GeneBook’s file system. The wrapper contains the code that queries GeneBook’s 
database, sends a request to the remote webservice and parses the returned result into 
a human readable format within a widget. All wrappers can be accessed directly, 
without being displayed in a widget in GeneBook. This independence allows users 







Figure 39 A) Cartoon of GeneBook interacting with webservices. User selects a feature (1). The query is 
sent to GeneBook’s server (2), which simultaneously queries the GeneBook database (3) and fires the 
request to external servers. This is returned and parsed by GB server (4) and then displayed on the 











Apart from the existing web services, some in house webservices were created too. 
That is web services that are hosted on the Roslin Institute servers. These 
webservices are located in the web directory but are completely independent of 
GeneBook (for more details about in-house webservices see 4.2.1.3.2). They are 
either in the CGI folder or in the Webservices folder, this is based on the whether 
they are programmed in Perl or PHP respectively. Although these services could be 
accessed by GeneBook directly they are accessed in exactly the same method as 
remote webservices (via wrappers). This means that that if a user wants to access a 
Roslin Institute webservice they can do so without having access to GeneBook or its 
database. Also, if GeneBook is installed locally onto a user’s machine they can still 
access the ‘in-house’ webservices without having to download them or their 
dependencies. 
 
To keep the GeneBook ethos of flexibility there is no hard coding of directories or 
files. The Webservices, CGI and Wrapper folders all contain a parameter file. This 
contains any directories used, meaning that if GeneBook or the in-house webservices 







Figure 40 GeneBook file structure, showing how the in-house webservices are independent of GeneBook all 













































































4.2.1.3 Integrating webservices 
Although GeneBook accesses both remote webservices and in-house webservices as 
remote webservices their development and integration have been described in 
distinct sections. This is because the integration of true remote webservices only 
requires a wrapper. Conversely, the development of each in-house webservice results 
in both the webservice itself and a wrapper. 
4.2.1.3.1 Remote webservices 
These webservices are hosted externally, a wrapper was designed for each website. 
These send the requests and parse the results into an attractive, human readable 
format. In total six remote webservices were integrated, each requiring different 
remote access protocols and methods for displaying the data. This section describes 
these web services in detail including how they are accessed, what the web service 
returns and what this is parsed into. 
ENZYME 
As described in the ERD earlier (Figure 37) EC number is an entity in the database. 
The ENZYME database [221] offers information about all EC numbers including 
their name/function and the reaction they catalyse. One can navigate around the 
database by simply changing the URL. For example the EC number 1.1.1.1 is for 
alcohol dehydrogenase. To find this entry on the ENZYME database one would enter 




This data is in the form of a web page where the data is displayed in a human 
readable format, arranged into headings, hyperlinks and tables. This formatting 
means that it is hard to extract information computationally, as a parser would have 
to navigate around the html tags and all the non-relevant data they contain. The 









The ENZYME wrapper accesses the ENZYME database by parsing the EC number 
onto the end of the URL (followed by ‘.txt’). The HTTP request function submits the 
URL and returns the text into an array. Each line of the text file starts with a header. 
These headers were used by the wrapper to parse the data into a more visually 
pleasing format and displayed into a widget (Figure 41). 
 
Accessing the ENZYME database using this method isn’t strictly using a webservice 
as there is no query being submitted, this is a hardcoded URL. This wrapper 
demonstrates that it can be possible to access remote data even when they don’t offer 
an API. 
 
One of the limitations of this wrapper is that it requires an entry in the EC entity. It is 
possible that newly submitted genomes won’t have enzyme information. Assigning 
orthologs to every feature could overcome this. Alternatively, software could be used 
which automatically predicts EC number, although these are often based on 










Figure 41 Widget with output from the Enzyme wrapper for STM0018, showing that there are two 







Many research institutes such as the EBI have made multiple web services [127] that 
allow users to access their databases and tools programmatically rather than through 
a GUI. The tool chosen for remote access was BLAST as this is a good starting point 
for inferring gene function, the EBI’s API use SOAP.  
 




The sequence is obtained from GeneBook’s database. The parameters for BLAST 
(sequence, program, database and sequence type) are then defined in an array. The 
SOAP client submits this array as a query to the EBI API. The wrapper uses a loop to 
poll the status of the job submitted, once the results are ready the output is saved as 
both a visual SVG (Figure 42) and an XML table. These outputs are parsed into 
separate widgets, visual BLAST and a table showing the results. 
 
Although SVG files appear as images they are actually in an XML format which is 
rendered by the browser. The visual SVG files are parsed so that each BLAST bar 
has an embedded hyperlink to the protein it hits in Uniprot [222]. This is then 
displayed as a widget with clickable proteins. 
 
The XML file is parsed into a table displaying the hit (with a hyperlink) and the 
scores. This is displayed in a separate widget, offering the users two ways of 









Figure 42 BLAST SVG output for STM0052 in a widget, the Uniprot IDs (circled in RED) have an 









Figure 43 The BLAST output for STM0052 in table format, showing the e-value, protein description and 
length of the match. The Uniprot ID is circled in red, these are hyperlinked to UniprotKB, allowing the 
user to easily get more details of the protein of interest from within GeneBook. 
GEO 
The Gene Expression Omnibus (GEO) [223] is a microarray data repository. 
Although it doesn’t have a true RESTful API, GEO can be queried using the URL. 
Microarray data is complex, in each experiment the data is organised into series, 
platform and sample.  
 
In terms of writing a wrapper for this there are two limiting factors. Firstly, 
GeneBook sends queries based on the locus tag or gene name. This information is 
stored in the GSE data, the data points themselves are in a different file, GPL, and 
are organised by a unique identifier (locus tag wouldn’t be unique because there can 
be more than one spot for each gene). The second problem is visualising the data, 
GEO does have the GEO2R tool that displays the data points for a given GSE ID 
dynamically in a graphical format, however, this is not designed to be accessed 
programmatically.  
 
To overcome the first issue the wrapper firstly gets the XML of the GSE data and 
finds the rows associated with the locus tag of interest. The rows have to be searched 
because the gene identifiers (in this case locus tag) are not consistently in the same 
column or under the same header. The IDs were parsed more easily because they are 








HTML code for GEO2R it became apparent that the graphs it makes are generated 
by a CGI script. The URL for the CGI was incorporated into an iframe tag within the 
wrapper and the IDs discovered from the previous step were parsed into the URL as 
parameters (Figure 44). 
 
 
Figure 44 GeneBook widget displaying output from the GEO wrapper. This information has been parsed 







KEGG also provides API access to their data. Above and beyond the identical 
genomic information that is held many similar repositories, KEGG also offers 
pathway data. 
 
The wrapper submits the locus tag to the KEGG server which returns the names of 
the pathways associated with this gene. In order to make the service more 
informative another request is sent which gets the descriptions of the pathways. This 
means that a user can see the pathway ID and its description.  
 
The pathway ID is sent to the KEGG API one last time, this is to get the image and 
colour the specific gene select. This link is embedded in a JavaScript fancybox which 
gets the image on the fly and displays it dynamically (Figure 45 and Figure 46).  
 
The functionality of KEGG’s SOAP API is somewhat restrictive. The programmer 
can access a lot of information but in order to construct complex queries they have to 
send multiple requests to the server, which limits the speed of the widget. 
 
KEGG have now migrated to a RESTful API, in theory this should offer 
programmers the ability to construct their own queries. In terms of GeneBook the 










Figure 45 Output of the KEGG wrapper in a widget. The output shows the pathways for STM3571 and the 
other genes from this genome that belong to the same pathways. Clicking on the pathway heading open up 
the pathway map dynamically in GeneBook (Figure 46). Clicking on another gene open a new page in 





Figure 46 A KEGG pathways map for STM3571 overlaying GeneBook. This is brought to the user on the 








ClustalW is also part of the EBI SOAP suite and was accessed in a similar way to the 
BLAST wrapper. ClustalW requires an array of sequences for the alignment. The 
wrapper currently sends a request to KEGG for orthology, this does limit speed but 
also keeps with the GeneBook paradigm of holding minimal information locally. If 
in the future all orthologs are calculated then this step can be taken out of the 
wrapper. 
 
The two outputs are an alignment (Clustalw) file and a dendrogram file (dnd). The 
user is then able to view these in a Jalview applet [224, 225]. This is a java alignment 
application which can be run through the browser. This allows users to view the 
alignment and dendrogram on the fly in fully interactive windows (Figure 47). 
 
One current limitation of this tool is that it relies on KEGG orthologs which do not 
include pseudogenes. If the gene of interest is a pseudogene this will not be identified 
as having any orthologs and if any genomes have an ‘ortholog’ which is a 
pseudogene this will also be omitted. With this in mind a buffered Clustalw widget 
was developed. 
ClustalW with buffers 
This widget works in the same way as the previous widget but the user can define 
how much sequence to include in the alignment up and downstream of the feature of 
interest. This means that one can look at a pseudogene by selecting the feature next 
to it and including a buffer large enough to encompass the pseudogene. 
 












Figure 47 Widget containing the ClustalW applet, Jalview is launched by clicking on the 'Start Jalview' button (A). This opens two windows, the alignment and the 









E-utilities – Conserved Domain Database 
The Entrez Programming Utilities (E-utilities) offer an interface to the Entrez system 
which is comprised of 38 biological databases [226]. The eutils CDD (Conserved 
Domains Database) widget is a proof of concept, demonstrating how any of the 
Entrez databases can be accessed using E-utilities. The Conserved Domains Database 
consists of in-house NCBI-curated domains and several external domain resources 
like Pfam and SMART [227]. 
 
The CDD is accessed using E-utilities’ RESTful API. The feature’s locus tag is 
submitted to the API, which returns a gene ID, this is submitted to the CDD and a list 
of matching domain IDs are returned, these are then submitted to the CDD to get the 
description for each match. This is returned in XML format which is parsed into a 
web list. The list is linked to an accordion JavaScript, meaning that the results are 
returned to the user as a list of domains, to get more information the user clicks on a 
domain and the list expands to show the description for this domain (Figure 48 and 
Figure 49). 
 
The limitation of this widget is that it relies on the gene ID being available in the 
database. If the sequence could be submitted this would be make the widget 
extendible to genomes that aren’t publically available. Alternatively, an ortholog 
could be submitted when the Gene ID isn’t available would also overcome this 
problem. 
 
The next step in the development of this widget would be to include some kind of 










Figure 48 Output of the E-utilities CDD wrapper displayed in a widget. This list of domains is 











4.2.1.3.2 In-house webservices 
In-house webservices are distinct from remote webservices in that they are located 
on the same server as GeneBook and they have been created as part of this project. 
The development of in-house webservices required not only a wrapper but the design 
and implementation of the webservice itself. For this reason these webservices are 
explained in a section separate from the standard remote webservices. As previously 
explained in section 4.2.1.2.3 they are treated and accessed the same way, that is, via 
a wrapper even though the in-house could accessed directly. This means that if in the 
future GeneBook is migrated to a different server but the in-house webservices are 
not GeneBook will still be able to access them without having to make any changes 
to GeneBook or its wrappers. 
 
Some of the webservices have been written use Perl CGI and some have been written 
in PHP, these webservices are kept in different folders and both have accompanying 
parameter files, meaning that all parameters are completely independent of the 
webservice scripts, this makes moving and updating GeneBook easier (Figure 40). 
4.2.1.3.2.1  Basic webservices 
The first webservices for this project were developed as tools for visualising the 
features in the context of their surrounding features and in the context of other 
bacterial strains. There are already methods for graphically displaying sequences 
[228, 229] but they don’t offer a method of easily making and displaying images on 
the fly into a web browser. One of the aims of the project is to use web 2.0 
technology, in this respect this would include interactive images with clickable 
regions, and again the currently available methods don’t offer this without hacking.  
Genebrowser 
This webservice produces a hyperlinked SVG file of the selected feature and its 
surrounding features. A query is submitted to the GeneBook database, which returns 
the feature location and the features within 10,000bp up and downstream of the 
feature. The results are parsed into a .dot file (dot-bracket notation) and submitted to 








with clickable features. When the user hovers over a feature the annotation 
description is displayed. 
 
This widget could have been made using Bio::Graphics or another similar tool such 
as GenomeGraphs or ggbio [228, 229, 231]. The reason these packages were not 
used is primarily because it is harder to incorporate hyperlinks but also the 
development of this widget shows the extendibility of GeneBook, any kind of 
















Figure 50 Genebrowser output displayed in a widget. The selected feature is highlighted in yellow, green show features on the forward strand and red on the reverse strand. 





Visualising KEGG Ortholog 
The KEGG database assigns orthologs for the majority of genes residing within it, 
these are referred to as KO (KEGG Orthologs). This widget sends a request to the 
KEGG API for orthologs from the other genomes in GeneBook. The ortholog 
locus_tags are returned. Each ortholog is made into a clickable SVG, using the same 
method as the GeneBrowser widget. These are then displayed alongside one another, 










Figure 51 output from the KO_genebrowser webservice displayed in a widget. The top sequence is the 
genome we are looking at (in bold top left). Yellow and blue features show the orthologs for the feature 
organised by host generalist and host restricted respectively. Green features are on the forward strand and 







Sometimes it is useful to have the sequence of a region of interest. This can be used 
to submit to other tools or for sequence searches in the ClustalW with buffer widget. 
This widget queries the GeneBook database to get the feature location and its 
orientation. Using Bioperl, the results from the database query are used to get the 
sequence from a FASTA file of the whole genome sequence. The user can state 
whether they want an amino acid sequence or DNA sequence, how much sequence 
up and downstream and the orientation of the sequence (the default for these is DNA, 
5000bp and the natural orientation of the feature). 
4.2.1.3.2.2 Generic quantitative webservices 
There has also been a surge in other next generation techniques such as RNA-seq, 
incorporating experimental methods gives a better indication of a protein’s role and 
whether it is functional. These annotations would be more accurate because they are 
based on actual experiment data rather than homology. Currently genomes can 
include evidence tags stating how the annotation was assigned, however, they are 
often omitted from the process. Including evidence qualifiers gives the user an idea 
of the reliability of the reference genome. The concept of assigning a level of quality 
to annotation is not novel, but is seldom used [159, 168]. 
 
This section explains the in-house webservices that have been developed to handle a 
user’s quantitative data. The premise is that they can submit a basic tab-delimited file 
which can interpret and visualise their data. This can be any kind of data as long as it 
is quantitative such as time-course, microarray or mutagenesis data. 
 
There is no prior knowledge of computing required, the file could be made in a 
common program like Microsoft Excel. These widgets work by the user changing the 










The purpose of this widget is to plot generic quantitative data, this is achieved by 
using the JavaScript library HighCharts [232]. This library is capable of making 
figures on the fly, no installation is required and it allows the user to download the 
output. 
 
The steps for making the data suitable for visualisation are as follows: 
 
 The data must be saved in a tab delimited file (this is an option in Microsoft 
Excel). 
 There must be a column which has the locus tags of the features which were 
analysed in the experiment.  
 The columns which hold the numerical results must be labelled data_XXX 
where XXX is the label for that piece of data. 
 If there are p-values for the data points, they are labelled as pval_XXX where 
XXX is the label for that piece of data 
 
The rows which correspond to the feature of interest are extracted, parsed according 
to their headings into a HighCharts compatible format. The image is then displayed 
in the widget. The user can see the p-value and whether it falls into the range of 
significance. Because the graph is made on the fly the user can chose which data 
points they see and what kind of graph is best for visualisation. Figure 52, Figure 53 
and Figure 54 show the visualisation of different types of data using the same generic 
graph webservice. Our in-house widget can display any type of quantitative data, is 
very fast and lightweight and allows users to download the output. 
 
One possible limitation with this method is that the experiment has features labelled 
as ORF1, ORF2 etc. rather than their true name. The question is how does the user 
know what ORF1 really is, presumably they do a sequence alignment or integrate 
their results with the true locus tags. It is not unreasonable to expect users to include 







Figure 52 Time course data displayed using the generic quantitative data widget .  This is in a widget 





Figure 53 Widget displaying private microarray data as a column graph showing replicates for batch and 
caecum. This is in a widget created on the fly by GeneBook, nothing is pre calculated. 
Log fold change 
Time (hours) 










Figure 54 Graph made in GeneBook using the quantitative graph widget showing data with p-values. This 








In terms of improving this webservice the first step would be to allow for p-values 
that are for the row of data of interest rather than just the data points. For example 
some microarray experiments are designed this way. This could be visualised by 
showing the p-value for the entire graph and highlighting whether it is significant. 
Allowing the user to easily see if the experiment is of interest for this feature. 
 
Another point of extendibility would be to find the data of interest based on sequence 
location. This could be used mutagenesis data which may have point mutations but 
no locus tag. 
Location/sequence context 
Another way of visualising data is in the context of the sequence. For example counts 
for sequencing data or point mutations in mutagenesis data. Two widgets were 
developed for this to demonstrate the different ways that quantitative data can be 
visualised. One was designed for generic quantitative data and the other was 
designed to visualise NGS data. 
 
The first webservice is for generic quantitative data to be visualised in the context of 
its sequence (Figure 55). The rules for the data are identical to the previous 
webservice’s, except a position_XXX heading is required too. The webservice gets 
the gene location (start and end) from the GeneBook database. These numbers are 
used as the range along the x-axis. Each position data point is used as the point for a 
scatter data point on the graph with the data_XXX being the number for the y-axis. If 
the user wants the orientation of the position to be visualised they add an 













Figure 55 Gene context graph created by GeneBook showing data which has location information. In this 
example this is mutagenesis data where the white triangles show the point (and direction of mutation), the 
coloured points shows the fold change for different hosts (A). B shows that the user can select what data 
they want to see, this is achieved by clicking on the legend to the right, in this case the user has selected to 









The other gene context quantitative data webservice is for NGS data. In theory if the 
user has made a count file for their NGS data this could be displayed in the former 
webservice. However, it isn’t reasonable to expect users with little knowledge of 
handling NGS to convert their file to counts. A count file is the number of reads that 
overlap each point in the sequence. The count files could be precalculated by 
GeneBook but this veers away from its dynamic, lightweight paradigm. Calculating a 
count file for the entire NGS output isn’t quick, which is why this webservice was 
developed separately from the generic quantitative data. It takes the NGS BAM file 
and just opens up the region of interest using an index, this is much more efficient. 
 
This webservice gets the feature of interest and the features up and downstream 
within the defined range. These features are made into a ‘track’ of the Bio::Graphics 
package, they are coloured according to their orientation and if they are pseudogenes. 
Bioperl has a package that deals with NGS BAM files, Bio::DB::SAM this is used to 
open the region of interest, it can handle BAM files stored locally or those on an ftp 
site. This package can automatically calculate counts for the region. The counts are 
then made into another track as a wiggleplot (Figure 56). This image is then saved 
into the temporary folder, allowing users to download the image if they require it.  
 
The fact that this webservice can handle ftp files reduces unnecessary file duplication 

















This widget is based on Spearman’s rank correlation coefficient. This is a way of 
comparing two sets of non-parametric data for their dependence. This webservice 
takes the data for the feature of interest makes it into an array and performs 
Spearman’s correlation against every other locus tag’s array of data. The results are 
then ordered by score. 
 
This webservice uses the generic data rules outlined earlier, meaning it requires 
clearly defined heading so that it can get the locus tags and data points. 
 
Basically, this webservice can give a list of features that show a similar pattern in the 
data. For example, this could be used with time course data identifying features 
which show a similar pattern of change over time. The variable analysed is the 
feature or gene in question, but in theory, as this widget is a generic data widget, it 
can be used on any tab-delimited data set that has multiple data points.  
 
The data is outputted into a table showing the features in order of correlation. The 
table consists of hyperlinks to the corresponding features and the correlation score. 
Currently the significance isn't calculated for these results but a p-value could easily 
be implemented into the output using a statistical test like a t-test. 
 
The resulting feature list would give the user an idea of what features are behaving in 
a similar way in a given experiment. If they have data for multiple experiments, it 
would be possible to see the results in the context of one another and if some features 
are appearing repeatedly across all experiments. From this the user can infer that 
these features are linked in some way, the feature allows users to form hypotheses 
from multiple data sets. 
Integration of NGS data 
As previously described NGS datasets are large and in a standardised format. With 








generic quantitative webservices. It is capable of accessing data uploaded to 
GeneBook and files from remote ftp. 
 
This webservice uses the Perl Bio::Graphics package and the Bioperl module 
Bio::DB::SAM, which handles SAM and BAM files. The locus tag of interest, file 
name of the BAM file and buffer are the main parameters. The sequence context for 
the region defined by the buffers and locus tag is made using Bio::Graphics. The 
same region is opened for the BAM file using Bio::DB::SAM. All the reads for this 
region are made into objects in bioperl. These are laid onto a Bio::Graphics track and 
displayed with their paired reads. 
 
During the course of developing this webservice became apparent that visualising 
stacked paired reads can produce very large diagrams in areas of high coverage. 
These diagrams were too big to look at in the context of other data. With that in mind 
a method of condensing the data was used. That was to overlay identical reads rather 
than stack them. The colour of the reads is a range from light to very dark blue. A 
light coloured read shows that there are not many overlaid reads, on the other hand, a 
dark coloured read shows that there are lots of identical reads that have been aligned 
to exactly the same location (Figure 57A). When the user hovers over a read with 
their cursor the paired reads are highlighted in red (Figure 57B). This is achieved by 
making an html image map which dynamically displays the matching paired reads 
using jQuery. 
 
The fact that this webservice uses a condensed method for displaying the data means 
that it is fast even over regions of high coverage. It allows users to look at the NGS 
data in the context of other data, without having to open a specialised NGS browser 









Figure 57 NGS pileup made by GeneBook displayed in a GeneBook widget. Image A shows pileup of NGS 
reads. The darkness of blue indicates the number of reads that occupy exact the same location in the 
alignment. Overlaying identical reads makes the image easier to view without scrolling. Image B shows 
highlighting when hovering over a read, The red reads correspond to all the paired reads for the read 










4.3 Using GeneBook to identify annotation inconsistencies and 
genes associated with host pathogenicity and pathogenicity 
Current methods of bacterial annotation produce errors and annotation discrepancies 
(Section 1.4.2). GeneBook can integrate remote data sources with the original 
annotation to display the most recent information available. It is capable of pulling 
together information from an unlimited number of resources, highlighting possible 
errors, inconsistencies and obsolete annotations, offering the most up to date 
information available. Section 4.3.2 uses real examples of the annotation problems in 
earlier sections to demonstrate how GeneBook overcomes some of these annotation 
problems using public and private data. 
 
After performing the analysis of an experiment researchers often have a list of genes 
of interest. At this point they only have a locus tag or gene name. In order to find the 
relevance of these genes the researcher will go to multiple websites/tools to elucidate 
the genes’ function and behaviour and try to draw conclusions in the light of their 
results. Further to this it is not unusual for the user to want look at the results of 
previous experiments in the context of their current results. Seeing all of this 
information can involve running multiple programs, opening many tabs in the 
browser and using multiple spreadsheets. Once this is repeated for each gene, it is a 
laborious process.  
 
As previously described in section 4.2.1.2 GeneBook is capable of integrating local 
and publically available data. The examples below use data, some of which is 
publically available but has been stored locally to demonstrate how one would 
integrate their local/private data into GeneBook. Section 4.3.2 takes some of the 
significant genes of interest from the results of locally stored experimental data for 
Salmonella Typhimurium LT2 to show how GeneBook can be used to augment the 
findings with public data. The data are as follows: 
 
 TraDIS – this has been explained in section 3.2.3.5. Essentially it shows the 





 Macrophage data – Microarray data showing complete transcriptional profile 
of S typhimurium genes at 4, 8 and 12 hours post-infection of murine 
macrophages [133]  
 Caecal data – Microarray data comparing the expression of all S typhimurium 
genes in bacteria harvested from the chicken caecal mucosa with bacteria 
growing at log-growth phase in broth culture [94] 
 
All of the examples shown in this chapter are from widgets within GeneBook, for 
ease of viewing in this document the individual widget results are shown as separate 
figures. In GeneBook all the widgets would be in one browser page for each 















4.3.1 Overcoming errors, outdated annotation  
The proliferation of errors is an on-going phenomenon, as new genomes are 
sequenced there will be always be continuity issues as described in section 2.3.2.1. In 
most genome databases the data is static, over time this will become out of date, with 
experimental discovery and as our understanding of bacterial genetics improves.  
 
This section demonstrates how GeneBook can overcome some of these 
inconsistencies by displaying up to date information in one browser window. 
4.3.1.1 Hypothetical proteins 
When a genome is first annotated, its open reading frames are aligned and compared 
to publicly available sequences using tools such as BLAST [79]. Many of these 
potential genes only hit other hypothetical proteins, which indicates sequence 
conservation but does not give any clues to functionality. After submission the 
proteins are automatically submitted to Uniprot. Uniprot is constantly being updated 
as new information about proteins is discovered. With that in mind it is possible that 
the original annotation is still labelled as a hypothetical protein but the corresponding 
annotation in other databases, such as Uniprot, show more informative, up to date 
annotation.  
 
Using GeneBook to look at features of interest can save the user the effort of 
searching across multiple websites and having multiple tabs open. Integrating one’s 
personal data with the public data can add evidence to a sequence feature actually 
being functional rather than being a false positive from feature prediction software 
such as GLIMMER [59]. 
 
For example, STM0081 is described as hypothetical protein. When it is viewed in 
GeneBook the BLAST widget shows the top UniprotKB hit is to:  
Q8ZRW6_SALTY Putative secreted protein OS=Salmonella typhimurium 
(strain LT2 / SGSC1412 / ATCC 700720) 
This is a hit to itself, but with a more informative annotation. The TraDIS data 








shows that STM0081 is negatively selected (with p-values less than 0.05) across all 
hosts meaning that this is needed for non-systemic infection.  
 
When looking at STM0081 in the genome context widget we can see that its 
neighbour STM0082 is also a hypothetical protein Clicking on the feature opens a 
new tab and displays the integrated information for this protein. As with STM0081 
there is a more up to date annotation in the BLAST results against UniprotKB: 
Q7CR88_SALTY - Putative secreted protein OS=Salmonella typhimurium 
(strain LT2 / SGSC1412 / ATCC 700720) 
The Conserved Domain Database (CDD) widget also offers some more information 
on the protein sequence. Amongst the DUF and hypothetical proteins is a hit against: 
PRK14864 putative biofilm stress and motility protein A; Provisional 
This description could explain why STM0082 is significantly up regulated in the 
Macrophage (mouse macrophage) data (Figure 60) as biofilm formation has been 
linked to intracellular proliferation [233]. 
 
Both of these proteins are up to date in Xbase and PATRIC, in the respect that they 
have the most recent Uniprot annotation. However the addition of the most up-to-
date BLAST results, CDD alignments and the private data sheds more light on these 
proteins’ behaviour in defined conditions and perhaps helps users identify genes of 








Figure 59 TraDIS data for STM0081 is significantly negatively selected across all hosts suggesting that it is 
essential for intestinal colonisation. The user can see that the results are all significant because the p-values 





Figure 60 Macrophage data for the 'hypothetical protein' STM0082, it is up regulated suggesting activity 
during macrophage infection. 
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It is worth noting that Xbase and PATRIC are not always completely up to date. As 
an example of this, STM2220 is a ‘hypothetical protein’ in the original genome 
annotation and in both the previously mentioned genome browsers. However, in 
GeneBook the BLAST results return: 
Q7CQ73_SALTY Putative cytoplasmic protein OS=Salmonella typhimurium 
(strain LT2 / SGSC1412 / ATCC 700720) 
There is also an interesting hit to the CDD using the eutils app: 
pfam06952 PsiA This family consists of several Enterobacterial PsiA 
proteins. The function of PsiA is unknown although it is thought 
that it may affect the generation of an SOS signal in Escherichia 
coli 
These two hits give some information above and beyond the genome annotation and 
the two main publically available bacterial genome browsers. Arguably, with their 
next synchronisation with Uniprot and other resources Xbase and PATRIC will be up 
to date again but until they are in sync with real time data their users will be unaware 
that this is out of date unless they visit other websites or use search tools to ensure 
they are receiving the most relevant information. BLAST is available on Xbase but 
as this is performed in a different window/tab on the browser it could prove 
confusing if the user has multiple tabs already open. GeneBook displays the BLAST 
results automatically in the same page as the rest of the data making it completely 
clear what results one is looking at in relation to a specific feature. 
 
As an aside, another possible indication that STM2220 is a truly functional protein 
and not a relic from the annotation process is that according to the widget which 
holds the macrophage data (Figure 61) the protein is up regulated during macrophage 





















4.3.1.2 Missing connections such as orthologs 
Data for orthologous genes is available in resources such as COG and KEGG. KEGG 
has an API allowing straightforward access to the gene information, including 
orthologs and pathways. A recurring theme throughout this project is that using the 
information gained through data sources relies on the assumption that the data is 
correct and up to date. KEGG contained less than ten Salmonella genomes at the 
time of writing. Each genome within KEGG has had its genes mapped to pathways. 
With that in mind it is a fair assumption that if a pathway is detected in one gene then 
it should as easily be detected in any equivalent genes.  
 
In GeneBook when the user selects STM1958 the KEGG ortholog browser widget 
returns one ortholog SC1961, Choleraesuis SC-B67 (Figure 62). The BLAST table 
widget shows that the other genomes do have this gene (Appendix A: 
STM1958_BLAST.xlsx).  
 
Using the genome context widget to look at the neighbouring gene STM1960 one 
can see that the fliB is present across all the genomes (Figure 63), hovering over the 
respective genes shows that they are all labelled as fliB, although their KEGG entries 
do not have any orthology or pathways assigned to them 
(http://www.genome.jp/dbget-bin/www_bget?see:SNSL254_A2119). 
 
On closer inspection, using the ClustalW widget we can see an alignment across this 
region. Figure 64A shows that the centre of the fliB gene is highly variable. It is 
possible that due to the variable region in the middle of the gene sequence the 
similarity threshold wasn’t low enough to recognise these other orthologs. High 
variability can be linked to adaptation to the host immune system [234]. Interestingly 
this gene has been suggested to influence pathogenicity, in their 2006 paper Frye et 
al. discuss the possibility of n-methylation of the lysine on flagella being linked to 
host evasion as Typhimurium is still motile when the fliB gene is mutated [235]. To 
further support this, the TraDIS widget shows significant negative selection across 
all hosts (Figure 65). Conversely the Macrophage data shows that the gene is 





systemically Typhimurium  uses different methods of host evasion or at least doesn’t 
require flagella expression during the entire course of infection. 
 
This example demonstrates that firstly relying on one resource for information is not 
failsafe, there can be errors. Secondly, relying on sequence homology alone is not 
always enough to find commonality between genomic features. By looking at the 
genome synteny, that is the pattern of the features around our region of interest, we 
can see that STM1960 has orthologs in other genomes and also a paralogous gene 
within its own genome. The method used in GeneBook to determine this isn’t ideal 
but there might be scope for developing a genome context widget that does not rely 
on sequence homology. Turning homology based on genome context information 
















Figure 63 Genome context for STM1960. Using this gene to align the orthologous regions in other genomes 











Figure 64 The alignment of STM1958, taken as a subsequence of the STM1960 (with 3500bp upstream and downstream (A) An overview of the alignment, black areas show 
gaps in the alignment. Vertical lines of the same colour show conservation, disjointed colours (such as the area in red) indicate sequence variation between genomes. (B) 








Figure 65 TraDIS data for STM1958 showing significant negative selection across all hosts. 
 
 













4.3.1.3 Uninformative and common gene names  
Gene names change as we find out more about their behaviour. For example, y-genes 
which were discussed in section 2.4.2.3 are hypothetical proteins, whose gene name 
is specific to the location on circularised Escherichia coli K-12 [158]. These names 
passed across to other serovars and even other species. For example STM0246 is 
tagged as having the gene name yaeE this has no context in Salmonella 
Typhimurium LT2 and gives no information regarding function. The protein 
description in xBase, PATRIC and GeneDB is: 
yaeE - DL-methionine transporter permease subunit 
GeneDB has noted an ortholog in the comments: 
Ortholog of E. coli yaeE (YAEE_ECOLI); FASTA hit to YAEE_ECOLI (217 
aa), 93% identity in 217 aa overlap 
However, those E.coli orthologs no longer exist, when searching for them in Uniprot 
one is taken to the more up to date entry (below). The KEGG pathway widget 
displays a pathway for this gene with the other LT2 genes in that pathway listed 
below the pathway description (Figure 67). When the user clicks on the link the 
image is dynamically displayed over the browser (Figure 68). The selected gene is 
automatically highlighted in red so that the user can clearly see where it lies in the 
pathway. In the case of STM0246 the gene in the pathway is described as MetI 
(Figure 69), showing a more up to date gene name. Further to this, the BLAST 
widgets support the new gene (Figure 70 and Figure 71). The BLAST table widget 
(Table 26) shows hits to TREMBL and Swissprot with the top hit being:  
 
METI_SALTY D-methionine transport system permease protein metI 
 
Finally, the table version of the KEGG orthology webservices shows that there is an 
in-paralog within LT2 and that there are orthologs and out-paralogs in the other 
genomes Table 27. It is also worth noting that the gene name and product names for 







Figure 67 KEGG widget showing the pathway hit for STM0246 and the other genes from LT2 that belong 
to this pathway. The pathway link opens the pathway map on top of GeneBook (Figure 68). The locus tag 

















Figure 69 GeneBook output for STM0246 from the KEGG Map widget zoomed in on part of the STM0210 ABC Transporters pathway diagram. The location of STM0246 is 









Table 26 Top 5 BLAST hits to UniprotKB for STM0246 from the BLAST table widget. In the widget the Hit id is a hyperlink taking the user to the Uniprot entry 
Hit id Hit accession Description E-value Length 
METI_SALTY Q8ZRN0 D-methionine transport system permease protein metI OS=Salmonella typhimurium 
(strain LT2 / SGSC1412 / ATCC 700720) GN=metI PE=3 SV=1 
1E-148 217 
Q57T10_SALCH Q57T10 Putative ABC superfamily (Membrane) transport protein OS=Salmonella Choleraesuis 
(strain SC-B67) GN=yaeE PE=3 SV=1 
1E-148 217 
F5ZM31_SALTU F5ZM31 DL-methionine transporter permease subunit OS=Salmonella typhimurium (strain ATCC 
68169 / UK-1) GN=yaeE PE=3 SV=1 
1E-148 217 
E8XIR6_SALT4 E8XIR6 DL-methionine transporter permease subunit OS=Salmonella typhimurium (strain 4/74) 
GN=yaeE PE=3 SV=1 
1E-148 217 
E1W8B8_SALTS E1W8B8 Hypothetical ABC transporter permease protein OS=Salmonella typhimurium (strain 









Figure 70 BLAST hits for STM0246 against Swissprot returns D-methionine transporter permease subunit 
as the top hit. The GeneBook output has hyperlinks embedded meaning that the user can click on the link 










Figure 71 Shows the Uniprot data within the BLAST widget, this is loaded without affecting the other widgets and can be returned to the BLAST results by using the 







Table 27 Output from the Table version of the KEGG ortholog widget. The putative in-paralog has been highlighted in red and the out-paralogs are italicised. 
Locus tag Gene 
name 
Product Serovar Strain 
STM0246 yaeE DL-methionine transporter permease subunit Typhimurium LT2 
SC0245 yaeE DL-methionine transporter permease subunit Choleraesuis SC-B67 
SPA0253 yaeE DL-methionine transporter permease subunit Paratyphi A ATCC 9150 
STY0273 yaeE DL-methionine transporter permease subunit Typhi CT18 
t0249 yaeE DL-methionine transporter permease subunit Typhi Ty2 
SeAg_B0287 metI D-methionine ABC transporter, permease protein Agona SL483 
SeD_A0268 metI D-methionine ABC transporter, permease protein Dublin CT_02021853 
SeHA_C0284 metI D-methionine ABC transporter, permease protein Heidelberg SL476 
SeSA_A0273 metI D-methionine ABC transporter, permease protein Schwarzengrund CVM19633 
SNSL254_A0268 metI D-methionine ABC transporter, permease protein Newport SL254 
SEN0254 yaeE putative ABC transporter permease protein Enteritidis P125109 
SG0250 yaeE putative ABC transporter permease protein Gallinarum 287/91 
STM0512 sfbC putative ABC transporter permease component Typhimurium LT2 
SC0553 sfbC putative binding-protein-dependent transport systems inner membrane component Choleraesuis SC-B67 
SeAg_B0559  ABC transporter integral membrane protein Agona SL483 
SeD_A0561  ABC transporter integral membrane protein Dublin CT_02021853 
SeHA_C0620  ABC transporter integral membrane protein Heidelberg SL476 
SEN0493 sfbC ABC transporter integral membrane protein Enteritidis P125109 
SeSA_A0576  ABC transporter integral membrane protein Schwarzengrund CVM19633 
SG0523 sfbC ABC transporter integral membrane protein Gallinarum 287/91 
SNSL254_A0566  ABC transporter integral membrane protein Newport SL254 
SPA2210 sfbC ABC transporter integral membrane protein Paratyphi A ATCC 9150 
STY0560 sfbC ABC transporter integral membrane protein Typhi CT18 








4.3.1.4 Annotation inconsistencies between genomes  
The transferral of annotation from one genome to another relies on the assumption 
that the original annotation is accurate. The eutM/eutN example is explained in 
section 1.4.2. This model can be demonstrated in GeneBook. Selecting STM2464 
shows that this is the eutN gene. This eutN description concurs with the original 
annotation, and the general consensus of the BLAST results and CDD show this too. 
However, if the user wanted to look at the ortholog SPA0404 (genome NC_006511 
Paratyphi C) the annotation describes the gene name as eutM, the BLAST widget 
and BLAST ortholog widget (Table 28) both show that the closest relatives are eutN. 
This suggests that the gene name for SPA0404 is an error, presumably a typo. 
 
The eutN/M example is interesting beyond the annotation inconsistencies, Figure 72 
shows the variation between genomes. Two areas of interest are the eutN genes for 
the Typhi strains being considerably larger than the other eutNs and the eutMs in 









Table 28 Orthologous hits to the eutN gene in Typhimurium, STM2464, from the KEGG API. The product descriptions are varied and the gene name for SPA0404 
(highlighted and underlined) is eutM rather than eutN indication a possible annotation error. 
Locus tag Gene 
name 
Product Serovar Strain 
STM2464 eutN putative detox protein Typhimurium LT2 
STY2701 eutN putative ethanolamine utilization protein eutN Typhi CT18 
t0394 eutN putative ethanolamine utilization protein eutN Typhi Ty2 
SPA0404 eutM putative ethanolamine utilization protein eutN Paratyphi A ATCC 9150 
SC2460 eutN putative detox protein in ethanolamine utilization Choleraesuis SC-B67 
SNSL254_A2657 eutN ethanolamine utilization protein Newport SL254 
SeHA_C2724 eutN ethanolamine utilization protein Heidelberg SL476 
SeAg_B2609 eutN ethanolamine utilization protein Agona SL483 
SG2495 eutN ethanolamine utilization protein Gallinarum 287/91 
















4.3.1.5 Pseudogene assessment  
Pseudogene detection, definition and determination could be a thesis in itself. Trying 
to identify a true pseudogene is no mean feat. For example, a gene that has an indel 
which has led to a frameshift could still be functional. Transcription of a given gene 
doesn’t necessarily confer function either, some pseudogenes are still transcribed, 
they just don’t make a functional protein. By definition a pseudogene is a gene that is 
no longer functional due to random mutations. These mutations can result in: a 
frameshift, disrupting the gene; an introduced stop codon, truncating the gene; a 
different three dimensional structure that renders the protein useless. The final 
example couldn’t be conclusively proved as a pseudogene but exploration for non-
synonymous SNPs would identify the mutation could form a basis for functional 
studies. In silico pseudogene is possible for the first two examples. Scrompt-
Ruttedge do this by taking hypothetical proteins (on the basis that they might be 
truncated genes) and intergenic regions (possible parts of pseudogenes that are no 
longer in an open reading frame). They compare these regions to Uniprot, when they 
get a hit they look for stop codons/indels in the flanking regions [Liu 2004].  
 
Trusting the annotation from a reference genome can lead to the misannotation of 
pseudogenes. The eutM/N example can be used to demonstrate how the user can 
explore pseudogenes and assess the annotation for themselves. Figure 72 shows the 
discrepancies between different genomes around eutN/M highlighting a couple of 
questions: 
 
 Is the eutN/M model incorrect, should it just be eutN and those which show 
two open reading frames are pseudogenes?  
 Is the Typhi eutN gene a merged eutN and eutM as a result of a frameshift 
resulting in one open reading frame?  
 Are the eutMs in Newport and Agona labelled as pseudogenes because their 










GeneBook was used to look at eutN in Typhi (t0394). The ‘alignment with buffers’ 
widget shows the ClustalW alignment with 1500 bases added either side of the 
orthologs. The extra bases allow the shorter orthologs and eutM to align to the larger 
Typhi eutN which spans both. Figure 73 shows that there is a deletion in t0394 
relative to its orthologs which has resulted in a frameshift that merges eutN and eutM 
into one open reading frame.  
 
eutM, Newport SNSL254_A2658 and Agona SeAg_B2609 are both annotated as 
pseudogenes. Using the ‘alignment with buffers’ widget and highlighting areas of 
conservation we can see how these eutMs differ from the consensus (Figure 77). 
There are no indels relative to the other eutM genes in other genomes but there are 
two substitutions that are shared only in Agona, Newport and Typhi (Figure 74). A 
substitution alone wouldn’t be grounds for annotating the genes in Agona and 
Newport as pseudogenes. According to the neighbour joining tree made by the 
widget the large Typhi open reading frame is most similar to Agona and Newport 
which are identical to one another (Figure 75). The GenBank annotation for these 
two ‘pseudogenes’ is the same too: 
 
“ethanolamine utilization protein eutM; this gene contains a frame 
shift which may be the result of sequencing error; identified by 
match to protein family HMM PF00936” 
 
This annotation does not concur with the eutN/M model as there is no apparent 
frameshift. If, however the annotation is based on the Typhi eutN/-M model then 
there is a frameshift relative to eutN in Typhi. If this is the case and Agona and 
Newport are pseudogenes due to an insertion relative to t0394 then all of the other 
ortholog should be labelled as pseudogenes too. Unfortunately, as the GenBank 
annotation of these pseudogenes does not state what protein they are similar to it is 







Figure 73 The ClustalW alignment of t0394 eutN. The deletion in t0394 which leads to a frameshift is 
present at the 278th base. This deletion is just within the eutM according the ortholog in Typhimurium 





Figure 74 ClustalW alignment from alignment with buffers widget. The alignment is coloured by 











Figure 75 Neighbour joining tree of the sequence spanning Typhi eutN made by the alignment with buffers 
widget, showing that there is a lot of sequence similarity between genes, with the pseudogenes SeAg_b2609 





Another example of pseudogene interpretation is the Copper homeostasis protein 
cutF gene (Figure 76). This is a pseudogene in Choleraesuis SC-B67 (SCPS46) and 
Typhimurium LT2 (STM0241). Looking at the pseudogene in GeneBook will not 
return an alignment because the alignment is based on orthology from KEGG, which 
does not include pseudogenes. The alignment with buffers widget allows the user to 
look at the gene next to the pseudogene of interest as the extra bases (padding 
defined by the user) can span the pseudogene. The user can then isolate the region 
which specifically covers the pseudogene and view it separately. 
 
The alignment shows that there is a deletion of ‘ATGT’ in Choleraesuis and an 
insertion of ‘ATGT’ next to this in Typhimurium (Figure 77). Closer inspection 
shows that in fact all of the orthologs across all of the Salmonella genes have this 4-
mer, it is present once in this region in Choleraesuis, three times in Typhimurium and 
twice in the rest. With that in mind it is a big coincidence for these 4-mer indels to 
occur in a repeat region, this suggests that there may be a sequencing error rather 
than any pseudogenes. 
 
GeneBook can help users to decipher the annotation around pseudogenes. Currently 
there is no silver bullet to predict pseudogenes, there are no hard and fast rules. 
Looking at the annotation in the context of multiple pieces of information empowers 
the user to decide the accuracy of the annotation rather than taking the annotations in 
public databases at face value. 
 
In summary Section 4.3.1 shows how GeneBook is able to augment annotations that 
have little information by combining it with remote data sources as seen in section 
4.3.1.1 and 4.3.1.3. Further to this section 4.3.1.2 demonstrates that GeneBook can 
identify errors in other data sources. Integrating multiple data sources gives users a 
fuller picture and allows them to make judgements based on all the data provided. 
 
Further to this GeneBook is able to solve some of the problems of the eutN/M locus 
described in 1.4.2. The user can see their gene in context of all other genomes, and 









Figure 76 genome context diagram of STM0240 with orthologous genes from other serovars, based on 
KEGG orthology. This serves as a method for seeing the neighbouring pseudogene STM0241 alongside its 





Figure 77 Subsequence from the ClustalW alignment of STM0240 with 1500bp up and downstream, 
specifically the pseudogene sequence of STM0241. The insertion in Typhimurium LT2 and deletion in 





4.3.2 Salmonella growth in different conditions 
Often, scientists have multiple data sets from the same organism. It would be useful 
for them to view the data in context of each other. It is possible to parse/merge these 
data but this becomes complex when there are more than a couple. Allowing users to 
integrate their own data into GeneBook, means that they can try to piece together a 
story. For example, the user may have a list of significant genes from a microarray, 
they can simply click on these genes in GeneBook and see how they are acting in 
other experiments and what data is publically available too. 
 
This section shows some examples of how GeneBook can be used to augment the 
scientific meaning to genes of interest taken from the data explained at the beginning 
of this chapter. In these examples the ‘user’ has a list of gene of interest which are 
viewed in GeneBook to get a clearer picture of what they are and how they behave. 
In this scenario the user has a list of genes which they discovered to be significantly 
up regulated in the Macrophage data. That is the genes are up regulated in chicken 
macrophage when compared to broth. 
 
When looking at the significant gene list in GeneBook, some genes showed up 
regulation in the Macrophage data too. These genes are being highly expressed in 
both extracellular (Caecum) and intracellular (Macrophage) colonisation relative to 
the control. 
 
For example, STM0018 shows up regulation in both Caecal and Macrophage data 
(Figure 78 and Figure 79). The user can see both these widgets in the context of one 
another. Looking at the TraDIS data shows that the one of the point mutations is 
significantly negatively selected in calves and pigs (Figure 80). As there are four 
different point mutations and only one shows any significance, the user might want 
to see the point of this mutation. Looking at the context widget reveals the location 
of the mutation of interest (Figure 81). A simple domain search reveals that mutation 









The BLAST results return this as a ‘putative exochitinase’ and the eutils widget 
which describes the associated domains and functions (Appendix G), concurs with 
this stating that the protein is an exochitinase. The question that arises from these 
findings is; what is the relevance of chitinase in extracellular and intracellular 
infection? There is evidence in the literature that ChiA is up regulated in macrophage 
infection (Eriksson et al. 2003 in [236]). Further to this in 2010 Larsen et al. try to 
verify the role of exochitinase in Salmonella as chitinases are uncommon in bacteria 
[236]. Their findings showed enzyme activity towards both chitin and LacNac, which 
they state can be related to pathogenic strains that bind to the human intestinal 














Figure 79 Macrophage data showing the fold change in macrophage (compared to control) at different 
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Figure 80 TraDIS data for mutation in STM0018 showing the significant negative selection in calves and 
pigs. The legend shows some data points faded out, this highlights the fact that the user can select which 




Figure 81 TraDIS context widget showing the mutation locations in STM0018. The triangles show the 







Another example from the Caecal significant gene list is STM3764 (Figure 82) 
which codes for the MgtC protein, part of the Mg2
+
 transporter operon. This gene is 
also up regulated in the Macrophage data and negatively selected across all hosts in 
the TraDIS data (Figure 83 and Figure 84). Previous studies have shown up 
regulation in human and mouse macrophage (Typhi and Typhimurium respectively), 
with the gene being required for growth in magnesium poor environments [237].The 
paper which supports the Caecal data, recognises that MgtC is up regulated in caeca 
but they connect this to redundant expression of the gene due to its location in that 
Salmonella pathogenicity island SPI-3. [94]. However, in a study to investigate the 
regulation of mgtC in serovar Typhi Retamal et al. found that the gene mutants 
showed impeded growth in human epithelial cells [237]. Further to this, the universal 
significant attenuation across all hosts supports the inference that the up regulation in 
















Figure 83 Macrophage Data for STM3764 showing significant up regulation of this gene in mouse 
macrophage when compared to the control 
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GeneBook is a web-based bacterial genome browser that displays data from remote 
resources into a single instance. Users are able to customise their view making it 
relevant to their interests and personal datasets. The data available for not only 
Salmonella but many pathogens is disparate and there is a need for integration. 
Current enterobacterial resources hold their data locally. This is both memory 
intensive and the data is liable to become superseded. The PATRIC system [122] 
does continually update its information but it is constrained to holding the data 
locally. The PATRIC user interface does offer some personalisation with workspaces 
but there is still no option for integrating private data. At the time of starting this 
chapter (2009) none of the current resources had the functionality to upload and 
process raw sequences, now Xbase and PATRIC both offer an annotation service, 
although unlike GeneBook neither allow the integration of private genomes into their 
databases. 
 
The fact that GeneBook draws information in live from any given data source means 
that it is as up-to-date as the primary source. This confers an advantage compared to 
other resources which rely on regular updates, sometimes from secondary data 
sources. This means that the quality of annotation for a feature can be assessed. 
Annotations that are out of date, misannotated, uninformative or unclear can be 
resolved allowing users to not only get a more holistic view of the feature of interest 
but also make informed decisions on the quality of an annotation. Overcoming these 
problems would normally rely on the use of multiple resources and running multiple 
tools, GeneBook does this automatically. 
 
The in-house generic quantitative webservices can handle any quantitative data. The 
requirements are simple to adhere to, firstly tab delimited format and secondly, the 
use of GeneBook recognisable headers. Most text editors and spreadsheet software 
(such as Microsoft Excel) can save into tab delimited format and most scientific data 
has column headings which are easily edited. These webservices give users a quick 
method of visualising their own data in the context of other data. The alternative to 





In terms of handling experimental data GeneBook does not currently perform 
complex analyses, rather, it offers a robust foundation for hypothesis building. The 
advantage of seeing different experiments in the context of one another is that users 
can build hypotheses based on what the data indicates. Section 4.3 shows some of the 
hypotheses that can be made and what the next steps would be for a researcher in 
order to confirm their hypotheses. 
 
This chapter has shown a method of integrating remote data sources allowing users 
to see many different types of data in one place. GeneBook integrates two microarray 
datasets, with the private TraDIS data along with public databases and data such as 
BLAST results, Domains, Orthologs and multiple alignments. These are all displayed 
from within a single browser window. This methodology is unique to GeneBook and 
impossible to achieve in any other single system. The methods such as a lightweight 
database and webservices are following the trends we see in web technology. There 
is general movement towards cloud computing and the paradigm of anyone accessing 
anything anywhere. GeneBook attempts to adhere to this model, relying on remote 
data sources rather than keeping the data locally. 
4.5 Future work 
The possibilities for future developments of GeneBook are endless due to the nature 
of it being customisable and extendible. In this section I have described some stages 
that I feel would be the next logical stage in its development.  
4.5.1 Improving current widgets 
The generic quantitative webservice can display p-values but I think that it could be 
enhanced by highlighting whether the results in the graph are significant. This could 
be as a note on the graph. It would allow a user to automatically see if the results 
from various experiments were significant. This could be achieved as a significance 
column or the p_value header could have an extra clause which is significance. That 
is the user would change the header to p_value_0.05 meaning anything lower than 
0.05 would be highlighted as significant. This improvement would be especially 
useful for experiments that have multiple data points for each feature, users could see 








One limitation of GeneBook in its current state is that some webservices rely on 
locus tags. This means that novel genomes which haven’t been submitted to 
GenBank or Embl wouldn’t get any results in these widgets as there is no publically 
available data for these genomes. I think that the way to improve this would be 
through orthology. All webservices would try the genome’s locus tag and if this fails 
the ortholog’s locus tag would be submitted. This could be achieved in two ways: 
 
1) Extend the GeneBook database to include orthologs. This would be an extra 
entity that contains pairings of features that are calculated to be homologous. 
It would have a many to many relationship with the feature entity and use 
locus tag as the foreign key. The orthologs could be calculated by using 
reciprocal fasta against all the features available in GeneBook or by using the 
top hit from a BLAST search against nr. 
2) Calculate orthologs on the fly, the sequence would be submitted to a 
alignment tool like BLAST, the top hit would be parsed for its ID which 
would then be used as the query. 
 
Both options have their advantages and limitations. Option 1 would be faster as it is a 
simple query to the GeneBook database, however this method goes against the 
GeneBook model of a lightweight database with minimal information. Arguably a 
better ortholog might become available at a later date. Conversely, option 2 will be 
more up to date but it relies on a good internet connection and fast webservices, 
currently this could be a limitation but with the pace that internet speed is increasing 
there will become a point where the difference between running something locally 
and remotely will be negligible. 
4.5.2 New widgets 
With new tools and databases being developed constantly and a vast amount of 
resources already available the idea of developing a webservice to cover most areas 
of microbiology is well beyond the scope and timescale of this project. The paradigm 
of GeneBook is that if a user finds themselves repeatedly performing the same task 





looks at some webservices that weren’t developed but would be next given more 
time. 
  
I described using e-utilities to access the CDD and return lists of domains that match 
the query feature. The next step would be to develop a webservice that can visualise 
domains in the context of the sequence. An example of it use would be in 
conjunction with pseudogene assessment to see whether domains are disrupted. I 
have already shown webservices in GeneBook that can visualise sequence data. 
Using pfamscan would give the location of domains which could then be visualised 
using the Bio::Graphics package in Perl. 
 
Another widget I would like to develop would be a ‘note box’, allowing the user to 
make notes on the feature of interest that would be kept for future visits. This could 
be used to record discrepancies, perhaps links to literature of interest or some ideas. 
The obvious way of keeping the notes would be to add the records to a new entity in 
the database, this again, would not follow the GeneBook model but as the notes are 
limited to GeneBook perhaps this would be acceptable. However, a really exciting 
and novel method recording notes would be to develop a webservice that connects to 
note taking services like EverNote. In the case of Evernote this could be achieved via 
their cloud API [238], With this sort of webservice a user could make a note about a 
particular feature in the note taking software which could then be accessed via 
GeneBook when looking at the respective feature. 
4.5.3 Next steps 
If I had more time I would extend the search functionality of GeneBook. Rather than 
just looking at features users could look at a region of a genome either by giving two 
base locations or stating how far up and downstream of a feature they would like to 
look. This could rely on both locus tag/identifiers and sequence based queries. 
Regional searches would also entail some new webservices, perhaps looking for 










The next major task in terms of searchability would be to allow genome wide 
searches. Allowing the user to submit a sequence as the query, which returns 
features/regions which are encompassed. Another genome wide search would be to 
query an external resource which returns a list of features that match the query. For 
example the user could submit a sequence this is queried against KEGG which 
returns a list of all the genes (within GeneBook) that are part of the same reaction in 
the same pathway. This list would then allow users to interrogate GeneBook based 
the results of their complex query. These genome wide searches could be extended to 
personal datasets, for example the scripts used for the enrichment analysis could be 
applied to certain datasets and bring back a list of enriched features.  
4.5.4 Improving the system 
There are several areas that would benefit from development that are not user-
oriented, they are behind the scenes but affect operability. 
 
A really interesting route with GeneBook would be to explore the possibility of not 
having a database at all. That means that all information would be obtained via 
webservices. For example the user would enter a protein ID of interest and genome 
ID. This query would shoot off to RefSeq and return the sequence for the given 
feature, it would also return the results from a protein database like UniProtKB. 
These results would then be sent off as queries against all the webservices that form 
the widgets in GeneBook. This would basically mean that GeneBook is a tool for 
integrating different web sources without holding any information at all. As far as the 
user is concerned the front end of GeneBook could be exactly the same, however 
behind this interface there would not be a database. One limitation of this method is 
that it would require a very fast internet connection and fast webservices as two 
waves of queries are fired off to remote data sources. However, this method would 
mean that genomes would never need to be uploaded to GeneBook, it could adapt to 
any publically available genome, or private genomes on an ftp site.  
 
In conclusion, the state that GeneBook is in currently gives users the power to see 





extend this resource and this section covers some diverse options. I believe that with 
the advances in internet speed the concept of developing GeneBook to hold no 
biological data is a feasible possibility and would serve to truly give users the most 












This chapter consolidates the previous chapters, giving an overview of the project 
and drawing conclusions from all of the pieces of work. 
 
Bacterial genome sequencing has moved from sequencing one clonal bacterium to 
projects where thousands of bacteria are sequenced from the same population either a 
specific serovar or a metagenome to find bacterial variation or species distribution 
respectively. With this in mind the bottle neck in the process will be annotation and 
analysis. There are now annotation tools that can transfer annotation very quickly 
[151], but the problem still remains that relying on orthology means that the 
annotation is only as good as the genome it is transferred from. Also, if we are 
looking for differences and novelty in these genomes, these areas might be missed as 
by their very nature they are novel, there won’t be any information to transfer across. 
The Shiga toxin in Escherichia coli O104:H4 (the strain that caused the outbreak in 
2011) was missed during annotation transferral because it was in an HGT island. 
This was the crucial part of the genome that explained its high virulence. Only after 
careful review by multiple groups did they find the toxin [50]. In order to get a 
reasonable quality annotation there is still a requirement for manual 





low, compromising the quality of the overall annotation. In fact for most of these 
studies the genomes are never submitted to public repositories. 
 
Further to the bottleneck created by big sequencing projects, there is also the deluge 
of quantitative post-genomic data. NGS technology has brought new technologies 
like RNA-seq and TraDIS in its wake. Although they have had teething problems, 
the experiments are at a point where the sequencing/experimental stage is negligible 
compared to the analysis. 
 
Our sequencing effort has barely scratched the surface in terms of mass genome 
sequencing efforts. However the project does have merit. The four serovars, that we 
sequence in chapter 2, are of high biological interest, all isolated from infected hosts, 
important food-producing animals, all with known, well defined pathogenicity. 
These genomes can answer genotypic questions based on very specific phenotypes. 
With that in mind the fact that these are publicly available and more strains from the 
same serovars are being sequenced means that we have more scope for robust 
analyses of known traits. 
 
S.enterica serves as a good model for pathogenicity studies. It is growing to be an 
important systemic human pathogen in developing countries and is associated with 
foodborne disease in the UK [6, 12]. It has a broad range of hosts and different 
serovars cause varying degrees of infection. The relationship between pathogenicity 
and host specificity is a complex one. The host pathogenicity model can be broadly 
summarised as servoars with a wide host range cause less severe infection and those 
which are restricted to one host cause severe systemic infection. Chapter 3 took the 
well-defined phenotypes from our serovars and used functional enrichment analysis 
of pseudogene formation in pathways and mutagenesis data to explore this model. 
This analysis forms a good foundation for building hypotheses around the 
Salmonella host specificity and pathogenicity model. For example, only the host 
generalist, S. typhimurium maintained had no pseudogenes/absences in Fructose 
metabolism, implying a link between gut colonisation and Fructose metabolism. 








Typhimurium to colonise all hosts. The next steps with this analysis is to test some of 
the hypotheses formed by performing knockouts. 
 
The analysis of pathways is limited by the arbitrary method that we define them, the 
proof of concept for network analysis of the entire KEGG network showed that this 
type of analysis is hindered by file formatting and the fact that clustering of man-
made networks tends to result in a skewed hairball structure, with a few nodes 
partaking in most of the interactions rather than the ideal network (for clustering 
purposes) that would have a similar frequency of interactions for each node. In order 
to perform an analysis that avoids the described bias in KEGG pathways, the analysis 
could be repeated using GO terms or a network of the TraDIS data could be made 
and the KEGG pathways could be mapped to this. 
 
 Assimilating different data at a genomic level is no mean feat, in terms of writing 
scripts, there are always exceptions to the defined rules which are missed and as 
previously discussed, orthology mapping isn’t without its flaws. Even with its 
complexity, genome-scale analysis and integrating different datasets can lead to 
insights into Salmonella biology. This type of analysis is useful as it brings forth 
areas for hypothesis testing, but needs to be followed up by targeted experimental 
validation before any hard conclusions can be drawn. 
 
The analysis in chapter 3 took a site wide approach to bacterial genomics. On the 
other hand chapter 4, the development of GeneBook took a feature level stance. The 
fact that a person is searching for a feature on a genome browser means that it is of 
some biological interest to them, whether they came across a gene in a paper or they 
have a feature that came up as significant during experimental validation. With the 
pace that data is being produced, it is not easy to keep up to date. GeneBook uses 
webservices to take the data directly from the primary source. Beyond being used as 
a general feature browser, user can upload their own data and see it in the context of 
public data and their other private datasets. Currently this type of activity would 
require multiple windows open compared to a simple point and click offered by 





presented at several conferences and shown to colleagues. It has received good 
feedback with people recognising that it fills a unique niche. To take the GeneBook 
project forward beta-testing is required, with critical feedback being returned. The 
development of GeneBook so far doesn’t offer a genome wide analysis, rather it 
serves as a means of viewing features of interest in the context of multiple, 
potentially remote, datasets. In terms of future work this is described in great detail 
in section 4.5, but one particular area of development that I would like to pursue is 
the direct enrichment analysis of data to provide lists of interest as a means of 
interrogating GeneBook, this would be achieved by modifying the scripts used in 
chapter 3 to be able to take generic quantitative data. In terms of priority areas of 
development for a beta-testing standard version I feel that automatic ortholog 
mapping will increase the functionality for genomes that have little data in the public 
domain, also increasing the functionality beyond basic gene feature to regions would 
increase the kinds of data available for GeneBook. 
 
Another logical step forward would be towards complete use of webservices, that is 
no underlying database, thus truly following the dynamic up-to-date paradigm of 
GeneBook. This is a foreseeable step as we are on the verge of the super-fast internet 
era.  
 
With the future of bacterial genomics moving towards thousands of genomes being 
sequenced we need to consider what happens to these genomes. Where are they 
stored, are they annotated? The manual aspect is no longer feasible. We are moving 
away from good quality annotations, the premise of gold standard genomes, outlined 
in section 2.4.3 could form a basis for improving quality. If this was integrated with 
webservices providing the most up to date information there would be less need for 
storing data in multiple places rather it would be accessed remotely when required 
reducing the risks of becoming obsolete and out of date. This project has shown the 
different aspects of bacterial genome analysis from sequencing and annotation of 
four serovars of biological interest through to analysis of the serovars and integration 
with other data type and finally visualisation of bacterial genomes in context of these 








specificity are complex, although there are no smoking guns this analysis has shown 
that it is possible to find patterns in pathways and patterns between mutagenesis in a 
host generalist and orthologs for the corresponding host using genome wide methods 
















Appendix A Files and Scripts 
All of the files and scripts are located on the disk provided and can also be found at 
https://github.com/limeyloos/GeneBook, they are described in the 






Appendix B Full description of the submission process into GenBank 
Submission process 
The genomes were all annotated based on genomes available in GenBank and 
UniprotKB. Based on this our genomes were submitted to GenBank after they were 
annotated according to the method in 2.2.3. The sequences and their corresponding 
files were uploaded using the genome submission tool [153] 
 
These annotations were not accepted by GenBank based on various annotation 
discrepancies (described in 2.3.1). The volume of these was so large that scripts were 
needed to process the discrepancies. Below are the steps used to make further 
submissions ultimately meeting GenBank’s new annotation standards.  
2nd Submission 
Asn2disc, the NCBI programme for detecting annotation discrepancies 
(http://www.ncbi.nlm.nih.gov/GenBank/asndisc.html), was run against our primary 
submissions. Figure A1 shows an example of a discrepancy file summary. 
 
All types of hypothetical proteins (including those labelled as ‘conserved 
hypothetical protein’ and ‘putative uncharacterized 
protein’) were extracted (Appendix A: get_hyp_prot.pl) and BLASTed against 
Swissprot and TREMBL.  
 
The script parseBLAST2GenBank.pl was used to parse the BLAST results into 
the annotation (Appendix A: parseBLAST2GenBank.pl). Each hypothetical protein 
was checked for a hit (>85% across the length of the hit and the length query and 
>75% identity) to Swissprot, and failing that a hit to TREMBL, if there were no hits 
the annotation remained as a hypothetical protein (if the annotation was originally 
‘conserved hypothetical protein’ or ‘putative 
uncharacterized protein’ these were converted to ‘hypothetical 
protein’). The output consisted of both GenBank file format and tab-delimited. It 















Figure A1 Summary section from a discrep file produced by the software asn2disc. This shows the areas of 
genome annotation that need to be assessed for successful submission into GenBank. An example of a full 
discrepancy file is in Appendix A: full_discrepancy.txt 
  
Summary 
DISC_SOURCE_QUALS_ASNDISC:taxname (all present, all unique) 
DISC_FEATURE_COUNT:gene: 4518 present 
DISC_FEATURE_COUNT:CDS: 4145 present 
DISC_FEATURE_COUNT:tRNA: 75 present 
DISC_FEATURE_COUNT:rRNA: 22 present 
EXTRA_GENES:276 gene features are not associated with a CDS or RNA 
feature. 
DISC_COUNT_NUCLEOTIDES:1 nucleotide Bioseqs are present 
GENE_PRODUCT_CONFLICT:47 coding regions have the same gene name as 
another coding region but a different product. 
DUPLICATE_GENE_LOCUS:71 genes have the same locus as another gene on the 
same Bioseq. 
EC_NUMBER_NOTE:1 features have EC numbers in notes or products. 
OVERLAPPING_CDS:28 coding regions overlap another coding region with a 
similar or identical name. 
CONTAINED_CDS:42 coding regions are completely contained in another 
coding region. 
RNA_CDS_OVERLAP:9 coding regions overlap RNA features 
SUSPECT_PRODUCT_NAMES:132 product_names contain 'suspect phrase or 
characters' 
 1 product names end with binding 
 3 product names end with domain 
 1 product names end with repeat 
 1 product names contain 'Includes:' 
 1 product names contain 'Salmonella' 
 2 product names contain 'gene' 
 1 product names contain 'utilisation' 
 1 product names contain 'fold' 
 5 product names contain 'three or more numbers together, not after 
'UPF' or 'DUF' or 'IS' and not followed by the word 'family' and not 
preceded by either 'cytochrome' or 'coenzyme'' 
 66 product names contain 'Brackets or parenthesis [] ()' 
 1 product names contain 'containg' 
 1 product names contain 'dependant' 
 1 product names contain 'disulphide' 
 2 product names contain 'golgi' 
 1 product names contain 'haem' 
 1 product names contain 'homeserine' 
 1 product names contain 'hpothetical' 
 1 product names contain 'hpothetical' 
 1 product names contain 'puative' 
 1 product names contain 'puative' 
 1 product names contain 'putaive' 
 1 product names contain 'putatve' 
 1 product names contain 'signalling' 
 2 product names contain 'sulpho' 
 1 product names contain 'C-term' 
 1 product names contain 'N-term' 
 10 product names contain 'Two or more sets of brackets or 
parentheseis' 
 1 product names contain 'double space' 
 2 product names contain '_' 
 3 product names contain 'ending with period, comma, hyphen, 
underscore, colon, or forward slash' 
 15 product names contain 'may contain a plural' 
 1 product names contain 'unbalanced brackets or parentheses' 
N_RUNS:1 sequences have runs of 20 or more Ns 









Many of the annotations still had suspect names according to the discrepancy file but 
we believed that because they hit proteins in reference genomes with functional 
domains that these names would be acceptable. However, this was not the case, 
communication with the GenBank submission team returned this statement: 
 
 
Figure A2 Excerpt from email communication with GenBank Sequence Submission staff explaining why 
transferred description can lead to poor annotation. 
With the explanation from the GenBank submission staff in mind Asn2disc was run 
against this annotation to get discrepancies. The number of suspect proteins was so 
large that a script, get_bad_anno_prots.pl was written to extract the FASTA 
sequences for the suspect protein names (according to the discrepancy file) 
(Appendix A: get_bad_anno_prots.pl). These were then BLASTed and added to the 
annotation using parseBLAST2GenBank.pl (as described previously). Any 
suspect proteins which did not hit Swissprot or TREMBL within the previously 
stated thresholds were manually checked and corrected. This output was converted to 
.sqn as before and these sequences were then checked manually for the overlap 
discrepancies (RNA_CDS_OVERLAP, OVERLAPPING_CDS and 
CONTAINED_CDS). If the overlap discrepancies were the same as the reference 
genome or a hit to Swissprot/TREMBL then they were accepted. If the overlap 
discrepancies were not present in the reference genome and they had no domains 
(according to a pfam search [62]) they were removed from the annotation. This was 
then converted into .sqn (and the other appropriate files) again and submitted to 
GenBank. 
 
“It's an ongoing process to improve annotation on new submissions, rather than 
just duplicating poor annotation on old submissions. Therefore, we appreciate 







All of the overlap discrepancies that were kept in the 3
nd
 submission were present in 
reference genomes or UniprotKB. They were kept even if they were very short or did 
not have domain because of their high conservation to other genomes. 
Communication with the GenBank submission team (Figure ) explained that 
overlapping proteins are rare in bacterial genomes and that conservation across 
genomes does not indicate a true CDS. 
 
 The script remove_bad_hyps.pl was written to take all the CDS with an 
overlap discrepancy and remove those which are less than 250bp and labelled as a 
hypothetical protein (Appendix A: remove_bad_hyps.pl). This reduced the list 
enough for manual annotation. The remaining overlapping proteins were checked for 
domains using pfam scan, if they were hypothetical and had no domains they were 
removed from the annotation. At this point any other discrepancies were checked 
manually, some discrepancies were kept in the annotation because upon closer 
inspection they weren’t misannotations (explained in section 2.3.2.1). 
 
 
Figure A2 Excerpt from email communication with GenBank Sequence Submission staff explaining that 
the fact that 'protein' appears in TREMBL does not mean that it a true protein, especially if it overlaps 
other better annotated proteins. 
“I have been discussing the Salmonella annotation with our Reference sequence 
staff. They are looking into correcting the reference genomes since these were 
annotated before we had all of the current checks in place. All of the proteins 
from these reference genomes were propogated into other databases, such as 
TREMBL. Therefore, matching something in TREMBL is not grounds for keeping 
it as that is an uncurated archive. We strongly recommend that you not include 
CDS features that are completely contained in other CDS features. There are 
some very large proteins in bacteria, but they are usually polyketide synthases 
and have domain hits that show this. A protein that has no domain hits (or is 
called "hypothetical protein") and overlaps a protein with a 'real' name is likely 
an artifact. Please review the overlapping CDS hits and only keep the ones that 








Appendix C  Pathways that have functional genes but no pseudogenes across any serovar  
Description 
Gene totals for each pathway Expected pseudogene totals for each pathway 
Gallinarum 
Choleraesui





Nucleotide Metabolism 104 101 102 99 
 
4 2 1 0 
Purine metabolism 80 77 78 75 
 
3 1 1 0 
Replication and Repair 57 55 59 59 
 
2 1 1 0 
Pyrimidine metabolism 53 51 51 51 
 
2 1 1 0 
Folding, Sorting and Degradation 49 47 47 48 
 
2 1 1 0 
Citrate cycle (TCA cycle) 32 32 33 33 
 
1 1 0 0 
Aminoacyl-tRNA biosynthesis 28 27 28 28 
 
1 0 0 0 
Homopercous recombination 28 27 28 29 
 
1 0 0 0 
Lipopolysaccharide biosynthesis 27 27 27 27 
 
1 0 0 0 
Propanoate metabolism 25 24 24 26 
 
1 0 0 0 
Galactose metabolism 23 26 21 25 
 
1 0 0 0 
Phenylalanine, tyrosine and 
tryptophan biosynthesis 23 23 23 23 
 
1 0 0 0 
Mismatch repair 23 22 25 25 
 
1 0 0 0 
Glycerolipid metabolism 18 19 17 18 
 
1 0 0 0 
Ubiquinone and other terpenoid-
quinone biosynthesis 18 18 18 18 
 
1 0 0 0 
Lysine biosynthesis 18 18 18 18 
 
1 0 0 0 
Protein export 18 17 16 18 
 
1 0 0 0 
DNA replication 18 16 19 19 
 






Nicotinate and nicotinamide 
metabolism 16 16 17 16 
 
1 0 0 0 
Sulfur relay system 16 15 17 16 
 
1 0 0 0 
RNA degradation 15 15 14 14 
 
1 0 0 0 
Base excision repair 14 14 13 14 
 
1 0 0 0 
Folate biosynthesis 14 13 14 15 
 
1 0 0 0 
Histidine metabolism 13 14 13 13 
 
1 0 0 0 
One carbon pool by folate 13 11 14 12 
 
1 0 0 0 
Fatty acid biosynthesis 12 12 12 12 
 
0 0 0 0 
Terpenoid backbone biosynthesis 12 12 12 12 
 
0 0 0 0 
Biosynthesis of Other Secondary 
Metabolites 12 9 12 14 
 
0 0 0 0 
RNA polymerase 10 10 10 9 
 
0 0 0 0 
Transcription 10 10 10 9 
 
0 0 0 0 
Riboflavin metabolism 9 9 9 9 
 
0 0 0 0 
Nucleotide excision repair 8 8 8 8 
 
0 0 0 0 
Streptomycin biosynthesis 8 5 8 10 
 
0 0 0 0 
Lysine degradation 7 8 8 7 
 
0 0 0 0 
Biotin metabolism 6 7 7 6 
 
0 0 0 0 
Biosynthesis of unsaturated fatty 
acids 6 6 6 6 
 
0 0 0 0 
Biosynthesis of siderophore 
group nonribosomal peptides 6 6 6 6 
 
0 0 0 0 
Phenylalanine metabolism 5 6 6 6 
 
0 0 0 0 
D-Glutamine and D-glutamate 
metabolism 5 5 5 5 
 








Polyketide sugar unit 
biosynthesis 5 2 5 5 
 
0 0 0 0 
Novobiocin biosynthesis 4 4 4 4 
 
0 0 0 0 
Phosphonate and phosphinate 
metabolism 4 4 4 4 
 
0 0 0 0 
D-Alanine metabolism 4 4 4 4 
 
0 0 0 0 
Taurine and hypotaurine 
metabolism 4 3 4 3 
 
0 0 0 0 
Aminobenzoate degradation 3 4 4 4 
 
0 0 0 0 
Dioxin degradation 3 3 3 3 
 
0 0 0 0 
Lipoic acid metabolism 3 3 3 2 
 
0 0 0 0 
Inositol phosphate metabolism 2 2 2 6 
 
0 0 0 0 
Sphingolipid metabolism 2 2 2 3 
 
0 0 0 0 
Arachidonic acid metabolism 2 2 2 2 
 
0 0 0 0 
Limonene and pinene 
degradation 2 2 2 2 
 
0 0 0 0 
Caprolactam degradation 2 2 2 2 
 
0 0 0 0 
Polycyclic aromatic hydrocarbon 
degradation 1 2 1 2 
 







Appendix D Pathways that have pseudogenes across every serovar 
pathway description Total gene counts for each pathway Observed pseudogene counts for each pathway 
Gallinarum Choleraesuis Dublin Typhimurium Gallinarum Choleraesuis Dublin Typhimurium 
2 Metabolism 705 690 695 712  22 11 10 3 
01100 Metabolic 
pathways 
650 637 639 652  21 9 10 2 
8 Carbohydrate 
Metabolism 
305 297 293 321  17 9 7 2 
12 Membrane 
Transport 
265 267 272 277  15 5 7 1 
01110 Biosynthesis of 
secondary 
metabolites 





196 188 190 201  4 3 2 1 
1 Amino Acid 
Metabolism 
206 207 201 206  10 2 1 2 
18 Energy Metabolism 139 129 133 136  4 3 1 1 
02060 Phosphotransferase 
system (PTS) 




34 32 27 37  2 1 1 1 
00910 Nitrogen 
metabolism 

















STM0018 yes Putative chitinase  
STM0032 ABSENT arylsulfatase  
STM0033 ABSENT 5'-nucleotidase  
STM0035 YES arylsulfatase  
STM0293 ABSENT hypothetical protein  
STM0305 ABSENT hypothetical protein  
STM0517 YES glyoxylate carboligase (EC:4.1.1.47) stm00630 Glyoxylate and dicarboxylate metabolism 
stm01100 Metabolic pathways 
STM0723 ABSENT ABC-type polysaccharide/polyol phosphate transport 
system ATPase component 
Stm02010 ABC transporters 
STM0810 YES inner membrane protein  
STM0810 YES inner membrane protein  
STM0810 YES inner membrane protein  
STM0859 yes LysR transcriptional regulator  
STM0859 yes LysR transcriptional regulator  
STM0859 yes LysR transcriptional regulator  
STM1018 ABSENT hypothetical protein  
STM1092 ABSENT hypothetical protein  






STM1094 ABSENT pathogenicity island-encoded protein D 
STM1094 ABSENT pathogenicity island-encoded protein D 
STM1332 ABSENT O-antigen polymerase  
STM1555 ABSENT transcriptional regulator  
STM1939 YES glucose-6-phosphate dehydrogenase 
STM2189 YES galactose/methyl galaxtoside transporter ATP-binding 
protein 
 stm02010 ABC transporters 
STM2189 YES galactose/methyl galaxtoside transporter ATP-binding 
protein 
 stm02010 ABC transporters 
STM3083 yes Putative mannitol dehydrogenase  
STM3254 ABSENT fructose-1-phosphate kinase stm00051 Fructose and mannose metabolism 
STM3254 ABSENT fructose-1-phosphate kinase stm00051 Fructose and mannose metabolism 
STM3255 ABSENT phosphotransferase system fructose-specific component 
IIB (EC:2.7.1.69) 
stm00051 Fructose and mannose metabolism 
stm01100 Metabolic pathways 
stm02060 Phosphotransferase system (PTS) 
STM3255 ABSENT phosphotransferase system fructose-specific component 
IIB (EC:2.7.1.69) 
stm00051 Fructose and mannose metabolism 
stm01100 Metabolic pathways  
stm02060 Phosphotransferase system (PTS) 
STM3638 yes long polar fimbrial outer membrane usher protein 
STM4204 yes inner membrane protein  
STM4204 yes inner membrane protein  
STM4204 yes inner membrane protein  
STM4204 yes inner membrane protein  
STM4213 yes Phage tail sheath protein  
STM4413 yes metallo-dependent hydrolase  








STM4413 yes metallo-dependent hydrolase  
















Appendix G The domains associated with STM0018 and their 
descriptions 
cd06548 GH18_chitinase 
The GH18 (glycosyl hydrolases, family 18) type II chitinases hydrolyze chitin, an 
abundant polymer of N-acetylglucosamine and have been identified in bacteria, 
fungi, insects, plants, viruses, and protozoan parasites. The structure of this domain is 
an eight-stranded alpha/beta barrel with a pronounced active-site cleft at the C-
terminal end of the beta-barrel. 
cl00046 ChtBD3 
This group contains proteins related to the cellulose-binding domain of Erwinia 
chrysanthemi endoglucanase Z (EGZ) and Serratia marcescens chitinase B (ChiB). 
Gram negative plant parasite Erwinia chrysanthemi produces a variety of 
depolymerizing enzymes to metabolize pectin and cellulose on the host plant. 
Cellulase EGZ has a modular structure, with an N-terminal catalytic domain linked 
to a C-terminal cellulose-binding domain (CBD). CBD mediates the secretion 
activity of EGZ. Chitinases allow certain bacteria to utilize chitin as a energy source. 
Typically, non-plant chitinases are of the glycosidase family 18. Bacillus circulans 
Glycosidase ChiA1 hydrolyzes chitin and is comprised of several domains: the C-
terminal chitin binding domain, an N-terminal catalytic domain, and 2 fibronectin 
type III-like domains. Bacillus circulans WL-12 ChiA1 facilitates invasion of fungal 
cell walls. The ChiA1 chitin binding domain is required for the specific recognition 
of insoluble chitin. although topologically and structurally related, ChiA1 lacks the 
characteristic aromatic residues of Erwinia chrysanthemi endoglucanase Z 
(CBD(EGZ)). Streptomyces griseus Chitinase C is a family 19 chitinase, and consists 
of a N-terminal chitin binding domain and a C-terminal chitin-catalytic domain that 
effects degradation. ChiC contains the characteristic chitin-binding aromatic 
residues. Chitinases function in invertebrates in the degradation of old exoskeletons, 
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